Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42754,-0.206547888404253,0.00505738006030621,-0.216460353322453,-0.196635423486053,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.137166430379825,0.00321885819406735,0.130857468319453,0.143475392440197,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,42346,-0.532933769457455,0.0122585646457678,-0.55696055616316,-0.508906982751751,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.235485643131981,0.00490120364615255,-0.24509200227844,-0.225879283985522,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42611,-0.209032254488992,0.00414817208348876,-0.21716267177263,-0.200901837205354,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42721,-0.28023213165007,0.0062245719003897,-0.292432292574834,-0.268031970725306,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.113874914971834,0.00278950660064138,0.108407482034577,0.119342347909091,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.175418008775895,0.00398738721579777,-0.183233287718859,-0.167602729832931,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42568,-0.175229523078283,0.00409100713380421,-0.18324789706054,-0.167211149096027,0
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,40539,0.266722965490408,0.00674586014532403,0.253501079605573,0.279944851375243,1.11253692925461e-308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,40511,-0.319199129957021,0.00808656129171913,-0.335048790088791,-0.303349469825252,1.11253692926474e-308
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42636,0.169227442190076,0.00460943277840824,0.160192953944396,0.178261930435756,2.71496679687982e-281
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.118748976719567,0.00328382272094677,0.112312684186512,0.125185269252623,2.54049519514854e-273
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.106657010559503,0.0030213221207166,-0.112578801916107,-0.100735219202898,5.04631449782279e-261
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,40532,0.0819038438017324,0.00236454876929336,0.0772693282139174,0.0865383593895473,5.40167580288842e-250
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.410119873271017,0.0119594374014354,0.386679375964203,0.43356037057783,3.04465332291418e-247
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42587,-0.300536098955963,0.00910429664560371,-0.318380520381347,-0.28269167753058,8.16328725496185e-230
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9,Complement component C9,40532,0.171197098530668,0.00529483784590032,0.160819216352703,0.181574980708632,1.84668217801289e-219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.108798874715742,0.00344515165165357,-0.115551371952983,-0.102046377478501,2.91690922331339e-211
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42611,-0.128588934590405,0.00410609981098416,-0.136636890219934,-0.120540978960877,7.63012904255132e-208
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,40116,-0.318239073531311,0.01023805291851,-0.338305657251591,-0.298172489811031,2.42190335022301e-203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.211123171802889,0.0068595530662051,-0.224567895812651,-0.197678447793127,6.20757577200937e-201
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42661,-0.245424605996083,0.00812358909329053,-0.261346840618933,-0.229502371373234,4.64701619590053e-194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42655,-0.101930629765817,0.00338076570279061,-0.108556930543287,-0.0953043289883475,2.64216144412707e-193
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42636,-0.181122384652763,0.00607251716872775,-0.193024518303469,-0.169220251002056,2.42682871213734e-189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42569,-0.220037225599358,0.00738992146164712,-0.234521471664186,-0.20555297953453,1.0897454198706e-188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42752,0.106751968899012,0.00359819011820355,0.0996995162673328,0.113804421530691,1.80749605679104e-187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,40511,-0.267593837322338,0.00900096470234653,-0.285235728138937,-0.249951946505739,4.43356782751451e-187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.0926653308668463,0.00312952423062988,0.0865314633748117,0.0987991983588808,1.63513799398331e-185
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.406895319286716,0.0139035643182378,-0.434146305350462,-0.37964433322297,1.32550354249944e-182
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FURIN,Furin,42679,-0.0954051043618547,0.00328021221861559,-0.101834320310341,-0.0889758884133681,1.94568392752341e-180
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.237568327078355,0.0081911542996016,-0.253622989505574,-0.221513664651136,2.46857902224767e-179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.155929923457152,0.00540690256663378,-0.166527452487754,-0.14533239442655,1.73032909270447e-177
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.157853593594247,0.00552495261902181,-0.16868250072753,-0.147024686460964,2.16162712758572e-173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,42370,-0.228815950036271,0.0080372161507369,-0.244568893691715,-0.213063006380827,4.56949282221394e-173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42618,-0.162250047942947,0.00571358659458071,-0.173448677668325,-0.151051418217569,2.57386448078498e-172
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42663,0.0807823541310947,0.0028473050891331,0.0752016361563938,0.0863630721057956,4.94096814491162e-172
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.093336646835092,0.00333347192675863,-0.0998702518115389,-0.0868030418586451,9.93646974516996e-168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.328687407822525,0.0117998461880218,-0.351815106351048,-0.305559709294002,4.43386814178869e-166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.130929481399538,0.00474434707855197,-0.1402284016735,-0.121630561125576,3.87171726682145e-163
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,40532,0.136027135705108,0.00510859924784217,0.126014281179337,0.146039990230878,1.42355528372079e-151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.10321905369075,0.0038914584836775,0.0955917950627426,0.110846312318758,3.85135602492697e-151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,40033,0.116530645600082,0.00439470492398575,0.10791702394907,0.125144267251094,3.64431256143534e-150
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.0867333030384661,0.00331447030994559,-0.0932296648459594,-0.0802369412309727,2.75439978216266e-147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42794,-0.137008779083832,0.00528612360026321,-0.147369581340348,-0.126647976827316,1.29695484568215e-144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.145565072632632,0.00563506582136879,-0.156609801642515,-0.134520343622749,1.40909443133402e-143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.0882212484200017,0.00345055800449864,-0.094984342108819,-0.0814581547311843,8.63242187576327e-141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0562170310564974,0.00220873531510447,0.0518879098388926,0.0605461522741021,1.26525244438911e-139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42587,-0.143800141429628,0.0056525968912488,-0.154879231336476,-0.132721051522781,1.8335597955223e-139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42611,0.0700221680556125,0.00275952949885431,0.0646134902378581,0.075430845873367,8.76504745438274e-139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,40283,-0.0726057210737579,0.00287422699030568,-0.078239205974757,-0.0669722361727588,6.1104021553749e-137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42621,0.114643318764981,0.00455364537846024,0.105718173823199,0.123568463706763,1.05620851839743e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.138900896458337,0.00552356568020929,-0.149727085191547,-0.128074707725126,2.17348622720736e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.082280596316415,0.0032689580619529,-0.0886877541178427,-0.0758734385149873,6.57552837344496e-136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.078083535588603,0.00313930019136725,-0.0842365639636828,-0.0719305072135232,1.54449240189615e-133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,40182,-0.206729065820886,0.00829801638319205,-0.222993177931942,-0.190464953709829,2.57497715793588e-133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.135387505663987,0.00545884000153891,-0.146086832067003,-0.124688179260971,9.39893666026756e-133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42754,-0.0730161796554745,0.00294589256523564,-0.0787901290833363,-0.0672422302276126,1.12030599740135e-132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41747,-0.105469471667146,0.00427137028571049,-0.113841357427139,-0.0970975859071536,1.73059690871556e-131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.206080887713741,0.00835599769959278,-0.222458643204943,-0.189703132222539,2.21982766228116e-131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,42311,-0.129048422773188,0.00530887708092364,-0.139453821851799,-0.118643023694578,1.05394246549267e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0865945241385143,0.00356742794112573,-0.0935866829031207,-0.0796023653739079,1.97829344968171e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.082760258006131,0.0034160457656937,0.0760648083053714,0.0894557077068907,5.84560431847077e-127
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42600,-0.2519497138367,0.0105248666349004,-0.272578452441105,-0.231320975232295,4.79192321370502e-124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0643062083481914,0.00270679572132517,-0.0696115279619887,-0.059000888734394,9.44639429109932e-122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,40267,-0.0896374880537711,0.0037880874908492,-0.0970621395358355,-0.0822128365717067,8.38210095336191e-121
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.167086113856693,0.00707994798840137,-0.180962811913959,-0.153209415799426,1.10360816458174e-120
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42674,-0.111684107744075,0.00474435283917782,-0.120983039308864,-0.102385176179287,4.10357001875234e-120
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.358180537401425,0.0152435957265884,-0.388057985025538,-0.328303089777311,1.18448852156318e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.0729873569944401,0.00311819471356156,-0.0790990186330207,-0.0668756953558594,8.5031068287464e-119
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.202219471095723,0.00867875189177122,-0.219229824803594,-0.185209117387851,2.53339303510198e-117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0741500387737804,0.00319715318450146,-0.0804164590154033,-0.0678836185321576,1.00648515036916e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.0790510094883173,0.00341313710795827,-0.0857407582199155,-0.072361260756719,2.15957845176562e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42663,-0.0425167710880279,0.00183624938212063,-0.0461158198769843,-0.0389177222990714,2.43475138202616e-116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFM,Afamin,40539,-0.0467663476094448,0.00202744890474345,-0.0507401474627419,-0.0427925477561476,4.34962185814378e-115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.124575690457532,0.00542215810947596,0.113948260562959,0.135203120352105,1.42245337132221e-114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.17590673435226,0.00764538779341819,-0.190891694427359,-0.16092177427716,1.62205352820357e-114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.150368782317756,0.00655524622859792,-0.163217064925808,-0.137520499709705,3.28231195757121e-114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.14417012748135,0.00631120980831442,0.131800156257054,0.156540098705646,2.29554020152386e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.177325302724578,0.00776498547703403,-0.192544674259564,-0.162105931189591,3.12365813951898e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42754,-0.080834770058428,0.00354132309787721,-0.0877757633302673,-0.0738937767865886,3.38463533885548e-113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.186876924753919,0.00820909962813532,-0.202966760025064,-0.170787089482773,1.389990886688e-112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.126699348602806,0.00558061407267418,-0.137637352185247,-0.115761345020364,5.86793474912924e-112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.0782203878680657,0.0034759474346166,0.0714075308962172,0.0850332448399142,3.90180649097788e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0845273631330864,0.00375908706171158,-0.0918951737740411,-0.0771595524921317,5.88994079307526e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.181540073308832,0.00807807610489528,-0.197373102474426,-0.165707044143237,8.04980508512864e-110
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42706,-0.0477704711095378,0.00213315819176524,-0.0519514611653977,-0.043589481053678,4.27840619638789e-109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.134049915767292,0.0060154117422692,-0.145840122782139,-0.122259708752444,5.16226518919459e-108
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42611,-0.0703368139358872,0.00317917274875899,-0.0765679925234548,-0.0641056353483195,1.46940120964196e-106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42587,-0.182139793441368,0.00827652003894004,-0.19836177271769,-0.165917814165045,1.81402854543597e-105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42721,0.0804814898824876,0.00367299936441961,0.0732824111282252,0.0876805686367501,1.31415885814297e-104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.107457605539783,0.00491940186387944,-0.117099633192986,-0.0978155778865788,6.03808835303407e-104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,40527,0.134341386649934,0.00614604568298961,0.122295137111274,0.146387636188594,8.8938680786284e-104
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42654,0.044201361239608,0.00202921436217539,0.0402241010897442,0.0481786213894717,2.05777784149938e-103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42754,-0.0587576092457496,0.0027129521684498,-0.0640749954959113,-0.053440222995588,2.73035469356543e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,40424,-0.0558294706477667,0.002574181641747,-0.0608748666655908,-0.0507840746299426,3.26033320325109e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0534797633272239,0.00247566465166949,-0.0583320660444961,-0.0486274606099517,8.98407234848626e-102
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0663131913572063,0.00307700640007965,0.0602822588130502,0.0723441239013624,2.62929147031147e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42636,-0.0750274240278743,0.00349147364744111,-0.0818707123768589,-0.0681841356788898,9.74103564531419e-101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.176935427227694,0.00830099714139503,-0.193205381624829,-0.16066547283056,3.63081153966681e-99
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.0613545169028377,0.00288214225053031,-0.0670035157138771,-0.0557055180917983,1.24644492104056e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.187049779206101,0.00881599990430206,-0.204329139018533,-0.169770419393669,2.73145271645596e-98
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.078847149915507,0.00372991325416325,-0.0861577798936669,-0.071536519937347,1.38786938501623e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.174768476983461,0.00828803346453749,-0.191013022573954,-0.158523931392967,4.21595550541686e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.0481077852769306,0.00228396934159234,-0.0525843651864516,-0.0436312053674096,6.24899473347982e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.0735583997490202,0.0034869966006681,-0.0803929130863297,-0.0667238864117107,6.35621744790363e-97
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0846822257358624,0.00403383863295879,-0.0925885494564617,-0.0767759020152632,2.54603815465536e-96
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.15868249247992,0.00756990294053919,-0.173519502243377,-0.143845482716463,9.44777298276258e-96
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.11757805397395,0.00567001588675815,-0.128691285111996,-0.106464822835904,5.09713618826496e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.220839359639434,0.010657707273489,-0.241728465895472,-0.199950253383395,6.59967538387865e-94
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0689430835848983,0.00336816092792544,-0.0755446790036322,-0.0623414881661645,9.83628164617412e-92
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0973284315537269,0.00475333687987623,-0.106644971838284,-0.0880118912691695,1.72415948380835e-91
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.0461990386113475,0.0022698667381599,-0.0506479774181409,-0.0417500998045541,1.78074184616859e-90
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.102802329931451,0.0050825032055133,-0.112764036214257,-0.0928406236486451,2.3076172778521e-89
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.0579640333552877,0.00287147374536731,-0.0635921218962077,-0.0523359448143678,4.73325428725738e-89
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0853659123919591,0.00424840899360161,-0.0936927940194182,-0.0770390307644999,1.62228487321373e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,42326,-0.122747336091254,0.00611840466987715,-0.134739409244213,-0.110755262938295,3.30755398595535e-88
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42754,-0.0626166965748365,0.00314070884543197,-0.0687724859118832,-0.0564609072377899,3.42554533612588e-87
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0813514216493423,0.0040979406200308,-0.0893833852646027,-0.0733194580340819,1.79047726960773e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.102445430921142,0.00516139907020939,-0.112561773098753,-0.0923290887435318,1.9097231000111e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0550451860151025,0.00277323945071308,0.0496096366917049,0.0604807353385001,1.94731890629525e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42636,-0.119605391931112,0.00602632290727234,-0.131416984829366,-0.107793799032858,2.00601662472191e-86
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0804091514776433,0.00407087683105036,-0.088388070066502,-0.0724302328887846,1.26278813862869e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42611,-0.111871675101108,0.00567039433917532,-0.122985648005892,-0.100757702196324,1.96365448733069e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.096702350364284,0.00490950938383709,-0.106324988756605,-0.0870797119719633,3.79504108683477e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42754,-0.0893033650819731,0.00454124591817385,-0.0982042070815939,-0.0804025230823524,6.53554837826408e-85
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,40223,-0.12579490129041,0.00641045819129959,-0.138359399345358,-0.113230403235463,2.652576047733e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42659,0.107916546482076,0.00551230830394347,0.0971124222063463,0.118720670757805,3.55470269839572e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.114538833587816,0.00584323999501063,-0.125991583978037,-0.103086083197595,3.98707318840359e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0841189812692111,0.0042981245282754,-0.0925433053446309,-0.0756946571937913,3.99461647239889e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.078713521707783,0.0040291714434949,0.070816345678533,0.086610697737033,7.93795171403471e-84
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.143821901125885,0.00741705751949395,-0.158359333864093,-0.129284468387676,2.02927061174041e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.116359262555085,0.00600519328008841,-0.128129441384059,-0.104589083726112,2.82215468499526e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,40482,-0.0873658934980551,0.00451394813054699,-0.0962132318339272,-0.078518555162183,3.96071197028175e-82
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.162467524533342,0.00845417510493233,-0.179037707739009,-0.145897341327674,3.37309090259392e-81
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42594,-0.0976524627435307,0.00512555045940488,-0.107698541643964,-0.0876063838430971,7.15604532978681e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42671,-0.0604579596339822,0.00317503210173515,-0.0666810225533831,-0.0542348967145814,8.56689688386629e-80
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.121730910894882,0.00639933358199232,0.109188217074177,0.134273604715587,1.24648168153538e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,40283,0.0453019244336299,0.00237955140461259,0.0406380036805892,0.0499658451866706,1.52356030151522e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.073832540210029,0.00387928254191463,-0.0814359339921817,-0.0662291464278764,1.68615066618107e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,40283,-0.0753642553282372,0.00397569773452683,-0.0831566228879098,-0.0675718877685647,6.88780208672414e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.107078287790913,0.00565799218028206,-0.118167952464266,-0.09598862311756,8.00885674226976e-79
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEP,Leptin,42636,-0.128413819447853,0.0067947520554966,-0.141731533476626,-0.11509610541908,1.21278671286602e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.100486592914249,0.00531578135073902,-0.110905524361697,-0.0900676614668002,1.74435121057742e-78
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42794,-0.0976002722126287,0.0051969422782945,-0.107786279078086,-0.0874142653471715,1.04920277827935e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.14094531778698,0.00751724859354398,-0.155679125030326,-0.126211510543634,1.94391913673759e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.052668112661608,0.00281075762372064,-0.0581771976041004,-0.0471590277191155,2.35415382274633e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.239347666230563,0.0127911195000627,-0.264418260450686,-0.21427707201044,3.71225598860433e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.055342277111273,0.0029603800537071,-0.061144622016539,-0.0495399322060071,5.13112489975979e-77
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42611,-0.043912303661831,0.00236904157360817,-0.048555625146103,-0.039268982177559,9.33478468089199e-76
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,40342,-0.0458285256314874,0.00247090034189151,-0.0506714903015947,-0.04098556096138,1.17273894739179e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42764,0.104768533303756,0.00566267940112162,0.0936696816775578,0.115867384929955,1.69650731636469e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.125865442446654,0.00683578538976435,-0.139263581810593,-0.112467303082716,8.57929268133237e-75
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,40449,-0.21009131790491,0.0114313237544952,-0.232496712463721,-0.1876859233461,2.37487486993787e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.064741835783351,0.00352727698600991,-0.0716552986759305,-0.0578283728907716,2.41641298992364e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42676,-0.0684639931249844,0.00373318677963484,-0.0757810392130687,-0.0611469470369001,3.20387900484363e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.109892115916355,0.00600207268439594,-0.121656178377771,-0.0981280534549387,5.6667084239432e-74
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,40516,0.069261821753674,0.00378713160790839,0.0618390438021735,0.0766845997051744,1.16429535346874e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.112481326678447,0.00616177824214437,-0.12455841203305,-0.100404241323844,1.46297083798943e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,40346,-0.0521659727024156,0.0028627549951765,-0.0577769724929615,-0.0465549729118696,3.93378743960577e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.0661642559856241,0.00364209968312174,-0.0733027713645427,-0.0590257406067054,6.98285252864277e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.14217934437889,0.00783132594183654,-0.15752874322489,-0.12682994553289,8.48508996966433e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REN,Renin,42636,-0.159507724370948,0.00878844755487141,-0.176733081578496,-0.1422823671634,9.51847169026457e-73
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42636,-0.118191256408787,0.00651460821716341,-0.130959888514427,-0.105422624303147,1.08188148080216e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.0857543055279891,0.0047531554050072,-0.0950704901218032,-0.076438120934175,6.32592755686217e-72
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42670,-0.121079732639357,0.00677269574893195,-0.134354216307264,-0.107805248971451,1.15145718169663e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.169144565098134,0.00948442271386248,-0.187734033617305,-0.150555096578964,2.58331926070886e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.084351052798134,0.0047480301029537,-0.0936571917999232,-0.0750449137963447,8.1083410211796e-70
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42794,-0.0814983285563722,0.00459438613866705,-0.0905033253881597,-0.0724933317245848,1.2804931467318e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,40539,-0.0356157109692045,0.00200798260983183,-0.0395513568844749,-0.0316800650539341,1.8725154363083e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,40283,-0.115299928391767,0.00650251174978196,-0.128044851421339,-0.102555005362194,2.16111601935164e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42587,-0.0641451019817937,0.00362511747824946,-0.0712503322391626,-0.0570398717244248,2.82821440925708e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.0929239241857632,0.00525883022534845,-0.103231231427446,-0.0826166169440802,4.21306862994043e-69
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.0906964471288276,0.00515786193580178,-0.100805856522999,-0.0805870377346561,1.91137924873971e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.122325267038208,0.00695696549111223,-0.135960919400788,-0.108689614675628,2.88031748614277e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0759770630285108,0.00433205343365091,-0.0844678877584666,-0.0674862382985551,4.15107317690651e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,40223,-0.100814535630168,0.00575620613718693,-0.112096699659055,-0.0895323716012821,9.21084032874069e-68
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0695444068705492,0.00398666870684142,-0.0773582775359584,-0.0617305362051401,2.13834953065872e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42794,-0.108376855499941,0.00622848252424244,-0.120584681247456,-0.0961690297524256,4.3736456555867e-67
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.101414419508444,0.0058379612827558,-0.112856823622645,-0.0899720153942423,1.00157401922078e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.108149665440214,0.00622821479242027,0.0959423644470703,0.120356966433358,1.17606979780619e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42711,-0.107475256605761,0.00621222513768238,-0.119651217875618,-0.0952992953359035,2.40872763779323e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.0967217871649877,0.00559104762692884,-0.107680240513768,-0.0857633338162072,2.4584133386513e-66
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0478119906096935,0.00277447756688846,-0.0532499666407949,-0.0423740145785921,1.07701220664122e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.143618489361236,0.00836831489373737,-0.160020386552962,-0.127216592169511,2.61675603656171e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.0809959208430732,0.00473481710953118,-0.0902761623777543,-0.0717156793083921,6.66010788205107e-65
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42594,-0.155104991636591,0.00909083732358081,-0.172923032790809,-0.137286950482373,1.37444644132045e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0551443729215662,0.00323809126770566,-0.0614910318062693,-0.0487977140368631,3.16474895527401e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POSTN,Periostin,40527,0.0673036323106022,0.00396543959848854,0.0595313706975646,0.0750758939236397,8.03246562911071e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42594,0.0590186730101696,0.00348336808317068,0.0521912715671551,0.0658460744531841,9.97697588952666e-64
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.0473576731506203,0.00279622903444335,0.0418770642431113,0.0528382820581292,1.11375322089448e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42676,0.0733828701136204,0.00435140736641102,0.0648541116754548,0.081911628551786,3.66118980433796e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,40223,-0.102140607400252,0.00605489472283253,-0.114008201057004,-0.0902730137435003,4.67483526918126e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.0626395043853938,0.00371777993097621,-0.0699263530501071,-0.0553526557206804,4.7822555352083e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0856250831852022,0.00508787357025814,0.0756528509874962,0.0955973153829081,8.62847341317237e-63
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.162924816124419,0.00971109764465007,-0.181958567507933,-0.143891064740904,1.5521187375632e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0707873700668255,0.00424343830726522,0.0624702309845857,0.0791045091490654,7.47908309409537e-62
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.0678239642137887,0.00407248741226086,-0.07580603954182,-0.0598418888857574,1.1743093184374e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.088273046434027,0.0053144216960131,-0.0986893129582127,-0.0778567799098414,2.38623544941429e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42659,-0.0515851819551196,0.00310614370065292,-0.0576732236083994,-0.0454971403018399,2.50414882813393e-61
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42587,-0.0722839524451109,0.00438427686695742,-0.0808771351043474,-0.0636907697858743,1.78953906114754e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.0595054455371237,0.00360935336092635,0.0524311129497081,0.0665797781245394,1.80665671387445e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.0431917717769872,0.0026198176504925,-0.0483266143719525,-0.0380569291820219,1.80827829343177e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42689,-0.0946433345946423,0.00574187280798103,-0.105897405298285,-0.0833892638909995,1.8924742033651e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.0615662000856732,0.0037367748341503,-0.0688902787606078,-0.0542421214107386,2.12177273208439e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OCLN,Occludin,40482,-0.0763208729497052,0.00463196350549845,-0.0853995214204822,-0.0672422244789282,2.70873694300123e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42743,-0.0408357663723817,0.00248392645387984,-0.0457042622219862,-0.0359672705227772,3.77753740050712e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42620,-0.0545330255444153,0.00331835366298099,-0.0610369987238581,-0.0480290523649726,4.23003666213786e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42636,-0.0457760645709137,0.00278839996721225,-0.0512413285066497,-0.0403108006351777,5.57247284581687e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,42475,-0.0572737524225023,0.00348899078827252,-0.0641121743675164,-0.0504353304774881,5.75881497603978e-60
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0533698662457252,0.00327719923804873,-0.0597931767523007,-0.0469465557391497,4.61582482489619e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42613,0.286552377306613,0.0176364982204636,0.251984840794504,0.321119913818721,8.43649490586582e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42721,0.0273845856017695,0.00168602828383332,0.0240799701654562,0.0306892010380828,9.13698710110886e-59
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.07484740468667,0.00460705081830169,-0.0838772242905413,-0.0658175850827987,1.14040579162849e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.111848451520064,0.00688634112000442,-0.125345680115272,-0.0983512229248551,1.16847533941727e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,0.062299684735,0.00385588750055232,0.0547421452339174,0.0698572242360825,3.55789001682483e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.0454211594321061,0.00281970290226916,-0.0509477771205536,-0.0398945417436585,7.74311499554604e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,40199,-0.136116717048154,0.00844937662338376,-0.152677495229986,-0.119555938866322,9.95522723625615e-58
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.119640443237196,0.00746435024906622,-0.134270569725365,-0.105010316749026,2.78799738957937e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.167196354092159,0.0104523510723794,-0.187682962194023,-0.146709745990295,4.75415280111013e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.063964816408872,0.00400234138402259,-0.0718094055215563,-0.0561202272961877,5.74194246768612e-57
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.105078845748463,0.00659202147270928,-0.117999207834973,-0.0921584836619527,1.10344239164768e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42613,-0.0508279121031251,0.00320308931657192,-0.0571059671636061,-0.0445498570426442,3.39936567138647e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.0602598448694168,0.00380751297536798,-0.067722570301138,-0.0527971194376955,6.6097067777278e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.0714912592890248,0.00452147028666571,-0.0803533410508896,-0.06262917752716,8.2812804015833e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0496673889439982,0.00314283638453715,0.0435074296303054,0.055827348257691,9.33686354080037e-56
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.0705856223459042,0.00447926425863819,-0.0793649802928351,-0.0618062643989734,1.89479639700141e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42754,-0.057543781329661,0.00365216464872668,-0.0647020240411653,-0.0503855386181567,1.93448017004567e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39956,-0.037207955486455,0.0023654531510174,-0.0418442436624491,-0.0325716673104609,3.88276705449556e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.120486498733687,0.00766498366709136,-0.135509866721186,-0.105463130746188,4.39327994247876e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.132346952152782,0.0084358427890175,-0.148881204019256,-0.115812700286308,5.57832622114792e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.0606536301249919,0.00386682360861646,-0.0682326043978802,-0.0530746558521037,5.96341459238348e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,40283,-0.0734609432592173,0.00468213391530307,-0.0826379257332114,-0.0642839607852233,6.91960876462323e-55
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.10067288851253,0.00643655156069493,-0.113288529571492,-0.0880572474535679,1.15607243158574e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.0833241472041934,0.00532884812574749,-0.0937686895306585,-0.0728796048777283,1.24874921716783e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.135047851658179,0.0086356085306446,-0.151973644378242,-0.118122058938115,1.48005290929561e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.0579390137871869,0.00370966903146402,-0.0652099650888564,-0.0506680624855174,1.63431661440278e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.108906892636589,0.00697512760168639,-0.122578142735894,-0.0952356425372836,1.81184937514765e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.197471272707488,0.0126595589177983,-0.222284008186373,-0.172658537228604,2.23765741007336e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.181841324877009,0.0116797305501032,-0.204733596755212,-0.158949052998807,3.52059256649203e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42594,0.0707791915441432,0.00454730970774724,0.0618664645169586,0.0796919185713278,3.74333516979977e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.106726848490896,0.00685993313385964,-0.120172317433261,-0.0932813795485307,4.17461202336463e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0920109027149794,0.00591941912754749,-0.103612964204972,-0.0804088412249863,6.32693631322585e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42663,-0.0512948337916811,0.00330616610853088,-0.0577749193644016,-0.0448147482189605,8.03263662170895e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.089453579673453,0.00576395093167582,-0.100750923499538,-0.0781562358473684,9.58151839357596e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.0468581604500272,0.00302019743468475,-0.0527777474220093,-0.0409385734780451,9.88345064947587e-54
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.0904697806700327,0.00583680993164304,-0.101909928136053,-0.0790296332040123,1.00381091328717e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42794,-0.0994767366182847,0.00642623948297873,-0.112072166004923,-0.0868813072316464,1.36046944376645e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,40223,-0.0954180561077832,0.0061587424981067,-0.107489191404072,-0.0833469208114941,1.41433649043515e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.109973143137568,0.00712136272315815,-0.123931014074958,-0.0960152722001778,2.96596258138311e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,40511,-0.0421583673404681,0.00273092609437688,-0.0475109824854468,-0.0368057521954894,3.19454691453957e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42495,-0.138543203842209,0.0089858834557006,-0.156155535415382,-0.120930872269036,3.57711673923019e-53
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.0475828994286065,0.00310393548571748,-0.0536666129806127,-0.0414991858766002,1.34080171011173e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0598263463436564,0.00390877680964651,-0.0674875488905636,-0.0521651437967493,1.92366296808438e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXN,Paxillin,42311,-0.0804035171487594,0.00526435704376454,-0.0907216569545379,-0.0700853773429809,3.24436669867639e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.031055265652716,0.00203607660303764,-0.0350459757946698,-0.0270645555107622,4.4554519474347e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.0548782513209905,0.00359817360375441,-0.0619306715843491,-0.0478258310576318,4.48746206991825e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.032152682769289,0.00210949155669799,-0.036287286220417,-0.0280180793181609,5.0908219383007e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.0875930275483229,0.00575894281474746,-0.0988805554652279,-0.0763054996314178,9.85674098320834e-52
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42679,-0.0820352661099651,0.00540220944720333,-0.0926235966264836,-0.0714469355934466,1.17924274746418e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42754,-0.0643744566105201,0.00424357914402394,-0.072691871732807,-0.0560570414882332,1.48306677998634e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,40539,0.0432457734133171,0.00284843739631967,0.0376628361165306,0.0488287107101037,1.48592108701774e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42721,-0.0418457544679075,0.00276242899167459,-0.0472601152915897,-0.0364313936442253,2.05638064558504e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.103451946025029,0.00683026486585476,-0.116839265162104,-0.0900646268879537,2.1223471386997e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42668,0.0606539714282984,0.00400652362632901,0.0528011851206935,0.0685067577359033,2.37467270290073e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42721,-0.0874180354565332,0.00577706228970136,-0.0987410775443479,-0.0760949933687186,2.62216381947196e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.109837533504188,0.00726092911685191,-0.124068954573218,-0.0956061124351582,2.84067290852802e-51
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.169748604289245,0.011288074307898,-0.191873229932725,-0.147623978645765,1.09341149872955e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42594,-0.0853980260091972,0.00568824786402458,-0.0965469918226854,-0.074249060195709,1.55229487169819e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.0826870772018991,0.00551275378414882,-0.0934920746188308,-0.0718820797849674,1.9032578589784e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.174271432044505,0.01163790794273,-0.197081731612256,-0.151461132476754,2.75090747329008e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.091173658160624,0.00609176532534235,-0.103113518198295,-0.079233798122953,3.08536643772973e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.129822389248525,0.00868895977073134,-0.146852750399159,-0.112792028097892,5.49640650038202e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.0809987901347113,0.00543467436718366,-0.0916507518943913,-0.0703468283750314,7.74779685552832e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,40511,-0.104173722058588,0.00699049641661239,-0.117875095035148,-0.0904723490820275,9.43983051778841e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.0621483701699867,0.00417426423696098,-0.0703299280744302,-0.0539668122655432,9.67471135914518e-50
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.107854965404131,0.00725721318700604,-0.122079103250662,-0.0936308275575987,1.4509656137779e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42711,-0.0364333309085878,0.00245373779306188,-0.0412426569829891,-0.0316240048341865,1.75583327483163e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.0850576422048353,0.00576091726902737,-0.096349040052129,-0.0737662443575417,6.00465340525972e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.0678100502727784,0.00459159456949113,-0.076809575628981,-0.0588105249165758,6.88155894482991e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42613,-0.047938794101534,0.00325101098171623,-0.0543107756256978,-0.0415668125773702,7.88806558350054e-49
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42594,-0.08691139715381,0.00590601178493285,-0.0984871802522784,-0.0753356140553416,1.22353835609999e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0460340445087004,0.0031266436548857,-0.0521622660722764,-0.0399058229451244,1.29536382014851e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42749,-0.0418689699158475,0.00284779653823393,-0.0474506511307861,-0.036287288700909,1.47470529417839e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.0518344348522513,0.00353077000778506,-0.05875474406751,-0.0449141256369926,2.41168905400372e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.133339401986891,0.00912473705545071,-0.151223886615574,-0.115454917358207,5.472256287938e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.119675231332899,0.00819646428364821,-0.13574030132885,-0.103610161336949,7.76192060253957e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0766798163493317,0.00525776023891246,-0.0869850264176001,-0.0663746062810632,8.36612797879086e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.162990555003331,0.011175224669379,-0.184893995355314,-0.141087114651348,9.52602524076969e-48
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0615871105776048,0.00423755676516518,-0.0698927218373285,-0.053281499317881,1.69389129790879e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.144742526419788,0.00996267987804205,-0.164269378980751,-0.125215673858826,1.83577592931572e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0708607234006494,0.00489501837787398,-0.0804549594212824,-0.0612664873800164,4.5254501161946e-47
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.0924655250661404,0.00641210852621411,-0.10503325777752,-0.0798977923547608,1.00018046667601e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0399375477665029,0.00276974152237896,-0.0453662411503656,-0.0345088543826401,1.02625902694212e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.142502785341947,0.00989130060884361,-0.16188973453528,-0.123115836148614,1.04577226367922e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.134935943959895,0.00937329914870577,-0.153307610291359,-0.116564277628432,1.2188995969007e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELN,Elastin,40511,-0.0544779987995241,0.00378221645319343,-0.0618911430477833,-0.047064854551265,1.26578372069386e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,40169,-0.0436237438264375,0.00302996021467351,-0.0495624658471975,-0.0376850218056774,1.4244191666616e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42587,-0.104121754327279,0.00725217792295696,-0.118336023056275,-0.0899074855982835,2.11835672278945e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0593272469235189,0.00413679689332439,-0.0674353688344347,-0.0512191250126031,2.6490136340445e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42590,-0.135367986882611,0.00943930939170328,-0.15386903329035,-0.116866940474873,2.67451814680981e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.154709748750497,0.0108022639777476,-0.175882186146883,-0.133537311354112,3.50098729287931e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42705,0.0409179897071461,0.00286011429240076,0.0353121656940406,0.0465238137202516,4.33051234295546e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42683,-0.0542259972386432,0.00379828993856985,-0.0616706455182401,-0.0467813489590463,6.62761289145047e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.0527317164170145,0.0036938117272394,-0.0599715874024038,-0.0454918454316253,6.78129524960403e-46
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.101485318371274,0.00712547892249287,-0.11545125705936,-0.087519379683188,1.08774753208831e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42711,-0.0661589366658217,0.00465017896762249,-0.0752732874423617,-0.0570445858892816,1.325600891695e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0670202345910953,0.00471204585526018,-0.0762558444674052,-0.0577846247147853,1.41046878507489e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.156963026363511,0.0110282374470897,-0.178578371759806,-0.135347680967215,1.42333120050052e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,40527,-0.16759405386123,0.0117853324763022,-0.190693305514782,-0.144494802207678,1.68054183991472e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.0929933380774979,0.0065423193537079,-0.105816284010765,-0.0801703921442304,1.90198559575023e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREH,Trehalase,40527,-0.108660851611328,0.00765783950382014,-0.123670217038815,-0.0936514861838405,2.59835398685103e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,42188,-0.0582736495805972,0.00411092198707094,-0.0663310566752562,-0.0502162424859382,2.83145844581384e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.084993757791555,0.00602199653271063,-0.0967968709956679,-0.0731906445874422,6.49723980714255e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.092787339459323,0.00658055758461789,-0.105685232325174,-0.0798894465934719,8.02512124118881e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0583336836726181,0.00414130231564018,-0.0664506362112728,-0.0502167311339633,9.6638375693378e-45
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42648,-0.0467519068718826,0.00332187894888051,-0.0532627896116884,-0.0402410241320768,1.13891535148043e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.152525613928752,0.0108459056112748,-0.173783588926851,-0.131267638930654,1.3308209719758e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.105293922258158,0.00749095320080599,-0.119976190531738,-0.0906116539845785,1.46344741958301e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42594,-0.106679958760684,0.00761211118857857,-0.121599696690298,-0.0917602208310696,2.61083545095539e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0442906813558423,0.00317950487418197,-0.0505225109092389,-0.0380588518024456,8.36412091387402e-44
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.0275923892957155,0.00198854069154965,-0.0314899290511528,-0.0236948495402782,1.76187454513063e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD248,Endosialin,40527,0.0584532688054059,0.00421213891846378,0.0501974765252169,0.0667090610855949,1.96821645160404e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.064936890507304,0.00469802461748387,-0.0741450187575724,-0.0557287622570356,4.19321078923272e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0960235096188841,0.006952695440926,-0.109650792683099,-0.0823962265546691,4.29936703145979e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42636,0.0443109419946679,0.00321469876301512,0.0380101324191583,0.0506117515701775,6.24292126822637e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.045959554909857,0.00333562082626298,-0.0524973717293325,-0.0394217380903816,6.73321256423567e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.119445042828587,0.0086631585151266,-0.136424833518236,-0.102465252138939,6.85129525528337e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42618,-0.0476274085164335,0.00345963693690784,-0.0544082969127729,-0.0408465201200942,7.90945693105235e-43
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.129395196669429,0.00941546235708095,-0.147849502889308,-0.11094089044955,1.2358777982692e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.0407488045203756,0.00297007600164042,-0.0465701534835908,-0.0349274555571604,1.5196179776313e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42636,-0.0502111930096872,0.00366122996109855,-0.0573872037334404,-0.0430351822859341,1.6110794627504e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42721,-0.0909102787486308,0.00664465992771945,-0.103933812206961,-0.0778867452903007,2.49790084003782e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0389444346055902,0.00285064937264956,-0.0445317073759833,-0.033357161835197,3.2937832694203e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.121466742019367,0.00891064360008878,-0.138931603475541,-0.104001880563193,4.94004544750444e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.027960599802388,0.00205504915985142,-0.0319884961556968,-0.0239327034490792,7.01499583369452e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.0532187169528121,0.00391878287004069,-0.0608995313780919,-0.0455379025275324,9.78912538710195e-42
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42495,-0.0961193398303225,0.0070867354458984,-0.110009341304283,-0.0822293383563616,1.25030232599625e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0430999308884459,0.00317815180054477,-0.0493291084175137,-0.0368707533593782,1.2790293525627e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0457641815754447,0.00337535607817304,-0.0523798794886639,-0.0391484836622256,1.33254413053536e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0713890355358858,0.00527718731288249,-0.0817323226691355,-0.0610457484026361,2.0297765977891e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.0485879984336599,0.00360499278205884,-0.0556537842864952,-0.0415222125808246,3.89917970652138e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0808519080134935,0.00599898684948514,-0.0926099222384844,-0.0690938937885026,3.91638177524837e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.111371950387,0.0082919016875574,-0.127624077694613,-0.0951198230793876,8.14904050818636e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.0822949626881263,0.00613102934595184,-0.0943117802061919,-0.0702781451700607,9.15861244827389e-41
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.125127788629791,0.00933470362460469,-0.143423807734016,-0.106831769525566,1.03955549307224e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,42488,0.0384657123704972,0.00287094548913906,0.0328386592117846,0.0440927655292097,1.13589957630759e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.111656523931688,0.00833735245195315,-0.127997734737516,-0.0953153131258595,1.21669856237397e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0793509817893917,0.00593434385368328,-0.0909822957426109,-0.0677196678361724,1.61359136840893e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0224955772879879,0.00168273046265002,0.0191974255811938,0.0257937289947819,1.6642553481745e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0516201153200247,0.00386595461906394,-0.05919738637339,-0.0440428442666594,2.07193237037084e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0631152025877007,0.00472891589050925,0.0538465274423026,0.0723838777330988,2.2425690476256e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.108825378627549,0.00814893678189308,-0.124797294720059,-0.0928534625350386,2.25933020525327e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.101706957391142,0.00761953653800705,-0.116641249005636,-0.0867726657766486,2.44861896194506e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,40488,0.0268451246547085,0.00201186117781612,0.0229018767461889,0.0307883725632281,2.61102209191639e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42544,-0.0318998266524979,0.00239256874339564,-0.0365892613895534,-0.0272103919154425,2.69711454168443e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.115872394986349,0.00869566748427547,-0.132915903255529,-0.0988288867171688,2.97578019874135e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.0380579195014252,0.00286290261133265,-0.0436692086196372,-0.0324466303832132,4.53094291613443e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,42370,-0.0644808092642467,0.0048505677414129,-0.073987922037416,-0.0549736964910774,4.57541362740673e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.102891033203829,0.00774249265086988,-0.118066318799534,-0.0877157476081244,4.76371766688319e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.0421538674794829,0.00318236358602469,-0.0483913001080913,-0.0359164348508745,8.44883855311318e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42594,-0.128677792345922,0.00971487490617671,-0.147718947162028,-0.109636637529816,8.5272788466968e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0493026276796432,0.00372375619098931,-0.0566011898139822,-0.0420040655453041,9.21676631763111e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42613,-0.0589403539198372,0.00445197809834799,-0.0676662309925993,-0.0502144768470751,9.2562415730935e-40
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.0606300893604038,0.00458306184755071,0.0516472881392044,0.0696128905816032,1.05181686113418e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.102443982927668,0.00777288986741219,-0.117678847067795,-0.0872091187875396,2.01747153368732e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.0466753200512533,0.00356052325236916,0.0396966944766097,0.0536539456258969,5.04807489902518e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.0586366654344239,0.00447866069642283,-0.0674148403994126,-0.0498584904694351,6.29165837860667e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,42475,-0.0687130289760756,0.00524874280368656,-0.0790005648713012,-0.05842549308085,6.42650885890505e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0526070185440629,0.00402310022572498,-0.0604922949864838,-0.0447217421016419,8.58880370329954e-39
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0992096288532907,0.00759943275750457,-0.114104517058,-0.0843147406485817,1.15995862723983e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,42317,-0.0666525960574202,0.00510928948697273,-0.0766668034518867,-0.0566383886629536,1.17439556631997e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.186070839094654,0.014257941868646,-0.214016405157201,-0.158125273032108,1.20640055671911e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42679,-0.0764116259046186,0.0058635441251072,-0.0879041723898287,-0.0649190794194084,1.38241748170959e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0662400306175182,0.00508347372561522,-0.0762036391197241,-0.0562764221153124,1.40696506107939e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42587,-0.0718646845346959,0.00552050470746514,-0.0826848737613276,-0.0610444953080643,1.66018669414229e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0884303855589115,0.00679859306037613,-0.101755627957249,-0.0751051431605743,1.88896973670265e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42754,-0.0491868134704297,0.00378166309235271,-0.056598873131441,-0.0417747538094184,1.90409692393624e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.0970835589417241,0.00746169591247888,-0.111708482930183,-0.0824586349532655,2.03270354179158e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.0454593790849669,0.00350078589575369,-0.0523209194406442,-0.0385978387292897,2.52069762736825e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.0662825286213237,0.00510583778582896,-0.0762899706815485,-0.056275086561099,2.67040518024976e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0924067364617522,0.00712259412469142,-0.106367020946147,-0.078446451977357,3.2323616425815e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,40451,-0.131791611548616,0.0101680098624071,-0.151720910878933,-0.111862312218298,3.79508793440649e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.109662314496915,0.00847222148316456,-0.126267868603918,-0.0930567603899125,4.29690411263373e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.0331703138547228,0.00256473440248232,0.0281434344258575,0.0381971932835882,4.89734153064934e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,42311,-0.0824273110682526,0.00638643201402935,-0.0949447178157501,-0.0699099043207551,7.02152446301451e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.0921791213377998,0.007154789542127,-0.106202508840369,-0.0781557338352309,9.33261044092188e-38
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,40199,-0.124785764733628,0.00968525678380887,-0.143768868029893,-0.105802661437362,1.03583453860506e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.112347119616043,0.00872735124654022,-0.129452728059262,-0.095241511172824,1.07763615248761e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.0567293737084674,0.00441161975745781,-0.0653761484330847,-0.0480825989838501,1.27172673816007e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.110711233331791,0.00860422745723896,-0.12757551914798,-0.0938469475156029,1.28108735143059e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,42476,-0.0836347476533475,0.00650961533570431,-0.0963935937113279,-0.070875901595367,1.47924036405585e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.0908885331985114,0.00707490772572512,-0.104755352340933,-0.0770217140560902,1.66845747046488e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,40515,-0.0740293910529743,0.00577105247132543,-0.0853406538967722,-0.0627181282091765,2.08877275043672e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.076721154307193,0.00598468691453925,-0.0884511406596899,-0.0649911679546961,2.11274989186397e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42495,-0.0706505872122741,0.00551237588495222,-0.0814548439467805,-0.0598463304777678,2.19920421235397e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAST,Gastrin,40483,-0.192760048489894,0.0150412624742467,-0.222240922939417,-0.16327917404037,2.44624983750007e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.0839459073445428,0.00655280661249986,-0.0967894083050425,-0.0711024063840431,2.59800042382312e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.0454554227910844,0.00355195825005516,0.0384935846209763,0.0524172609611925,2.80349449427217e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0471615389635821,0.00368759926131008,0.0399338444114143,0.0543892335157498,3.10214642061997e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,42357,-0.0720571542627167,0.00563829206550232,-0.0831082067111013,-0.0610061018143322,3.52853126646672e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.0948007545582774,0.00741817500523911,-0.109340377568546,-0.0802611315480087,3.54962263356492e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.158876520601595,0.012436937366418,-0.183252917839775,-0.134500123363416,4.17400186923082e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.0693979941343149,0.00543856391343917,0.0587384088639741,0.0800575794046557,4.482697969686e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.0824851254017955,0.00647272656976767,-0.0951716694785402,-0.0697985813250509,5.60600128621371e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.0900684040491924,0.0070829097388639,-0.103950907137366,-0.0761859009610192,8.70820357949977e-37
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.0645047648420819,0.00508262315558993,-0.0744667062270382,-0.0545428234571256,1.19604100458105e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0333665729069392,0.00263247339174639,0.0282069250591162,0.0385262207547621,1.31235956405335e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.067709937447871,0.00534921612645934,-0.0781944010557313,-0.0572254738400107,1.7919700109267e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,40468,-0.0446272952853044,0.00353178666142169,-0.0515495971416909,-0.0377049934289179,2.35995942535476e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0400229379571322,0.00316788349282493,-0.0462319896030691,-0.0338138863111954,2.40927203541293e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.0381674202359184,0.00302320889865112,-0.0440929096772746,-0.0322419307945622,2.4893262386731e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,42437,-0.0553335590575371,0.00439031197487297,-0.0639385705282881,-0.0467285475867861,3.25682902896243e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.0545735461246788,0.0043358855627997,-0.0630718818277662,-0.0460752104215914,4.01120029790526e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,40511,0.045560755331744,0.00362185971977814,0.0384619102809788,0.0526596003825091,4.77571125157606e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42588,0.0501083732400178,0.00398625105086438,0.0422953211803236,0.057921425299712,4.91218530134177e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,42311,-0.0824487658500544,0.00656998721129515,-0.0953259407841929,-0.0695715909159159,6.44779894976284e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42594,-0.117111350007488,0.00935705387334687,-0.135451175599248,-0.0987715244157279,9.68883840144381e-36
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.140436805929972,0.0112394946450126,-0.162466215434197,-0.118407396425748,1.37244875974618e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,42346,-0.0960463926113011,0.00770684202108178,-0.111151802972621,-0.0809409822499808,1.89587259569123e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.0465953710452718,0.00373994980138043,-0.0539256726559774,-0.0392650694345661,2.17744122713015e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.0510306810973874,0.00410772899243392,-0.0590818299225579,-0.0429795322722169,3.08514493528452e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.085164224098661,0.00685342612514151,-0.0985969393039384,-0.0717315088933837,3.19268023083177e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42711,-0.0295346952777011,0.00237838376596111,-0.0341963274589848,-0.0248730630964173,3.2489440143125e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.0866448798472915,0.00698631454799189,-0.100338056361356,-0.0729517033332274,3.95739931497825e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0438596620741718,0.00353733577859084,0.0369264839481337,0.0507928402002098,4.11274569508764e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.0504201885192163,0.00406676522303943,-0.0583910483563736,-0.042449328682059,4.5919072959201e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42754,-0.119248581671731,0.00963109275608808,-0.138125523473664,-0.100371639869799,5.08044313386872e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.055965010337568,0.00452267457599724,0.0471005681686134,0.0648294525065226,5.57237520676921e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0868934593757016,0.00702576310926251,-0.100663955069856,-0.073122963681547,6.67965121830462e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.108100163356565,0.00876368398163366,-0.125276983960567,-0.090923342752563,9.0592845476653e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.0602955552383783,0.00488856695245919,-0.0698771464651983,-0.0507139640115583,9.17341498006179e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42594,-0.048837159273534,0.0039610983340155,-0.0566009120082044,-0.0410734065388636,9.72973967431979e-35
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42711,-0.046737093663058,0.00379161384164653,-0.0541686567926852,-0.0393055305334308,1.00272428185647e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.10896337196985,0.00883841208506996,-0.126286659656587,-0.0916400842831129,1.06486162006276e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.0836719798125915,0.00679959943564465,-0.096999194706455,-0.070344764918728,1.31261788641516e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.0789583042595139,0.00641791005536382,-0.091537407968027,-0.0663792005510008,1.34457216033696e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.142055562708006,0.0115414685475949,-0.164676841061292,-0.11943428435472,1.37321402960273e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.130901052786276,0.0106421294353279,-0.151759626479518,-0.110042479093033,1.38700066129627e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0588166615696019,0.00478540851439656,-0.0681960622578192,-0.0494372608813846,1.56259522159292e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,42336,-0.05043164409934,0.00410571019207846,-0.0584788360758138,-0.0423844521228663,1.72140628596646e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,40532,-0.036045661278354,0.00293900402680008,-0.0418061091708822,-0.0302852133858259,2.31622333637849e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.0760046173803053,0.006206692241322,-0.0881697341732964,-0.0638395005873142,2.72639792215379e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.0294182261975056,0.00240506319311933,-0.0341321500560195,-0.0247043023389917,3.19858836072046e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.104617966771597,0.00856448694210857,-0.12140436117813,-0.0878315723650641,3.91032485503738e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.122578136201879,0.0100381330846544,-0.142252877047802,-0.102903395355957,4.43954233966683e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0315191441019169,0.00258563922993573,0.0264512912112429,0.0365869969925909,5.31490157526237e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0668832952975121,0.00549370714613528,-0.0776509613039373,-0.056115629291087,6.43623807772421e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.118485730773611,0.00974232591772899,-0.13758068957236,-0.0993907719748619,7.5275637663816e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.124141744367285,0.0102066492021525,-0.144146776803504,-0.104136711931066,7.99042074206764e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,42255,-0.0866761715223673,0.0071333318701899,-0.100657501987939,-0.0726948410567951,8.63632820950067e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.0558513996159972,0.00459438849946939,-0.0648564010749573,-0.0468463981570372,8.69465552893712e-34
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42594,-0.100507602715198,0.00828607531615816,-0.116748310334868,-0.084266895095528,1.10378543804185e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0975870240540098,0.0080508570756474,-0.113366703922279,-0.0818073441857409,1.23193620115858e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.0566185162038593,0.0046752949514391,-0.0657820943086799,-0.0474549380990386,1.50819951959088e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42794,-0.068602989634326,0.00567996855300854,-0.0797357279982227,-0.0574702512704293,2.0449559092014e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.118329928479758,0.00980360158203804,-0.137544987580553,-0.0991148693789634,2.25719228542896e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.0490334901247573,0.00407250191384279,-0.0570155938758891,-0.0410513863736254,3.23572567571796e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.071978013608356,0.00598293663989304,-0.0837045694225464,-0.0602514577941657,3.91810294703985e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.0625786116301077,0.00520747854290405,-0.0727852695741996,-0.0523719536860157,4.27418692275699e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.121068124438648,0.010086717021991,-0.140838089801751,-0.101298159075546,5.05329477160173e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42581,0.077554082683616,0.00646503697167446,0.0648826102191341,0.0902255551480979,5.50872553694417e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,40527,-0.0347699233768008,0.00289732040761758,-0.0404486713757313,-0.0290911753778704,5.57951806320219e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.0733224036239562,0.00612266068580019,-0.0853228185681245,-0.0613219886797878,7.0221361804717e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.029715395530504,0.00248255020241768,0.0248495971337653,0.0345811939272426,7.51198643510548e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.0366767445307599,0.00306594942948796,-0.0426860054125563,-0.0306674836489635,8.17323079895421e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42581,-0.052374993759681,0.0043812527477864,-0.0609622491453423,-0.0437877383740196,9.0464898538021e-33
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0629536424702161,0.00527028649369149,-0.0732834039978515,-0.0526238809425808,1.01053799434249e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.0371053841009741,0.00310551638007731,-0.0431921962059256,-0.0310185719960226,1.05280557934108e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.104735694357882,0.00877260279847459,-0.121929995842892,-0.087541392872872,1.08425867761391e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,0.0405750526900909,0.00340412215627423,0.0339029732637934,0.0472471321163884,1.3628704320733e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0370461565956324,0.00310918738750613,-0.0431401638751444,-0.0309521493161204,1.44200814514505e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0443545944774587,0.00372533611636126,-0.0516562532655268,-0.0370529356893906,1.60071626745267e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,42346,-0.0782969399429557,0.00657723284620611,-0.0911883163215197,-0.0654055635643917,1.65205211999834e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.0956450156840599,0.00803366862471212,-0.111391006188496,-0.0798990251796241,1.73086003577505e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.0496692877253606,0.00417424640750941,-0.0578508106840791,-0.0414877647666422,1.74191977784027e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,40482,-0.127493185549336,0.0107116178440782,-0.14848795652373,-0.106498414574943,1.79960342201483e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,0.0578657634512054,0.0048682123552629,0.0483240672348901,0.0674074596675207,2.01891836830804e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.100909239386426,0.00848564074671966,-0.117541095249996,-0.0842773835228554,2.03910116482446e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.0876898532132953,0.00737636424673733,-0.1021475271369,-0.0732321792896901,2.13583913014376e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42566,-0.0569914400162739,0.00479673197352788,-0.0663930346843885,-0.0475898453481592,2.15433621832326e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0475114376313774,0.00399939076881575,-0.0553502435382562,-0.0396726317244985,2.19224216514755e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,40462,-0.0896307279666977,0.00754359053329284,-0.104416165411952,-0.0748452905214438,2.29844069710938e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.0913012083064665,0.00768444459500581,-0.106362719712678,-0.0762396969002552,2.33161829454832e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39872,-0.0299775334022397,0.00252376844982713,-0.0349241195639009,-0.0250309472405785,2.45803209055694e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42618,-0.0343164598280741,0.00289752022575848,-0.0399955994705607,-0.0286373201855875,3.36784764462092e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,42346,-0.058010175577205,0.00490110789373096,-0.0676163470489176,-0.0484040041054923,3.69666445522777e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0535579384615738,0.00453080813541795,-0.062438322406993,-0.0446775545161546,4.39720422053675e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.032450816236237,0.00274756632464245,-0.0378360462325362,-0.0270655862399378,4.94009279001353e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.0707828292056026,0.00599441817424938,-0.0825318888271314,-0.0590337695840738,5.10448111513579e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0739818235281639,0.0062676177646881,-0.0862663543469526,-0.0616972927093753,5.41432764165755e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0558062887719236,0.00472816553014013,-0.0650734932109982,-0.0465390843328489,5.41992867391181e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.138406883663993,0.0117280953044669,-0.161393950460748,-0.115419816867238,5.92737129881684e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42587,-0.0390414993709471,0.00331557209213791,-0.0455400206715374,-0.0325429780703568,7.52186245417899e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.069793155366579,0.00592914037595891,-0.0814142705034584,-0.0581720402296995,7.85587610256512e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.0263827743772187,0.00224064278248675,-0.0307744342308927,-0.0219911145235447,8.1557319928977e-32
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.0967878207737508,0.00823867741710893,-0.112935628511284,-0.0806400130362173,1.11736647334017e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.0878211531898985,0.00748728364805024,-0.102496229140077,-0.07314607723972,1.28366698036422e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42676,-0.0555017993541392,0.00473414868976667,-0.0647807307860818,-0.0462228679221965,1.3714398343737e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0332177274479829,0.0028387792469762,0.0276537201239096,0.0387817347720563,1.90028328612514e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42587,-0.122776430886361,0.0104997908296123,-0.143356020912401,-0.102196840860321,1.96219577110202e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0734645719623405,0.00628358760469019,-0.0857804036675332,-0.0611487402571477,2.00080796311626e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42495,-0.0498137482679141,0.00426247529404509,-0.0581681998442425,-0.0414592966915857,2.12541720996342e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0717982506321887,0.00615098698224638,-0.0838541851173916,-0.0597423161469858,2.50826241011054e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.0228567955727253,0.0019607993704857,-0.0266999623388772,-0.0190136288065733,2.99589150338308e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42640,0.0458124045709546,0.00393759778317911,0.0380947129159235,0.0535300962259856,3.87470064174673e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42613,-0.0443372574892282,0.00381160677725246,-0.0518080067726431,-0.0368665082058134,3.98857358511178e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.0371088052757163,0.00319570395331527,0.0308452255272183,0.0433723850242142,5.03304975540356e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.063985448295656,0.00550884589467644,-0.0747827862492218,-0.0531881103420902,5.24044563916223e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42594,-0.101002430133544,0.00872141577783408,-0.118096405058098,-0.0839084552089889,7.21811950893065e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.0540483329679493,0.004668657336457,-0.063198901347405,-0.0448977645884936,7.56663245500128e-31
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,42346,-0.0480850209215794,0.00417095375578651,-0.056260090282921,-0.0399099515602379,1.3290046618375e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.0494856888657361,0.00429670975744332,-0.057907239990325,-0.0410641377411472,1.59920376889331e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.0632669723266531,0.00550047164354183,-0.0740478967479951,-0.0524860479053111,1.78986780850508e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.100270050163881,0.00871566797273496,-0.117352759390442,-0.0831873409373206,1.85131847209733e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0498168602302235,0.00433275513848369,-0.0583090603016515,-0.0413246601587955,1.99986997271945e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.0282289442475334,0.00245791839979007,0.0234114241839448,0.0330464643111219,2.18009137905814e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.0315930049243395,0.00276192258255364,-0.0370063731861446,-0.0261796366625343,3.69238946895645e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42721,-0.0473102612701411,0.0041364879181136,-0.0554177775896438,-0.0392027449506385,3.74515097905898e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.0385899810687251,0.0033830943302349,-0.0452208459559855,-0.0319591161814647,5.69780585869216e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,40449,-0.122527436922014,0.0107595597912657,-0.143616174112895,-0.101438699731134,7.01020140945251e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42594,-0.0959319998187051,0.00842824439120243,-0.112451358825462,-0.0794126408119483,7.0341614461386e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.0609325861415094,0.00535471324886058,-0.0714278241092761,-0.0504373481737426,7.26455994962696e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,42509,-0.0624342587965461,0.00548749606012311,-0.0731897510743874,-0.0516787665187048,7.43085590326159e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.0334879702944333,0.00294775279255214,-0.0392655657678355,-0.0277103748210311,9.05093916758106e-30
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_E,,42594,-0.0361067159145132,0.00318104152428198,-0.0423415573021058,-0.0298718745269205,1.00677578205161e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNST,Consortin,42636,-0.126879405974962,0.0111824888242261,-0.148797084070445,-0.104961727879479,1.05644621633208e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42587,-0.0642490681803104,0.00566610533634583,-0.0753546346395482,-0.0531435017210726,1.14569700757184e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.0868673748777967,0.00766545554091546,-0.101891667737991,-0.0718430820176024,1.31045882197956e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.0928617827284306,0.00820361182739334,-0.108940861910122,-0.0767827035467396,1.51534983499866e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.0893569442550605,0.00790168265876561,-0.104844242266241,-0.0738696462438799,1.61905430031003e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.0419783111138639,0.00371264167609746,-0.049255088799015,-0.0347015334287129,1.64770854495373e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,40483,-0.0441370717372945,0.00390479053095728,-0.0517904611779708,-0.0364836822966182,1.8191211125696e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.0378705995195502,0.00335215143593926,-0.0444408163339912,-0.0313003827051093,1.83671093492713e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0622567876887542,0.00550850183312842,-0.0730534512816859,-0.0514601240958224,1.87366973048408e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,40223,-0.0468458454353156,0.00414769036120345,-0.0549753185432743,-0.0387163723273568,2.02737524239598e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0369507496827938,0.00327684612009306,0.0305281312874114,0.0433733680781762,2.42776705730581e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.0676360394104942,0.00600065968190045,-0.079397332387019,-0.0558747464339693,2.47427570478587e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0378131976004357,0.00335714162895815,-0.0443931951931936,-0.0312332000076777,2.69069918670984e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42495,-0.0695257089134828,0.00617392502390013,-0.081626601960327,-0.0574248158666385,2.76772976254689e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,40499,-0.0512570219866361,0.00455069137653135,-0.0601763770846376,-0.0423376668886347,2.84266858879312e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.0604964961192158,0.00537606855353496,-0.0710335904841443,-0.0499594017542873,3.03691956731996e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.0464254536717836,0.00412475116340416,-0.0545099659520558,-0.0383409413915115,3.11938836894237e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.0309059836918468,0.00274659657351338,-0.036289312975933,-0.0255226544077605,3.21644140337378e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.0665376321911739,0.00592137364485361,-0.078143524535087,-0.0549317398472608,3.65256110881112e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,40302,-0.149762713262893,0.0133263539563247,-0.175882367017289,-0.123643059508497,3.80656560812285e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,40257,-0.0581837490025412,0.00517829067464805,-0.0683331987248513,-0.048034299280231,3.89821734638538e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.050444631687987,0.0044919703325075,-0.0592488935397017,-0.0416403698362722,3.92986356321227e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0342963645942063,0.00305370245591654,-0.0402816214078027,-0.0283111077806099,4.09016925480461e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,40511,-0.0374337882610693,0.00333614453221483,-0.0439726315442104,-0.0308949449779283,4.59505881888213e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.124167732716298,0.0110664841729624,-0.145858041695304,-0.102477423737292,4.62549286380076e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0977876182454783,0.00873198089272533,-0.11490230079522,-0.0806729356957366,5.59412995751012e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.0766409291915881,0.00684990494495648,-0.0900667428837028,-0.0632151154994734,6.21329716405783e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.0521134623612531,0.00466284117324509,-0.0612526310608134,-0.0429742936616927,7.15145320489473e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0864715209403069,0.00773476986910018,0.0713113719968705,0.101631669883743,7.27002521983056e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.0727676444191336,0.00652522624942453,-0.0855570878680057,-0.0599782009702615,9.9191821459543e-29
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.102040528194754,0.00915391506076215,-0.119982201713848,-0.0840988546756603,1.04328245316558e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42676,-0.0487127182764715,0.00437308411271888,-0.0572839631374005,-0.0401414734155425,1.07842139471135e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0519489502943775,0.00466679214424756,-0.0610958628971027,-0.0428020376916523,1.2513310180013e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.0725782255737631,0.00653099104185587,-0.0853789680158006,-0.0597774831317256,1.52531664954586e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.0508299607437671,0.00457727045764924,-0.0598014108407596,-0.0418585106467746,1.67847514603736e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0671152081229075,0.0060492455193355,-0.0789717293408051,-0.0552586869050099,1.7644783502132e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.0550267712101632,0.00495879705374394,-0.0647460134355014,-0.0453075289848251,1.82620210329931e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,40283,-0.0376922618673276,0.0034003430460835,-0.0443569342376513,-0.031027589497004,2.09501394490466e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.15630150984523,0.0141104623867216,-0.183958016123204,-0.128645003567256,2.15479664595223e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0587155258177693,0.0053175322355452,-0.0691378889994379,-0.0482931626361007,3.19484881041933e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0893003159913883,0.00808556727093625,-0.105148027842423,-0.0734526041403533,3.27262002419899e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.0245002864446115,0.0022199481831873,0.0201491880055644,0.0288513848836586,3.38943573519418e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42495,0.0394929061789052,0.0035793693156371,0.0324773423202565,0.0465084700375539,3.49085260108173e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.0536386726382993,0.00486236072523767,-0.0631688996597652,-0.0441084456168335,3.55263576976305e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.0545749600605108,0.00494797652067583,-0.0642729940410354,-0.0448769260799862,3.64157266455628e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.0623901046194245,0.0056562550300222,-0.073476364478268,-0.051303844760581,3.83278562141038e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0263900810447187,0.00240782196270233,-0.0311094120916153,-0.0216707499978221,8.24923962018124e-28
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.039145838037886,0.00358721276240837,-0.0461767750522064,-0.0321149010235656,1.30992894920862e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0638792958209471,0.00586917626730581,-0.0753828813048665,-0.0523757103370277,1.78968807488808e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.0747421176570901,0.00687740449354649,-0.0882218304644412,-0.061262404849739,2.14757371498106e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0939645370431558,0.00865224842111586,-0.110922943948543,-0.0770061301377687,2.32078917378533e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0583426123117371,0.00537801911241015,-0.068883529772061,-0.0478016948514132,2.63100338460887e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42495,-0.0447242992917958,0.00413099739593703,-0.0528210541878324,-0.0366275443957592,3.3469442423964e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42689,-0.0625063221108623,0.00577488769430376,-0.0738251019916976,-0.0511875422300269,3.43325341244079e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0705418449593144,0.0065198456118813,-0.0833207423586017,-0.057762947560027,3.59874726398946e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0759238472997965,0.00701744107557212,-0.0896780318079178,-0.0621696627916751,3.62723650010116e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,40283,-0.079721911965439,0.00736760107876875,-0.0941624100798258,-0.0652814138510523,3.75679418509772e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.0380288236973921,0.00351751103876316,-0.0449231453333679,-0.0311345020614163,3.9390393451077e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.0374881095661602,0.00346728699550553,-0.0442839920773511,-0.0306922270549694,4.15489159316699e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COCH,Cochlin,40511,-0.0524601430887926,0.00485320289789485,-0.0619724207686666,-0.0429478654089187,4.21411240112239e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42611,0.028872278506117,0.00267321066094624,0.0236327856106623,0.0341117714015716,4.41911128891626e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0645981128341113,0.00598098516937782,-0.0763208437660918,-0.0528753819021308,4.66273254724172e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0691708759968986,0.00640713982165163,-0.0817288700473358,-0.0566128819464614,4.92674227628587e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.0296925072990398,0.00275202324761715,0.0242985417337102,0.0350864728643695,4.9925221615464e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0427490939532961,0.00396669887808606,-0.0505238237543448,-0.0349743641522475,5.70047009912498e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,42311,-0.0389118838549033,0.00361089589330067,-0.0459892398057726,-0.0318345279040339,5.78028194934636e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,40483,-0.0428126227571957,0.00397268756474691,-0.0505990903840997,-0.0350261551302918,5.99472200940716e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.104928433436684,0.00975420889905064,-0.124046682878823,-0.085810183994545,7.06627570421694e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.0721594230854653,0.00670993071835789,-0.0853108872934467,-0.0590079588774838,7.6843318214536e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.0424435676259517,0.00394962059673104,-0.0501848239955445,-0.0347023112563588,7.94372063347697e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,40283,-0.128225642791535,0.0119302482536117,-0.151608929368614,-0.104842356214456,8.21202263977486e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0448330561788385,0.00417667501081599,-0.0530193392000378,-0.0366467731576392,9.01451657045564e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0635203177319546,0.00592055403995743,-0.0751246036502712,-0.0519160318136381,9.59376467204378e-27
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.0638601808293904,0.00595633026899888,-0.0755345881566282,-0.0521857735021527,1.04206163573397e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.060781656801769,0.00567091803547231,-0.0718966561512947,-0.0496666574522432,1.07027039322016e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.084689642880592,0.00790021132978923,-0.100174057086979,-0.0692052286742051,1.10390257116623e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.086629962421865,0.00809904078658175,-0.102504082363565,-0.0707558424801648,1.41946333511058e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,40342,-0.120388016974491,0.0112606984035653,-0.142458985845479,-0.0983170481035033,1.50813572082272e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.0581098637252489,0.00544616588350557,-0.0687843488569198,-0.0474353785935779,1.79373961768808e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0457813973627369,0.00429274255241419,0.0373676219600051,0.0541951727654687,1.89804586515575e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.0990301932995521,0.0092827095104134,-0.117224303939962,-0.0808360826591418,1.91512861572602e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0730727031650753,0.00685112791962304,-0.0865009138875365,-0.0596444924426142,1.9760034996129e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0892512765224998,0.00837978341393469,-0.105675652013812,-0.0728269010311879,2.20369119822271e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0840624494958801,0.00789785679593,-0.0995422488159029,-0.0685826501758573,2.37819577260588e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.0638682608997279,0.00600428832261336,-0.07563666601205,-0.0520998557874057,2.56106446358141e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.0444734534318117,0.00418027592756014,-0.0526667942498296,-0.0362801126137938,2.630842920408e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.0216609158585643,0.00203704741146473,0.0176683029320935,0.0256535287850352,2.65048763716179e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,40223,-0.0566242892837926,0.00532450779763042,-0.0670603245671482,-0.0461882540004369,2.75599661081002e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0538710440483792,0.00506940376573664,-0.0638070754292231,-0.0439350126675354,3.00055690757779e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0711441509973612,0.00671178197184195,-0.0842992436621714,-0.057989058332551,3.77861168615355e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,40283,-0.056390477471136,0.00532074662165876,-0.0668191408495872,-0.0459618140926848,4.04857427276459e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42636,0.0565657298270434,0.00534042942551443,0.0460984881530351,0.0670329715010517,4.11442702206685e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0405572391057412,0.00382760410890005,0.0330551350522971,0.0480593431591853,4.12480639952778e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.0421045884989399,0.00397494367183652,-0.0498954780957394,-0.0343136989021403,4.30149385084671e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.0514313044191547,0.00485916015137261,-0.060955258315845,-0.0419073505224644,4.66643642431184e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.0186073406852331,0.00176114622899201,-0.0220591872940574,-0.0151554940764088,5.6868048157504e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0805501875811269,0.00762454179710031,-0.0954942895034436,-0.0656060856588103,5.74365561964356e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42721,-0.0412873110595631,0.0039101337473617,-0.048951173204392,-0.0336234489147342,5.82075508451624e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42636,-0.130725596366584,0.0124023479497444,-0.155034198348083,-0.106416994385084,7.09849907365729e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42794,0.0303660498529196,0.0028820449056615,0.024717241837823,0.0360148578680161,7.39264117476353e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.113970572547294,0.0108128989857425,-0.13516385455935,-0.0927772905352389,7.43588322609378e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42538,-0.0781692579336968,0.00742323634908256,-0.0927188011778986,-0.063619714689495,7.90463412148339e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.0306608781033957,0.00291731438000114,-0.0363788142881979,-0.0249429419185934,9.77248815483691e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.134086699207679,0.0127593384369149,-0.159095002544032,-0.109078395871325,9.88256339087415e-26
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.0671481476864236,0.00640166739756598,-0.0796954157856529,-0.0546008795871943,1.27061476422923e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.0514050065091264,0.00491103921476643,-0.0610306433700687,-0.0417793696481842,1.6086225081474e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0444662428390407,0.00425241205087407,-0.0528009704587539,-0.0361315152193275,1.70546740695882e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42611,-0.0270046869764788,0.00258739014922065,-0.0320759716689513,-0.0219334022840063,2.10131602845196e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,42136,-0.0986880777750427,0.00945545767918754,-0.11722077482625,-0.0801553807238351,2.11595357812637e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.112451815715262,0.0107975990608782,-0.133615109874583,-0.0912885215559407,2.65506967063848e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42613,-0.0419101900170924,0.00402618050392922,-0.0498015038047937,-0.0340188762293912,2.803014796541e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.0610894993043868,0.00587111349625642,-0.0725968817570493,-0.0495821168517242,2.94518625336189e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.104453413998015,0.0100445640573307,-0.124140759550384,-0.0847660684456472,3.13818269721164e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0310721024594167,0.00298937301248054,0.0252129313549549,0.0369312735638786,3.28478533467428e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,40527,-0.0300058171018517,0.0028864643182453,-0.0356632871656125,-0.0243483470380909,3.37853683192154e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42692,-0.0669695628064646,0.00644568308600291,-0.0796031016550303,-0.0543360239578989,3.43252528279104e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,40199,-0.0503079077282334,0.00484752219768591,-0.0598090512356978,-0.040806764220769,4.0738715025516e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0610729674752585,0.00588859087544668,-0.072614605591134,-0.049531329359383,4.18062759631975e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42636,-0.074671239067891,0.00720245758356427,-0.088788055931677,-0.060554422204105,4.33436758739196e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.0269040625791553,0.00259514689455305,-0.0319905504924793,-0.0218175746658313,4.35048206654042e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.0918272005778338,0.00885991931087618,-0.109192642427151,-0.0744617587285165,4.51059250223457e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0692921083350001,0.0066862747813344,-0.0823972069064155,-0.0561870097635847,4.5188021430376e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.0881922729124789,0.00851446520221442,-0.104880624708819,-0.0715039211161386,4.98254926910746e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.0519295087117819,0.00501560612107583,-0.0617600967090905,-0.0420989207144732,5.21540498554958e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,40379,0.116681923767216,0.0113011646544955,0.0945316410444052,0.138832206490027,7.04134132489635e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,40451,-0.088402517146338,0.00856405369259888,-0.105188062383832,-0.0716169719088442,7.19584274218698e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42711,0.0404719364102418,0.00393248669075529,0.0327642624963615,0.0481796103241222,9.4794423972096e-25
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.117570809628512,0.0114321718859307,-0.139977866524936,-0.0951637527320881,1.02772129737831e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42711,-0.0634460681266309,0.00616998124398676,-0.0755392313648449,-0.0513529048884168,1.0364695619231e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.0424525179184681,0.00413212062435016,-0.0505514743421944,-0.0343535614947418,1.18844506729072e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.0768978920417078,0.00748848899070231,-0.0915753304634843,-0.0622204536199313,1.20641067246852e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.0564426414337944,0.00549876950926024,-0.0672202296719445,-0.0456650531956443,1.31271435013384e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42754,-0.061177790135851,0.00596303185509478,-0.0728653325718367,-0.0494902476998652,1.31921800221084e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.101041469157056,0.00985792777241481,-0.120363007590989,-0.0817199307231226,1.45972849716882e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42638,0.022624785412105,0.00221472388126291,0.0182839266048297,0.0269656442193803,2.07262517235325e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.114834518028594,0.0112417636983816,-0.136868374877422,-0.0928006611797665,2.17051925964882e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0560653291882668,0.0054922467128668,-0.0668301327454858,-0.0453005256310479,2.32745600178487e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,40451,-0.022308517480688,0.0021891501626337,-0.0265992517994501,-0.018017783161926,2.78689089170128e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.0176796653781487,0.00173593361529081,-0.0210820952641187,-0.0142772354921787,2.95597672675729e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0620998924995662,0.00610031818861814,-0.0740565161492577,-0.0501432688498746,2.99105009680354e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,40449,-0.0736568675461432,0.00724124446844105,-0.0878497067042877,-0.0594640283879988,3.36960497992952e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,40482,-0.0578704747646696,0.00569452648932005,-0.0690317466837369,-0.0467092028456023,3.70424820626895e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.06342295538968,0.00624689759149896,-0.0756668746690179,-0.051179036110342,4.1133165286803e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0914328373662661,0.00901185303464399,0.0737696054183639,0.109096069314168,4.22173754686693e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.060189793547292,0.00594068611427477,-0.0718335383312706,-0.0485460487633135,4.88091475997405e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42794,-0.0613705627169284,0.00606667655736308,-0.07326124876936,-0.0494798766644968,5.70321026839585e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.09654085627263,0.00957336377404094,-0.11530464926975,-0.0777770632755097,7.91023628149341e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.0574375676392764,0.00569517602960406,-0.0686001126573004,-0.0462750226212525,8.09416116628822e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0530706765443884,0.00526200532330176,-0.0633842069780598,-0.042757146110717,8.10028013082316e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.115103792884873,0.0114343152737002,-0.137515050821325,-0.0926925349484205,9.43410906899019e-24
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.131040596297316,0.0130320118130097,-0.156583339450815,-0.105497853143817,1.10175412414286e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42721,0.0490198100149156,0.00488210036437231,0.0394508933007458,0.0585887267290853,1.22128097866234e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0251639458658167,0.00251017025365968,0.0202440121686437,0.0300838795629896,1.4343256944742e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.0704246103824293,0.00702584731992876,-0.0841952711294896,-0.0566539496353689,1.45095204580326e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,42339,-0.0399450363038393,0.00398990485986893,-0.0477652498291824,-0.0321248227784962,1.64664853517915e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.084442564602107,0.00843273806097378,-0.100970731201616,-0.0679143980025984,1.67559754282797e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42611,-0.04022037124969,0.00402199051809304,-0.0481034726651524,-0.0323372698342277,1.83907600221617e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42611,0.0297383645348497,0.00297441965428223,0.0239085020124565,0.0355682270572429,1.87775322296868e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.0457865991769231,0.00458509022763791,-0.0547733760230934,-0.0367998223307528,2.11961952013772e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.0242017563449154,0.00242335463639022,-0.0289515314322402,-0.0194519812575906,2.17324993438697e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.044688738620432,0.00447479270713943,-0.0534593323264253,-0.0359181449144387,2.17749374939686e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0808912676379047,0.00811198860163865,-0.0967907652971165,-0.064991769978693,2.4418666800306e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0401382137930358,0.00402534667919139,-0.048027893284251,-0.0322485343018207,2.46063183243738e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0462807515214295,0.00464664664864969,0.0371733240900761,0.0553881789527828,2.7463168895285e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0382719315680921,0.00384156970046555,-0.0458014081810045,-0.0307424549551796,2.78698804844813e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.0280551391615101,0.00281931352598848,-0.0335809936724475,-0.0225292846505727,3.10709991976401e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.0818556698001324,0.00822657197541727,-0.0979797508719503,-0.0657315887283146,3.13804464804997e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42594,-0.0362629749913008,0.00364934165570097,-0.0434156846364747,-0.0291102653461269,3.4613662071202e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,40136,-0.0413975412152831,0.00416433617389363,-0.0495596401161146,-0.0332354423144516,3.46237026712255e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.0683900626766749,0.00688777806231739,-0.081890107678817,-0.0548900176745328,3.72778416527963e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,40449,-0.0690484284318224,0.00696115527686305,-0.082692292774474,-0.0554045640891708,4.27624396609977e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.105058364766288,0.0106063284098193,-0.125846768449534,-0.0842699610830418,4.73577045235275e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0912685133085874,0.00921120827030654,-0.109322481518388,-0.0732145450987866,4.77810487272958e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42754,-0.0504354813818948,0.00509551856187429,-0.0604226977631684,-0.0404482650006212,5.08243001886984e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42679,-0.0405502494417586,0.0041008789888683,-0.0485879722599405,-0.0325125266235768,5.60818811802166e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42679,-0.0453343842704603,0.00458864554162919,-0.0543281295320535,-0.0363406390088671,6.10096501894799e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.029615076686974,0.00299795502918459,-0.0354910685441758,-0.0237390848297722,6.39953993297435e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0699418979379824,0.0070846790915379,-0.0838278689573966,-0.0560559269185681,6.56893061176473e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.104576884000762,0.0105895692646857,-0.125332439759546,-0.0838213282419784,6.61903656611256e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0338400365040624,0.00343847166658378,0.0271006320375582,0.0405794409705666,9.19368042696614e-23
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,40539,-0.0320393493451355,0.00325923363874315,-0.0384274472770721,-0.025651251413199,1.02699920040313e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42636,-0.055618672454568,0.00565991245018734,-0.0667121008569352,-0.0445252440522008,1.02973773268929e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,40483,-0.0631247967955197,0.00643629806216102,-0.0757399409973553,-0.0505096525936841,1.28530169858019e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.0350077334364999,0.00357276362629898,-0.0420103501440459,-0.0280051167289539,1.41324145453297e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.0282732779661612,0.00288712738812254,-0.0339320476468814,-0.022614508285441,1.43665564975765e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.0236578799913656,0.00241752671362667,-0.0283962323500739,-0.0189195276326573,1.54120897259522e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.0333084096959584,0.00341225385414702,-0.0399964272500866,-0.0266203921418302,1.95596235647224e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.0284965564115792,0.00292151900636336,0.022770379159107,0.0342227336640514,2.1091169399182e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.0829673269814589,0.00850379550877115,-0.0996347661786503,-0.0662998877842674,2.12107289281608e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.0285906310624545,0.00293182636906859,-0.034337010745829,-0.0228442513790801,2.1486263743087e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,42476,-0.0634023095979296,0.00650554947878146,-0.0761531865763413,-0.0506514326195179,2.28285011513466e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,40283,-0.0680138615043314,0.0069783557948397,-0.0816914388622172,-0.0543362841464456,2.34965038418901e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.0486715460713242,0.00499578325387076,-0.0584632812489109,-0.0388798108937376,2.43146002623265e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.0725701969018803,0.00744904622383129,-0.0871703275005896,-0.057970066303171,2.43888331607297e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.0779999443711601,0.00800924272125033,-0.0936980601048107,-0.0623018286375094,2.52293134110671e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.0384946281639692,0.00395538113901225,-0.0462471751964332,-0.0307420811315052,2.60494805526589e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0362713200913911,0.00372627224195919,-0.0435748136856311,-0.0289678264971511,2.64530870145531e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.053132345302876,0.00546193030308499,-0.0638377286969226,-0.0424269619088294,2.81725157313541e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,40483,-0.0563410511169986,0.00579423695145252,-0.0676977555418455,-0.0449843466921516,2.92321260933628e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42754,-0.0921435255552972,0.00948232480144617,-0.110728882166132,-0.0735581689444627,3.00420022529304e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.0281523693690636,0.00290820678489973,-0.033852454667467,-0.0224522840706601,4.3138321887755e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42624,-0.0551896340352144,0.00570262922927128,-0.0663667873245861,-0.0440124807458427,4.41800878084096e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0379334481827997,0.00392186664849593,-0.0456203068138517,-0.0302465895517477,4.66810319462635e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42611,-0.0739864707143822,0.0076531890358521,-0.0889867212246523,-0.0589862202041121,4.89392899494487e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,42311,-0.0672194278091789,0.00695383425512776,-0.0808489429492293,-0.0535899126691285,4.9543539309334e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.0710873851288151,0.00735524456659768,-0.0855036644793465,-0.0566711057782836,5.19247369007907e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42754,-0.0346134120348634,0.00358403375350731,-0.0416381181917378,-0.0275887058779891,5.36909725249695e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.0758357926520194,0.00785525059007379,-0.091232083808564,-0.0604395014954747,5.74251335666247e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0598164002972979,0.00620028239635133,-0.0719689537941465,-0.0476638468004493,5.96059422037116e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0578639919119786,0.00600636637291441,-0.0696364700028909,-0.0460915138210664,6.80015338246699e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.0653869128202847,0.00678551666855007,-0.0786865254906428,-0.0520873001499265,6.81808988539394e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.0653421737639709,0.00678352178964554,-0.0786378764716762,-0.0520464710562657,7.07631426331301e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.0760090161255332,0.00789168256593485,-0.0914767139547655,-0.0605413182963009,7.17390545901606e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,40451,-0.0394331217593958,0.00409583445042278,-0.0474609572822244,-0.0314052862365671,7.4207637755207e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0641764025298049,0.0066750047915435,-0.0772594119212302,-0.0510933931383797,8.17265076141856e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0379257122483986,0.00394657536222186,-0.0456609999583534,-0.0301904245384437,8.57225654656246e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.045041608278805,0.00468733697481178,-0.0542287887494361,-0.035854427808174,8.6046263211849e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0822118454466847,0.00855651484866884,-0.0989826145500756,-0.0654410763432938,8.68858830869514e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,40483,-0.0742899182095882,0.00773607117101987,-0.0894526177047871,-0.0591272187143893,9.39765306701214e-22
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0818342928570764,0.00854630894307062,-0.0985850583854948,-0.065083527328658,1.22670469622938e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPN,Asporin,40511,0.027952223029111,0.00291960917044426,0.0222297890550403,0.0336746570031818,1.242439712682e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.0435316521303689,0.00454687108492764,-0.0524435194568271,-0.0346197848039108,1.24883345785322e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.101613588925133,0.0106218356560159,-0.122432386810924,-0.080794791039342,1.33625733855656e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42689,0.0478594027897304,0.00500629337393369,0.0380470677768203,0.0576717378026404,1.38031575432756e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,40482,-0.0542938501543697,0.00568573204432613,-0.0654378849612489,-0.0431498153474905,1.57695893048188e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,42476,-0.0791361217979665,0.00829080929535887,-0.0953861080168699,-0.0628861355790631,1.59488249449195e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42654,-0.0576645897651805,0.00604253160966207,-0.0695079517201181,-0.0458212278102428,1.62116596656853e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0706553924341557,0.00741309635371633,-0.0851850612874397,-0.0561257235808717,1.82123661484108e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.0689375850213588,0.00723562566031553,-0.0831194113155772,-0.0547557587271403,1.88211879850163e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42644,0.0273315474582461,0.00286942887371404,0.0217074668657666,0.0329556280507256,1.92686223285264e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0343427711334684,0.00360725860920233,-0.041412998007505,-0.0272725442594319,2.01211205921515e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,40449,-0.0687703823282295,0.00722106259045789,-0.0829236650055269,-0.054617099650932,2.01460017244161e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.0966257106687883,0.0101566855046134,-0.116532814257831,-0.076718607079746,2.21568947411035e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0680374904671808,0.00715405410945147,-0.0820594365217056,-0.0540155444126559,2.21964567455179e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.0441651327440443,0.0046472852290729,0.0350564536950614,0.0532738117930272,2.36945367637413e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.048596770281178,0.00511411079227396,-0.058620427434035,-0.0385731131283211,2.48323557780349e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0318054663073629,0.00335029167545567,-0.0383720379912561,-0.0252388946234698,2.60761924980247e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.041529620387744,0.00437821857985658,-0.0501109288042629,-0.0329483119712251,2.82057129891181e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.0425956981749714,0.00449064221699854,-0.0513973569202885,-0.0337940394296542,2.91403072255407e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.0950896789225022,0.0100257967220371,-0.114740240497695,-0.0754391173473095,2.93590013409438e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.051661872315789,0.00545443670800861,0.0409711763680921,0.0623525682634859,3.21295716875166e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,40539,-0.0201989479231582,0.00213446032809469,-0.0243824901662238,-0.0160154056800927,3.57261422901452e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.0381074894551966,0.00402830976027719,-0.0460029765853399,-0.0302120023250533,3.58721478709015e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42534,-0.068439534372456,0.00723583085122603,-0.0826217628408591,-0.054257305904053,3.64184744690199e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42754,-0.04681107812496,0.00495894038583497,-0.0565306012811965,-0.0370915549687235,4.33780227236218e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,42311,-0.031349851359108,0.00332378333492697,-0.0378644666955649,-0.0248352360226511,4.69204082278709e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0678017650192388,0.00719276128517785,-0.0818995771381874,-0.0537039529002902,5.09524925003787e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42611,-0.0433960658977552,0.00460616682762761,-0.0524241528799053,-0.0343679789156051,5.17363019827312e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42556,-0.0809380093278902,0.00859851279061994,-0.0977910943975052,-0.0640849242582751,5.59813529213315e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.0676544214600634,0.00718790358654347,-0.0817427124896886,-0.0535661304304382,5.63104898291137e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0559667308859018,0.00594932057193041,-0.0676273992068854,-0.0443060625649182,5.92980360397112e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,42333,-0.0492843713888562,0.00523915036268143,-0.0595531060997118,-0.0390156366780006,5.9444676501689e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.0294618837071583,0.00313414207720236,0.0233189652358417,0.0356048021784749,6.30391056840428e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.101173227053749,0.0107662312155389,-0.122275040236205,-0.0800714138712927,6.48766020549527e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42689,-0.0965737472218712,0.0102859881881258,-0.116734284070598,-0.0764132103731446,7.02245541725731e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,40430,-0.0415068859764803,0.0044358746337376,-0.050201200258606,-0.0328125716943546,9.7494535756618e-21
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42587,-0.0867708588232931,0.00928320860608552,-0.104965947691221,-0.0685757699553655,1.04174292856097e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,40054,-0.0703660229250129,0.0075280983843741,-0.0851210957583861,-0.0556109500916396,1.07698916526263e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0475359568694806,0.00508989240845562,-0.0575121459900536,-0.0375597677489076,1.12360636434539e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.0938591262180621,0.0100472962596231,-0.113551826886923,-0.0741664255492007,1.12970599593115e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.052056514249354,0.00558401836974442,-0.063001190254053,-0.0411118382446549,1.35242595002298e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0432052828455595,0.00464384194815288,-0.0523072130639392,-0.0341033526271799,1.61173999885158e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,40223,-0.0650401259865804,0.00700948713537571,-0.0787787207719168,-0.0513015312012441,2.03232404210842e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NBN,Nibrin,42370,-0.0513030389949823,0.00553537555167166,-0.0621523750762587,-0.0404537029137058,2.18309695464271e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0311684791461547,0.00336644845393415,-0.0377667181158656,-0.0245702401764438,2.45485492636638e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0642663677553256,0.00694538879394025,-0.0778793297914485,-0.0506534057192027,2.57275372998582e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0319275701897008,0.00345544847295247,-0.0387002491966877,-0.025154891182714,2.83247280236621e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.0611617299817494,0.00662463421995568,-0.0741460130528625,-0.0481774469106362,3.11697826660721e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0728043616243419,0.00788861396809455,-0.0882660450018072,-0.0573426782468766,3.13546904703853e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0320904190842411,0.00348496949164506,-0.0389209592878654,-0.0252598788806168,3.80124440303836e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.0615255616313243,0.00668083115294202,-0.0746199906910907,-0.048431132571558,3.87658950023569e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0810285441877345,0.00879971507669747,-0.0982759857380616,-0.0637811026374075,3.91654646876913e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42721,-0.10349886799269,0.0112525166701247,-0.125553800666134,-0.0814439353192454,4.17925496472626e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.0594803766388526,0.0064730384061407,-0.0721675319148884,-0.0467932213628169,4.55486049426042e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42594,-0.0635510229962145,0.00692351048984157,-0.0771211035563039,-0.049980942436125,4.97925072140387e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.0446844328725359,0.00487164656174457,-0.0542328601335553,-0.0351360056115165,5.42583055868269e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42587,-0.0520768308430919,0.00568062869940178,-0.0632108630939194,-0.0409427985922644,5.54059075148199e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.0671809739892753,0.00734248765541986,-0.0815722497938982,-0.0527896981846523,6.52813464040179e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.0720607281316413,0.00787414023210378,-0.0874940429865647,-0.0566274132767179,6.60016388022137e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,40451,-0.0580730970928579,0.00634653298962938,-0.0705123017525315,-0.0456338924331843,6.64939802181401e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0630836445689155,0.00689832146783096,-0.0766043546458642,-0.0495629344919668,6.99624399239368e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDK,Midkine,42638,-0.0482576047245703,0.00528012970080665,-0.0586066589381513,-0.0379085505109893,7.16336529755594e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.0791189988748359,0.00865621285315495,-0.0960851760670196,-0.0621528216826522,7.30094450781877e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.0535466071611315,0.00586180190227822,-0.0650357388895968,-0.0420574754326662,7.47702819344397e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.0791309244937779,0.00867528368775998,-0.0961344805217875,-0.0621273684657684,8.70483746770348e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42754,0.0082473372766745,0.000904771613202467,0.00647398491479766,0.0100206896385513,8.92612050432525e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0727708038533554,0.00798684156942464,-0.0884250133294277,-0.0571165943772831,9.30024105558509e-20
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.0627748023722106,0.00690077553331314,-0.0763003224175043,-0.0492492823269168,1.05884625055237e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.0553316600697807,0.00608646468053286,-0.0672611308436251,-0.0434021892959363,1.12091094481462e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0332247647020579,0.00365527424695461,-0.0403891022260889,-0.0260604271780268,1.13260560914642e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,40283,-0.051091554178992,0.00562858542850308,-0.0621235816188581,-0.040059526739126,1.3026059588611e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42754,-0.0460921017498526,0.00508060774006346,-0.0560500929203769,-0.0361341105793282,1.32529735595225e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42636,-0.0979341686333363,0.0108140196390643,-0.119129647125902,-0.0767386901407703,1.53429038178355e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.093664278403695,0.0103437885762032,-0.113938104013053,-0.0733904527943368,1.55034962131212e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,42357,0.0220472404198303,0.00243524303732981,0.0172741640666639,0.0268203167729967,1.57841711309994e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.0358137709399968,0.00395635064072608,-0.0435682181958199,-0.0280593236841737,1.63083741116908e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.0730957644017735,0.00807836316999246,-0.0889293562149587,-0.0572621725885883,1.65372084020591e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0892569735206627,0.00986655921259975,-0.108595429577358,-0.0699185174639672,1.67985879696207e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.0373252388361825,0.00412516232609193,-0.0454105569953226,-0.0292399206770423,1.69112922007042e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,40449,-0.0805266715417897,0.0089115690806929,-0.0979933469399477,-0.0630599961436316,1.8865774844343e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,40283,0.0488369540008731,0.00540790577685527,0.0382374586782367,0.0594364493235094,1.98823065467772e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0569701808694152,0.00631533868280874,-0.0693482446877203,-0.0445921170511101,2.16595382253086e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0258690760897082,0.00286949793486852,-0.0314932920420505,-0.0202448601373659,2.22688564461311e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,42311,-0.0666697479448941,0.00739953761028497,-0.0811728416610526,-0.0521666542287355,2.34255329834074e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,40483,-0.0994091977416284,0.0110482984868656,-0.121063862775885,-0.0777545327073717,2.67282421782972e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0729637259906776,0.00812605317865622,-0.0888907902208438,-0.0570366617605114,3.09155528902531e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.0249344578271947,0.00277694952564521,-0.0303772788974593,-0.0194916367569301,3.16095637914995e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0448674671035074,0.00499935338617942,-0.054666199740419,-0.0350687344665957,3.2159946402955e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.0712537959419071,0.00793712724989769,-0.0868105653517066,-0.0556970265321076,3.22507900915958e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0341599780243636,0.00380930279967372,-0.0416262115117241,-0.0266937445370031,3.42971113610035e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,40539,-0.0198463251101917,0.00221323427797679,-0.0241842642950262,-0.0155083859253572,3.519919551799e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0625668099828283,0.00697937681411863,-0.0762463885385008,-0.0488872314271558,3.52498660625045e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.0368807388661455,0.00412403106701904,-0.0449638397575028,-0.0287976379747882,4.29233596578512e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.0695446552425713,0.00778752045247721,-0.0848081953294266,-0.0542811151557159,4.90646096374135e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42597,-0.037873029108109,0.00424862748353002,-0.0462003389758278,-0.0295457192403901,5.54237793226101e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0281322012261213,0.00315530053947518,-0.0343165902834926,-0.0219478121687499,5.60230267882154e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,0.0272328485438114,0.00305606627065473,0.0212429586533281,0.0332227384342947,5.6979576578611e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.0334873134572799,0.00375920077040373,-0.0408553469672712,-0.0261192799472886,5.85341692557484e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,40440,-0.0267671386757313,0.00300579462426812,-0.0326584961392968,-0.0208757812121658,6.14717952876435e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,40483,-0.0213808890401118,0.00240252943545604,-0.0260898467336056,-0.0166719313466179,6.47431962360271e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.063575026302675,0.00714789046629853,-0.0775848916166201,-0.0495651609887299,6.79298438563632e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.0324262071863908,0.00365001857236721,-0.0395802435882305,-0.0252721707845511,7.27251397472731e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.0597090843349585,0.00672282870666691,-0.0728858286000256,-0.0465323400698914,7.44050226055709e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.0354440451094732,0.00399229449007,-0.0432689423100104,-0.027619147908936,7.67027334193114e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.0269408720788193,0.00303601393454369,0.0209902847671136,0.0328914593905249,7.95230885090563e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42587,-0.0545152251120474,0.00614370042952569,-0.0665568779539178,-0.0424735722701771,7.98796008318919e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0285291097766495,0.00321539172310977,-0.0348312775539446,-0.0222269419993543,8.21496120168202e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.0299046801363817,0.00337648749655834,-0.0365225956296361,-0.0232867646431274,9.46797991794652e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,-0.0215961057453862,0.00243942309914791,-0.0263773750197161,-0.0168148364710563,9.57448730037281e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0249673866660488,0.00281974867224654,0.0194406792684456,0.030494094063652,9.65611504338115e-19
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,40449,-0.0535972746588303,0.00606295163055425,-0.0654806598547167,-0.041713889462944,1.09807145132558e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.0889088555214388,0.0100605178123658,-0.108627470433676,-0.0691902406092019,1.10029499668365e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.0535715248249376,0.00606200188240745,-0.0654530485144562,-0.041690001135419,1.12954885019567e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,42370,-0.0413954666345677,0.00468872698745991,-0.0505853715299891,-0.0322055617391463,1.19110423475211e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0400424258736363,0.00453629155011757,-0.0489335573118668,-0.0311512944354059,1.21278874190967e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.0231679756969756,0.00262487086997299,0.0180232287918286,0.0283127226021227,1.21303000484827e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,40511,-0.0586623045219202,0.0066530398643716,-0.0717022626560886,-0.0456223463877519,1.34295203903043e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0601203947522152,0.00682438801684818,-0.0734961952652377,-0.0467445942391928,1.43868227505145e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0263351885079166,0.00299381926730859,0.0204673027439918,0.0322030742718415,1.61979212754519e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0307955415624559,0.00350346412093098,-0.0376623312394806,-0.0239287518854312,1.68238731085695e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42636,-0.0225750123907892,0.00257043259532421,-0.0276130602776247,-0.0175369645039538,1.78904439665083e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.0250418917417741,0.00285070569616313,-0.0306292749062538,-0.0194545085772943,1.80457135499843e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0938682875080806,0.0106962565489432,-0.114832950344009,-0.0729036246721519,1.89997450129567e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,40116,-0.0708436830400638,0.0080742930601478,-0.0866692974379535,-0.0550180686421741,1.98081016289442e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.0294964673264391,0.00336491116565976,0.022901241441746,0.0360916932111323,2.07238194541093e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.0397467930430826,0.00453339282631991,-0.0486322429826696,-0.0308613431034956,2.09403042527169e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,40116,-0.0597334021270013,0.00682275972157789,-0.073106011181294,-0.0463607930727086,2.3410671542532e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.0217511340782391,0.0024872969483156,0.0168760320595406,0.0266262360969377,2.49482627298088e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0545581758516862,0.00624365178699688,-0.0667957333542,-0.0423206183491723,2.70195972485649e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.131455460325303,0.015075971374903,-0.161004364220113,-0.101906556430493,3.18500778347518e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.0226591339519465,0.00259989138520915,0.0175633468369366,0.0277549210669564,3.2287342623204e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,40451,-0.0292954012055483,0.00336359037235854,-0.0358880383353711,-0.0227027640757256,3.47592930189817e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.0961315247403946,0.0110431230651233,-0.117776045948036,-0.0744870035327529,3.61192752299337e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.0435952519726192,0.00500782392368639,-0.0534105868630445,-0.0337799170821938,3.61559720891132e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.0310269640504071,0.00356655615156555,-0.0380174141074756,-0.0240365139933386,3.79886171759965e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,40283,-0.0508892445867553,0.00585264162330477,-0.0623604221684327,-0.039418067005078,3.95323734710308e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.0501013063790473,0.00576955648390597,-0.061409637087503,-0.0387929756705916,4.36957315319123e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0512123688026723,0.00589862445041982,-0.0627736727254951,-0.0396510648798494,4.43351849107586e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0599662817823904,0.0069073305980483,-0.0735046497545651,-0.0464279138102157,4.45910017000574e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,40539,-0.0373644823767453,0.00430605740129967,-0.0458043548832926,-0.0289246098701979,4.6090300820006e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0851600882516685,0.00981855378236186,-0.104404453665098,-0.0659157228382392,4.68238053054598e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42587,-0.0268321943775534,0.00309481133999301,-0.0328980246039397,-0.0207663641511671,4.81091266981659e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0603001157853578,0.0069705711213863,-0.0739624351832749,-0.0466377963874406,5.83633858745127e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.0313038633427997,0.00362089497180537,-0.0384008174875383,-0.0242069091980612,5.97278010720795e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.0792335615059812,0.00916429653790545,-0.0971955827202759,-0.0612715402916865,6.07621472171464e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.0290487250418035,0.00336254774139515,-0.035639318614938,-0.0224581314686691,6.30216201155229e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42585,-0.0781012802056913,0.00904380200096599,-0.0958271321275847,-0.060375428283798,6.48014011543052e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0763218106918135,0.00883996426873806,-0.0936481406585401,-0.058995480725087,6.59870207359138e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,40483,-0.0256813639881934,0.00297673561913474,-0.0315157658016975,-0.0198469621746894,7.11747290333104e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0582122328701396,0.0067539608911888,-0.0714499962168696,-0.0449744695234095,7.6545780914436e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.0781865772980795,0.00907601515121156,-0.0959755669944542,-0.0603975876017048,7.95088954619919e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.0238968617680265,0.00277520726170902,0.0184574555350768,0.0293362680009762,8.20914379737698e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.0388393830429808,0.00451154692232372,-0.0476820150107353,-0.0299967510752263,8.20916082909588e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.0433588238443657,0.005035588753116,-0.0532285778004731,-0.0334890698882583,8.23738526111442e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0311181952024042,0.003615378295952,-0.0382043366624701,-0.0240320537423383,8.31478938279408e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.0372362309331905,0.00432768244456743,-0.0457184885245426,-0.0287539733418383,8.51980759127065e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0293940165466814,0.00341908814439325,-0.0360954293096922,-0.0226926037836706,9.0971324818473e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42636,-0.0331954146633367,0.00386271448273287,-0.0407663350494931,-0.0256244942771802,9.33380050883124e-18
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.0717030213091491,0.0083493130038268,-0.0880676747966496,-0.0553383678216486,1.00524962295558e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.0311060986744534,0.00362300322592188,-0.0382071849972603,-0.0240050123516465,1.02056261681838e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,40532,-0.0649480164272171,0.00756686375200301,-0.079779069381143,-0.0501169634732912,1.04268114696536e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.0708865184914781,0.00826631719348006,-0.087088500190699,-0.0546845367922572,1.09618715920017e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.0481062371780002,0.00561716273990282,-0.0591158761482098,-0.0370965982077907,1.23332541003271e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2,Brorin,42456,-0.0364459829885994,0.00425779712864023,-0.0447912653607343,-0.0281007006164646,1.25377933572625e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.0470368989212052,0.00549583958073243,-0.0578087444994408,-0.0362650533429697,1.26750062382972e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.0473117213907446,0.00553501190983145,-0.0581603447340143,-0.036463098047475,1.38886084021243e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,40408,-0.0829450325187527,0.00970591313335203,-0.101968622260123,-0.0639214427773827,1.44125580534506e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,40116,-0.0430321987383028,0.00504380142534517,-0.0529180495319793,-0.0331463479446262,1.63258352468475e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0498985689657693,0.00585466465346523,-0.0613737116865612,-0.0384234262449775,1.72110823170549e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0423118092520872,0.00496461466129672,-0.0520424539882288,-0.0325811645159457,1.72231028228443e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42592,-0.0494129583531406,0.00580614633237208,-0.0607930051645899,-0.0380329115416913,1.91510514375106e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0379676117160025,0.0044646968087926,-0.046718417461236,-0.029216805970769,2.02451192211279e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.0646976293822149,0.00762228790846702,-0.0796373136828103,-0.0497579450816196,2.37056912582129e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42594,-0.0418435410851433,0.00493401026645517,-0.0515142012073955,-0.0321728809628912,2.47230955171909e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42495,0.0302269583273872,0.00356422711173405,0.0232410731883885,0.037212843466386,2.47383458532344e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.028364057348415,0.00334670000565376,-0.0349235893594963,-0.0218045253373336,2.6371351641642e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0276346657631266,0.00326835210822938,-0.0340406358952562,-0.0212286956309971,3.06856024368975e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.0678412284963562,0.0080498143707623,-0.0836188646630503,-0.0520635923296621,3.88562314981316e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,40182,-0.0365790148491102,0.00434657675914273,-0.0450983052970299,-0.0280597244011904,4.39359823120682e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0351712437793848,0.00418086519187667,-0.0433657395554631,-0.0269767480033065,4.41864249597195e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.0415078526571374,0.00493584524721404,-0.0511821093416769,-0.0318335959725979,4.5398979700928e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.0525108474403219,0.00624567903144075,-0.0647523783419457,-0.040269316538698,4.61455926452004e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,40494,-0.0408112262363316,0.004869117923311,-0.0503546973660211,-0.031267755106642,5.83671023709719e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.0516950167111575,0.00617797327582684,-0.0638038443317781,-0.0395861890905369,6.57657489949128e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.0378731245628281,0.00452755018903374,-0.0467471229333342,-0.028999126192322,6.73301007666865e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0243614816959519,0.00291861742287051,-0.0300819718447781,-0.0186409915471257,7.69029872655642e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,0.0311450587234015,0.00373689525609035,0.0238207440214644,0.0384693734253386,8.52871927712678e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,42475,-0.0458081617510204,0.00549824673332854,-0.0565847253483444,-0.0350315981536965,8.7666380920316e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,40449,-0.0887236793824865,0.0106498459737939,-0.109597377491123,-0.0678499812738504,8.94623059816159e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0546123982194651,0.00656100992128585,-0.0674719776651854,-0.0417528187737448,9.50373392125124e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,40223,-0.0626719313985298,0.00753287445329616,-0.0774363653269902,-0.0479074974700693,9.84900440460727e-17
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.111575855850883,0.0134249513547113,-0.137888760506117,-0.0852629511956486,1.05990201954689e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42676,-0.0787164446972474,0.0094751373751299,-0.097287713952502,-0.0601451754419928,1.06838917218352e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.0710661050609939,0.00856197948852449,-0.0878475848585019,-0.0542846252634859,1.138189957256e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,40250,-0.0564707332239245,0.00680355332110808,-0.0698056977332963,-0.0431357687145526,1.16034942939406e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.0684543967313853,0.00825609648201568,-0.084636345836136,-0.0522724476266345,1.22444034370239e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0383760888238095,0.00462956801946347,-0.0474500421419579,-0.0293021355056611,1.26793652120127e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.077467139173649,0.00935161695017943,-0.0957963083960007,-0.0591379699512974,1.32779618951891e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,42346,-0.0368912355342196,0.00445442011450373,-0.0456218989586469,-0.0281605721097923,1.32824239299443e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,40116,-0.0339605610152423,0.00410084392754061,-0.0419982151132219,-0.0259229069172627,1.35980706083869e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.0394451871870457,0.00476666127362806,-0.0487878432833567,-0.0301025310907347,1.4014228431587e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.0245397615936403,0.00296609231585127,-0.0303533025327088,-0.0187262206545718,1.42192735764764e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.0774226273406073,0.00936850259410004,-0.0957848924250434,-0.0590603622561712,1.56377595004037e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,42476,0.0425314438867741,0.00516844518627185,0.0324012913216813,0.0526615964518669,2.06158598889215e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42636,-0.0298713153050855,0.00363261102100229,-0.03699123290625,-0.022751397703921,2.16392645848217e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.0965139494914923,0.0117376353771044,-0.119519714830617,-0.0735081841523678,2.20910025869275e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.0232857798325298,0.00283447821941532,-0.0288413571425838,-0.0177302025224758,2.30888044699323e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.110718238131343,0.0134777378371773,-0.137134604292211,-0.0843018719704754,2.31565108966748e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.0262370288621001,0.00319511383793105,-0.032499451984445,-0.0199746057397553,2.3791021608262e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0467579274750432,0.00569506834481808,-0.0579202614308867,-0.0355955935191998,2.41176158937702e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.0324983211574398,0.00396380932602861,-0.0402673874364558,-0.0247292548784237,2.65318081012611e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0389060726505098,0.0047537976463763,-0.0482235160374073,-0.0295886292636122,2.99167409170612e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0879916602493709,0.0107492404736274,-0.109060171577681,-0.0669231489210612,2.99969713177496e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42597,-0.0396184916020098,0.00484300640692873,-0.0491107841595901,-0.0301261990444295,3.07824790038685e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0544739949974581,0.00666233190760036,-0.0675321655363549,-0.0414158244585614,3.23657144445809e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.0502128793907703,0.00614914812776242,-0.0622652097211846,-0.0381605490603559,3.47438091356292e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0644517632320423,0.0078938668810217,-0.0799237423188448,-0.0489797841452398,3.50560281795544e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0326437535902253,0.00400207043489357,-0.0404878116426167,-0.0247996955378339,3.7472767238677e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42587,-0.0788061008872759,0.00969511600633403,-0.0978085282596906,-0.0598036735148612,4.72824190733315e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.0634094678902244,0.00780731542202669,-0.0787118061173967,-0.0481071296630521,4.99986297955436e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.0396256773683929,0.00488161464612864,-0.049193642074805,-0.0300577126619808,5.18872838051289e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.0302190672742039,0.00372383747698965,-0.0375177887291036,-0.0229203458193041,5.2734206237962e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0469942861434189,0.00579371096267478,-0.0583499596302615,-0.0356386126565764,5.44098187083928e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.0798039725723273,0.00984759893567143,-0.0991052664862433,-0.0605026786584113,5.78513114825569e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.0198076324905795,0.0024449569109099,-0.0245997480359629,-0.0150155169451961,5.89215929880907e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0551403510269504,0.00681029349070344,-0.0684885262687292,-0.0417921757851717,6.25099190599593e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42711,0.0256395296230719,0.0031682086130416,0.0194298407415104,0.0318492185046334,6.32826765240724e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.0631937678561257,0.00780897202135989,-0.0784993530179911,-0.0478881826942603,6.44608510708128e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.029706668943078,0.0036720090140135,0.0225095312756115,0.0369038066105444,6.58997186481518e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0411055767012468,0.00508468981520239,-0.0510715687390435,-0.0311395846634501,6.91190156957431e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0524658115389048,0.00649211432358008,-0.0651903556131218,-0.0397412674646879,6.93930795161353e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42546,-0.0468647575491337,0.00580379025079576,-0.0582401864406934,-0.035489328657574,7.33134734711015e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.032297626293443,0.00400653421319778,-0.0401504333513106,-0.0244448192355753,8.19060801261647e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.0281728436513686,0.00349496991196244,0.0213227026239222,0.035022984678815,8.21132386857846e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.0462193363011673,0.00574120419488017,-0.0574720965231324,-0.0349665760792021,8.93532550026156e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0792029571081771,0.0098446518075696,-0.0984984746510135,-0.0599074395653407,9.32453700969697e-16
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42494,-0.0579947858321651,0.00721802045765871,-0.0721421059291762,-0.0438474657351541,1.01652902354022e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42611,-0.0227641739600412,0.00283398052673215,-0.0283187757924362,-0.0172095721276462,1.03363246796252e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAYN,Layilin,42476,-0.0314594776865057,0.00391696338533146,-0.0391367259217553,-0.023782229451256,1.04273341648477e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.0337472958826681,0.00420150901995897,-0.0419822535617877,-0.0255123382035485,1.05286764845933e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0513514131328814,0.00640089669674225,-0.0638971706584962,-0.0388056556072666,1.12042500550397e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,40199,-0.041609472284397,0.00519692761045665,-0.0517954504008921,-0.031423494167902,1.29839521837449e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,40199,-0.0352207921717053,0.00440084563690191,-0.043846449620033,-0.0265951347233776,1.33417630509573e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.0326722454488139,0.00408719829235359,-0.040683154101827,-0.0246613367958009,1.41395350757784e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.05945506476658,0.00744277551541671,-0.0740429047767968,-0.0448672247563633,1.50481405097883e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0765718370017604,0.00959064294159337,-0.0953694971672834,-0.0577741768362374,1.55367637915174e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0234935900095963,0.00294688854745975,-0.0292694915626174,-0.0177176884565752,1.68131567102228e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0426715858303975,0.00535642557026285,-0.0531701799481126,-0.0321729917126823,1.76425033146389e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.0375271634869548,0.00471209211115294,-0.0467628640248145,-0.028291462949095,1.82968655486434e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.104452333492934,0.0131230663324835,-0.130173543504601,-0.078731123481266,1.86596708854622e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0356706209354879,0.00448175976056597,-0.0444548700661972,-0.0268863718047786,1.87124142257352e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.0249783105638509,0.0031384533562075,-0.0311296791420176,-0.0188269419856842,1.90424179324285e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.055705586341514,0.00700639293764142,-0.0694381164992912,-0.0419730561837369,2.03201536333909e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,40283,-0.0883709941163745,0.0111194003739537,-0.110165018849324,-0.0665769693834253,2.08807171606488e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,0.0125568140989617,0.0015805101605224,0.00945901418433776,0.0156546140135856,2.12957010594241e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,40451,-0.0391481384962468,0.00492751588133878,-0.0488060696236708,-0.0294902073688228,2.13015563554679e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.0880735192462589,0.011106063339275,-0.109841403391238,-0.0663056351012799,2.3613757848278e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.0883784468174282,0.0111445817541694,-0.1102218270556,-0.0665350665792563,2.39458250966633e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42592,-0.0544922359946848,0.00687374567880123,-0.0679647775251352,-0.0410196944642344,2.4103351902784e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.0662320616207468,0.00836492572485457,-0.0826273160414617,-0.0498368072000318,2.64957271514234e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0350898050827815,0.00443279398973786,0.0264015288628953,0.0437780813026678,2.68863931963436e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.0431069132751639,0.00545456695087306,-0.0537978644988751,-0.0324159620514527,2.94135234987358e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42636,-0.0344057701001223,0.00436174128626208,-0.042954783021196,-0.0258567571790487,3.30462366417084e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.0640598154910617,0.00812329232933653,-0.0799814684565613,-0.0481381625255621,3.3664737306474e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,40527,-0.0676763118902741,0.00858672852017408,-0.0845062997898153,-0.0508463239907329,3.53058036311294e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.0760126651444293,0.00965163843081729,-0.0949298764688312,-0.0570954538200274,3.70094878517653e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0952322740527057,0.0120925144676144,-0.11893360240923,-0.0715309456961816,3.71023738409672e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.0558802954265046,0.00709776813001531,-0.0697919209613346,-0.0419686698916746,3.7867239675525e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASN,Vasorin,42449,0.0224835123411995,0.00285839491156024,0.0168810583145414,0.0280859663678575,3.95083355685106e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.025281823015805,0.00321533919563361,-0.0315838878392468,-0.0189797581923631,4.09654491930872e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0536158009683075,0.00682046886986701,-0.0669839199532468,-0.0402476819833681,4.16245740598565e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0235880118674809,0.00300353028254297,0.0177010925136967,0.0294749312212651,4.35018691950528e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.0298720413848074,0.00380458541753894,-0.0373290288031837,-0.0224150539664311,4.48939629746721e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.0460899144745036,0.0058703433842776,-0.0575957875076877,-0.0345840414413195,4.49548081769745e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.0342269383892598,0.00435950840112464,-0.0427715748554641,-0.0256823019230555,4.50380889088222e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0716395649440964,0.00912616227969832,-0.0895268430123051,-0.0537522868758877,4.54952335468969e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.0200445298560213,0.00255614034624081,-0.0250545649346533,-0.0150344947773894,4.77675958790005e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,40283,-0.0466268149185665,0.00594678863333661,-0.0582825206399063,-0.0349711091972268,4.89189434426261e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.025141990286399,0.003209036137594,-0.0314317011160833,-0.0188522794567148,5.11902262578849e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.0721064363322781,0.00920362509879769,-0.0901455415259216,-0.0540673311386346,5.12745817706117e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,42346,-0.0315000805224591,0.00402490661007344,-0.0393888974782031,-0.0236112635667152,5.40752473445695e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,40449,-0.0613660817748152,0.00784612734609724,-0.0767444913731658,-0.0459876721764646,5.69957432310964e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.0457733609765795,0.00585503549682454,-0.0572492305503556,-0.0342974914028034,5.86685383019974e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42554,-0.067824015791357,0.00868074328880695,-0.0848382726374186,-0.0508097589452953,5.99235835619296e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2,Complement C2,42663,-0.0185398646650054,0.00237397949409907,-0.0231928644734396,-0.0138868648565712,6.15888484869771e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPART,Spartin,40283,-0.0620677890382946,0.00794938145926261,-0.0776485766984493,-0.0464870013781399,6.33954750171496e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0230835614098484,0.00296007505052211,-0.0288853085088717,-0.0172818143108251,6.8455199079444e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.030730767388662,0.00394371502371803,0.0230010859421747,0.0384604488351493,7.06660309159605e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.0386865209778359,0.00496376077904885,-0.0484154921047716,-0.0289575498509001,7.07493773713014e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.0257910111493555,0.00331148030310246,-0.0322815125434363,-0.0193005097552747,7.396599961059e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0326083635186058,0.00418778056072828,-0.0408164134176332,-0.0244003136195783,7.40436724791765e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,40483,-0.0564099238304094,0.00725053557537304,-0.0706209735581406,-0.0421988741026783,7.87756121355942e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.02768361507822,0.00356222087596772,-0.0346655679951167,-0.0207016621613232,8.32297298234021e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0319243126575728,0.00411253397036213,-0.0399848792394825,-0.023863746075663,8.9099151654556e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42794,0.0242483397294487,0.00312433336511602,0.0181246463338213,0.0303720331250761,9.0165540802151e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0727840818416252,0.00937849689699028,-0.0911659357597261,-0.0544022279235242,9.06487648092554e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42711,-0.030152908874897,0.00388710082684766,-0.0377716264955184,-0.0225341912542756,9.30457973153708e-15
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42754,-0.0489273698537562,0.00632078680365741,-0.0613161119889247,-0.0365386277185877,1.05840362383954e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.0414290839414994,0.00535890600021813,-0.0519325397019269,-0.0309256281810719,1.1589127912344e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0699745072434271,0.0090752801555562,-0.0877620563483173,-0.052186958138537,1.34192518903424e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C3,Complement C3,39989,-0.0377828653066241,0.00490102373844794,-0.0473888718339821,-0.0281768587792661,1.37758003320211e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0663667144553607,0.00862221128396575,-0.0832662485719336,-0.0494671803387878,1.49105389572939e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42580,-0.0230817220868775,0.00299988519746224,-0.0289614970739035,-0.0172019470998516,1.5231543314232e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.0238257040466993,0.00309934537570088,0.0177509871103256,0.0299004209830731,1.60508030918738e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42669,-0.0238382515222481,0.00310227563328482,-0.0299187117634864,-0.0177577912810099,1.64674793413876e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0602436163050001,0.00784348868211811,-0.0756168541219516,-0.0448703784880486,1.69099391598777e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.0320143981538368,0.00416879951450174,-0.0401852452022602,-0.0238435511054134,1.72831793223022e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.0537124245827166,0.00699936681114075,-0.0674311835325525,-0.0399936656328808,1.78360124205675e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0397991390935475,0.00519331869638559,-0.0499780437384633,-0.0296202344486318,1.96101939504808e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39870,-0.0984556831586087,0.012861379778657,-0.123663987524776,-0.073247378792441,2.09776921982469e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.03803309256947,0.00497063178102732,-0.0477755308602836,-0.0282906542786565,2.12327724306729e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.0228903609644894,0.00300065293593781,-0.0287716407189275,-0.0170090812100513,2.53422435520984e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,40511,-0.0427467330633633,0.00560800558382102,-0.0537384240076524,-0.0317550421190741,2.68794381577012e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0300413044010258,0.00394223723373483,0.0223145194229055,0.0377680893791461,2.69874174744817e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0526354301066173,0.00691106075643822,-0.0661811091892362,-0.0390897510239984,2.78852772391863e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0186089781613865,0.00244359956699824,-0.023398433312703,-0.0138195230100699,2.80593191576154e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.061941269921462,0.00814225368313899,-0.0779000871404144,-0.0459824527025096,2.98455039715714e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0488246165151351,0.00642365460631052,-0.0614149795435037,-0.0362342534867665,3.17721860643716e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42590,-0.0238682756881492,0.00314428420878718,-0.0300310727373721,-0.0177054786389264,3.38387747676997e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42611,0.0189452734045425,0.00249594683938633,0.0140532175993453,0.0238373292097397,3.3988932326075e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42611,-0.0348146663383261,0.00459972722514014,-0.0438301316996008,-0.0257992009770514,4.01050743658414e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.0465341470745667,0.00614853247356248,-0.0585852707227491,-0.0344830234263842,4.03164606795271e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.0800298970194961,0.0105836460883793,-0.10077384335272,-0.0592859506862727,4.29442786416861e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.066198588745368,0.00875575595057663,-0.0833598704084982,-0.0490373070822378,4.32948368275869e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.060131673815484,0.00795611161998769,-0.0757256525906599,-0.0445376950403081,4.41344013485013e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42679,-0.05467321501192,0.00724048759746758,-0.0688645707029565,-0.0404818593208836,4.59503283919552e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.0883924931072975,0.0117090166716902,-0.11134216578381,-0.0654428204307847,4.66544731951827e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,-0.0274295051065158,0.00363364689344365,-0.0345514530176653,-0.0203075571953662,4.68317400886036e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,40483,-0.106134594728325,0.0140580844357266,-0.133688440222349,-0.0785807492343005,4.69795073831561e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RETN,Resistin,42598,-0.0338612523715235,0.00449166240034439,-0.0426649106761985,-0.0250575940668485,5.05164078869786e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.04286328269093,0.00568708161253872,-0.0540099626515059,-0.0317166027303541,5.11923956404799e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,40418,-0.0357648400300455,0.00474464006433051,-0.0450643345561333,-0.0264653455039577,5.14192428438808e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0262678103968944,0.00348535896244163,-0.03309911396328,-0.0194365068305088,5.20200570865207e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.0558451015733924,0.00741528447440645,-0.0703790591432291,-0.0413111440035558,5.34893232656614e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,40136,-0.0424044663482333,0.00563529169635382,-0.0534496380730868,-0.0313592946233798,5.69436240609688e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,40511,-0.0233935534228282,0.00311198758535846,-0.0294930490901308,-0.0172940577555256,6.01686492025029e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0896494823957383,0.0119286370206868,-0.113029610956284,-0.0662693538351923,6.02955805613039e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,40471,-0.0655115996907308,0.00872508226359821,-0.0826127609273833,-0.0484104384540783,6.43570412636976e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.0721793322926934,0.00963225565786818,-0.091058553382115,-0.0533001112032718,7.12909235402406e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.0406316415308014,0.00542250428138723,-0.0512597499223203,-0.0300035331392824,7.14555240024821e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0408571197743843,0.00545564610195207,-0.0515501861342104,-0.0301640534145583,7.45952670343574e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.0406364338602827,0.00542991364697134,-0.0512790646083466,-0.0299938031122189,7.67838220087674e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42594,-0.051955300481469,0.00694427987625292,-0.0655660890389248,-0.0383445119240133,7.79083548714059e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42689,-0.0385174151708096,0.00516734480492208,-0.0486454109884569,-0.0283894193531624,9.60584733341071e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0254688584434536,0.00341750845946446,0.0187705418629033,0.032167175024004,9.84853178226002e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,42357,-0.0383004111718363,0.00514111429297603,-0.0483769951860693,-0.0282238271576033,9.92844484220369e-14
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.070552045932387,0.00949172165421658,-0.0891558203746515,-0.0519482714901225,1.14016589717623e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.018847123973092,0.00253625381351186,-0.0238181814475752,-0.0138760664986087,1.14236280645239e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,40463,-0.0756288330015243,0.0101754643716953,-0.0955727431700471,-0.0556849228330014,1.14306006008487e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.0515644976310722,0.0069412065348319,-0.0651692624393427,-0.0379597328228016,1.17535425161896e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.0357722052433429,0.00481603191156714,-0.0452116277900144,-0.0263327826966713,1.18437331236795e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.0231050015728145,0.00311413481730627,-0.0292087058147348,-0.0170012973308942,1.24723111583551e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.022012847602242,0.00296756124053606,-0.0278292676336926,-0.0161964275707913,1.27574451946993e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,40419,-0.0262909441249377,0.00354679113144855,-0.0332426547425769,-0.0193392335072985,1.32753141409703e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0435111041107386,0.00587001020843092,-0.0550163241192632,-0.032005884102214,1.33070246738415e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.037729892873409,0.00509597939626267,-0.0477180124900838,-0.0277417732567342,1.41857328199346e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.0362267289369649,0.0048977076973548,-0.0458262360237803,-0.0266272218501494,1.47911490299426e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.0925649823723363,0.0125208373045911,-0.117105823489335,-0.0680241412553378,1.52478882104151e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0326449357456011,0.00441980433173538,-0.0413077522358024,-0.0239821192553997,1.60081659377395e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.0329340680982835,0.00446404556129433,-0.0416835973984204,-0.0241845387981467,1.72436102482334e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.0462068829036958,0.00626728637403034,-0.0584907641967952,-0.0339230016105963,1.76934961196684e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0404348197067868,0.00548411665322507,-0.051183688347108,-0.0296859510664657,1.7884276089047e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42679,-0.0470125716345897,0.00641119290035967,-0.0595785097192946,-0.0344466335498847,2.38080767375307e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.048398727552466,0.00660061020556449,-0.0613359235553724,-0.0354615315495596,2.39208937012445e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,40199,-0.0340252553580009,0.00463977313227467,-0.0431192106972592,-0.0249313000187425,2.40174065230939e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0751948126721556,0.0102694979053757,-0.0953230285666919,-0.0550665967776193,2.58051370918019e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0463372970866016,0.00632903378744342,-0.0587422033099907,-0.0339323908632125,2.59414642771593e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0498332485628608,0.00680564869144604,-0.0631723199980951,-0.0364941771276266,2.60293343712813e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0525947117109739,0.00719783398855482,-0.0667024663285414,-0.0384869570934065,2.886063024204e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0459958068552864,0.00630971357308257,-0.0583628454585283,-0.0336287682520446,3.31389367544601e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.0511117303220507,0.0070240972209661,-0.0648789608751442,-0.0373444997689571,3.6497163455441e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.062203237402751,0.00854861930855162,-0.0789585312475122,-0.0454479435579899,3.6598323931659e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,40470,-0.024520148048371,0.00337239735945267,-0.0311300468728982,-0.0179102492238437,3.809158562285e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,0.0303651438123866,0.00417801281566066,0.0221762386936917,0.0385540489310815,3.85357126193528e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.0609929187103261,0.00839207577275689,-0.0774413872249296,-0.0445444501957226,3.90241171171264e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0666057296817408,0.00916988969658282,-0.0845787134870432,-0.0486327458764385,3.9799128757656e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0303746726992687,0.00418141854554089,-0.0385702530485288,-0.0221790923500085,3.99961746049135e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42760,-0.0214450827522099,0.00295282793297385,-0.0272326255008387,-0.0156575400035812,4.00537294197218e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.0265599122773768,0.00365731919877081,-0.0337282579069676,-0.019391566647786,4.06788261502283e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0437663086431724,0.00603321993883539,-0.0555914197232898,-0.031941197563055,4.30443619179161e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.0159661212302424,0.00220312086492953,-0.0202842381255042,-0.0116480043349805,4.49271977290605e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0321064886700236,0.00443568010305492,-0.0408004216720112,-0.023412555668036,4.85041097444479e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI3,Elafin,42446,-0.0426660376582502,0.0058963844002593,-0.0542229510827584,-0.031109124233742,4.8764779233246e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,40199,-0.0428716071382159,0.0059237783083288,-0.0544822126225403,-0.0312610016538914,4.88525602611397e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.0632225943792215,0.00874018720678555,-0.0803533613045212,-0.0460918274539218,4.9656773943629e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0649743938306481,0.00899804721290297,-0.0826105663679379,-0.0473382212933583,5.50277044813143e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.0622526771990846,0.00862721581904895,-0.0791620202044206,-0.0453433341937487,5.64817639216311e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,40527,0.0373891445955394,0.00518086358861578,0.0272346519618524,0.0475436372292263,5.6634449986145e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.0459057355813147,0.00636678022218736,-0.058384624816802,-0.0334268463458275,5.89320890633403e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0634467761476,0.00879908784900367,-0.0806929883316472,-0.0462005639635528,5.93290128495352e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0407619601803173,0.00565424365862731,-0.0518442777512269,-0.0296796426094078,6.0053007699241e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.0404960743649625,0.00562328939726843,-0.0515177215836087,-0.0294744271463164,6.27581139420114e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0391006451407375,0.00543923308185156,-0.0497615419811666,-0.0284397483003085,6.88696247034492e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42734,-0.0513390087906423,0.00714183880351531,-0.0653370128455323,-0.0373410047357523,6.89460998519051e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.0655352799319484,0.00911535544156373,-0.0834013765974133,-0.0476691832664835,6.91304560284243e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.0495865205941961,0.00691246004662511,-0.0631349422855813,-0.0360380989028109,7.7028687538014e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0670109933663105,0.00935492557501568,-0.0853466474933413,-0.0486753392392798,8.3864342339358e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.0319570700138155,0.00446762370967547,-0.0407136124847794,-0.0232005275428516,8.93625636665859e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0223448172784541,0.00312390412978951,-0.0284676693728415,-0.0162219651840666,8.93671153699114e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,40449,-0.0264798401133484,0.0037042993658703,-0.0337402668704542,-0.0192194133562426,9.32259048818846e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0307615629954308,0.00430516668132321,-0.0391996896908243,-0.0223234363000373,9.54580798743257e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42552,-0.0181959873486814,0.00254716812555795,-0.023188436874775,-0.0132035378225878,9.56172985610977e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,40449,-0.0755626932490509,0.0105763372134488,-0.0962923141874104,-0.0548330723106913,9.59004704637721e-13
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0607404828407302,0.00850993440533237,-0.0774199542751816,-0.0440610114062787,1.00819869955405e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAX,Protein max,42311,-0.0773072826479505,0.0108486784161844,-0.0985706923436719,-0.0560438729522292,1.08756042749306e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,42130,-0.0184683150804533,0.0025974335116982,-0.0235592847633817,-0.0133773453975248,1.21947345358161e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.0268610050021324,0.00377835664723348,-0.03426658403071,-0.0194554259735548,1.2269411109359e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0431367674081586,0.00606674622601983,-0.0550275900111575,-0.0312459448051598,1.2275109938785e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.03777815774101,0.00531560597456717,-0.0481967454511616,-0.0273595700308583,1.24537055380775e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.088025104762998,0.0123945103182432,0.0637318645392413,0.112318344986755,1.29266654750564e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,40302,-0.0402350715923433,0.00567199776804441,-0.0513521872177103,-0.0291179559669762,1.3858336908697e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.0338457675092415,0.00477459882029856,-0.0432039811970266,-0.0244875538214563,1.42079858322187e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0399282376114316,0.00563480968274373,-0.0509724645896093,-0.0288840106332539,1.4649012016385e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.036187234705035,0.00510980400100435,-0.0462024505470036,-0.0261720188630665,1.50644612044252e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.0258529642952203,0.00365388425406847,-0.0330145774331945,-0.0186913511572461,1.58000500036005e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0654010459253199,0.00924871739669107,-0.0835285320228344,-0.0472735598278054,1.61027216351683e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,40449,-0.0411829915928939,0.00582365206494873,-0.0525973496401934,-0.0297686335455944,1.6214452791926e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.015606138367001,0.00220796882856912,0.0112785194630055,0.0199337572709964,1.66298174609918e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.0551269051015119,0.00780114106780644,-0.0704171415944126,-0.0398366686086113,1.66704899965897e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0749822524763538,0.0106328925097442,-0.0958227217954524,-0.0541417831572552,1.85121697518512e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.0233741891807716,0.00331807310635828,0.0168707658923094,0.0298776124692339,1.97148271424889e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,-0.0168340204288415,0.00239431531601301,-0.0215268784482269,-0.012141162409456,2.15106408125548e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42711,-0.0954476461733859,0.0135807697824978,-0.122065954947082,-0.0688293373996901,2.19327395795927e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.0331976311393995,0.00473347906119841,-0.0424752500993484,-0.0239200121794507,2.45944506248987e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.042381239581429,0.00604528226438961,-0.0542299928196326,-0.0305324863432254,2.48570606053583e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.0129261103643029,0.00184412941364591,0.00931161671355696,0.0165406040150489,2.50915716837699e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.0501664271363787,0.00716786202105271,-0.064215436697642,-0.0361174175751154,2.73301380942894e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.025039143618475,0.00357786824786203,-0.0320517653842846,-0.0180265218526654,2.73931029535071e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,-0.0189902616976219,0.00271459728889195,-0.0243108723838501,-0.0136696510113936,2.7897421861922e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.0307533091150088,0.00440028114693988,-0.039377860163011,-0.0221287580670066,2.90065479305361e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.0217025109441771,0.00311087279275419,-0.0277998216179753,-0.0156052002703789,3.17464257944475e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.020178293400897,0.00289279718777069,-0.0258481758889275,-0.0145084109128664,3.22628414021872e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.0622788068999257,0.00892868045798621,-0.0797790205975787,-0.0447785932022727,3.22648776561038e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0828859839434621,0.0118856817937116,-0.106181920259137,-0.0595900476277874,3.23583291167625e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0205016781255592,0.00294068071333191,-0.0262654123236897,-0.0147379439274287,3.277453695399e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42611,-0.033608652602937,0.00482289843921973,-0.0430615335438077,-0.0241557716620664,3.35151027238361e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0329994511998723,0.00473647613611626,-0.0422829444266601,-0.0237159579730844,3.41872509225147e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.0349349154964725,0.00501581185810419,-0.0447659067383567,-0.0251039242545883,3.44092258953787e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,40223,-0.065613924911249,0.00943113553997146,-0.084098950569593,-0.0471288992529049,3.6687379947273e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.0706260417147917,0.0101543615250748,-0.0905285903039384,-0.0507234931256451,3.68597020910472e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,42216,-0.0549301862801144,0.00790538350361073,-0.0704247379471914,-0.0394356346130373,3.86882582838472e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.0343027786910341,0.00494265726921991,-0.0439903869387051,-0.024615170443363,4.13112924707743e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42654,-0.0615709824902291,0.00888260132534291,-0.0789808810879012,-0.044161083892557,4.34941714778081e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.0354209102717867,0.00511404521316644,-0.0454444388895929,-0.0253973816539805,4.52369653566724e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,40116,-0.0419658342386473,0.00605893698587758,-0.0538413507309673,-0.0300903177463272,4.56372791348264e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0412489272327285,0.0059578798348961,-0.0529263717091249,-0.0295714827563322,4.64778970138109e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0695934285687085,0.0100608523963502,-0.0893126992655548,-0.0498741578718621,4.85392653058151e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0502437073478859,0.0072855634564038,-0.0645234117224373,-0.0359640029733344,5.62102262339319e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0194773431020615,0.00282985116541898,-0.0250238513862827,-0.0139308348178403,6.12740747130896e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42604,-0.0653101957883089,0.00949789209698453,-0.0839260642983986,-0.0466943272782192,6.41545280579638e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0306066394437307,0.00446108995012288,-0.0393503757459715,-0.0218629031414898,7.21594276317134e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.0519569509242053,0.00757865287585103,-0.0668111105608733,-0.0371027912875372,7.40626859986074e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.037064633385412,0.00541047156945965,-0.0476691576615529,-0.026460109109271,7.68557820591986e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0617271163524284,0.00901162753942727,-0.0793899063297059,-0.044064326375151,7.78530501403227e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0508401487872509,0.00742642750141661,-0.0653959466900274,-0.0362843508844743,7.93158028032189e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,40375,-0.0699769009288458,0.0102324052928018,-0.0900324153027372,-0.0499213865549543,8.40512671785074e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0372520639536819,0.00545898192291188,-0.0479516685225892,-0.0265524593847747,9.30648067590121e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.0495222349868835,0.00725870756275414,-0.0637493018098816,-0.0352951681638854,9.33381814597682e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0648437891278811,0.00950724222493434,-0.0834779838887524,-0.0462095943670098,9.47075706506474e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.0369824459565629,0.00542332598861772,-0.0476121648942536,-0.0263527270188721,9.63721868935724e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.0255961765556431,0.00375488043723737,-0.0329557422126283,-0.0182366108986578,9.78293007735023e-12
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,-0.0441324055929857,0.0064801858524973,-0.0568335698638805,-0.031431241322091,1.02417705481202e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42611,0.0223483464382902,0.00328372889613549,0.0159122378018647,0.0287844550747158,1.0476918672635e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,40483,-0.0588889157647191,0.00865683289306281,-0.0758563082351222,-0.041921523294316,1.07946984534494e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,40532,-0.0487509867459494,0.00716713223213995,-0.0627985659209437,-0.0347034075709551,1.08351919674763e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,40182,-0.0345422446257145,0.00508345243728545,-0.044505811402794,-0.024578677848635,1.13887942481087e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0408403189795916,0.00601642702625927,-0.0526325159510597,-0.0290481220081234,1.18464617815907e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42679,-0.0404843232564367,0.00598054706399757,-0.052206195501872,-0.0287624510110015,1.347263313424e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0510974892493875,0.00755346644009592,-0.0659022834719755,-0.0362926950267995,1.40102222068156e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.0595835283295126,0.00881206561788185,-0.0768551769405611,-0.0423118797184642,1.43226232997806e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0639181529839285,0.00945394761136808,-0.0824478903022099,-0.045388415665647,1.4397952153568e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,40166,-0.0314098660393812,0.00465221301712803,-0.0405282035529521,-0.0222915285258102,1.53611690804531e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.0212835432316584,0.00315383105513478,-0.0274650520997226,-0.0151020343635942,1.56706410984925e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.0765152088835293,0.0113474707456882,-0.0987562515450781,-0.0542741662219805,1.61544357791203e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.0363911138165853,0.00539732595964407,-0.0469698726974877,-0.0258123549356829,1.62257952660587e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42495,0.0179863643622235,0.00266852859148656,0.0127560483229099,0.0232166804015372,1.64710529833265e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.0630532049100172,0.00935636338147655,-0.0813916771377112,-0.0447147326823232,1.6714330856158e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.0175905277767158,0.00261103782559597,-0.0227081619148839,-0.0124728936385477,1.68266597186686e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.0373610809796831,0.00554923452784097,-0.0482375806542514,-0.0264845813051148,1.74655154377701e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0577134805680303,0.00858263212797073,-0.0745354395388529,-0.0408915215972077,1.83377902076828e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.082557348725913,0.0122888596266185,-0.106643513594085,-0.0584711838577407,1.93172745255745e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.0279816758245141,0.00416513473716406,-0.0361453399093556,-0.0198180117396725,1.93232605806252e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.0248082671312,0.00369403195292616,-0.0320485697589353,-0.0175679645034647,1.94757780548611e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,0.078964621078533,0.0117576262382276,0.0559196736516069,0.102009568505459,1.96260870846888e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.0702077642124553,0.0104636456700872,-0.0907165097258262,-0.0496990186990844,2.02885584568171e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.0216875324507556,0.00323538766404697,-0.0280288922722877,-0.0153461726292236,2.11940336689162e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.0457223070982832,0.00682878599776239,-0.0591067276538975,-0.032337886542669,2.23608210308757e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.0240367796040562,0.00359182212138097,-0.0310767509619629,-0.0169968082461495,2.2865485140459e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42779,-0.0246039277984471,0.00368210971354332,-0.031820862836992,-0.0173869927599022,2.44856759638176e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.0449675189534915,0.00673279383765568,-0.0581637948752966,-0.0317712430316863,2.50243288346982e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,42141,0.0223314466842633,0.00334988846977485,0.0157656652835046,0.028897228085022,2.72921689320911e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELL,L-selectin,40539,0.0165577909656712,0.00248362880804734,0.0116898785018984,0.0214257034294439,2.73620554824279e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.0364177566858906,0.00546538601630756,-0.0471299132778535,-0.0257056000939278,2.80157628461434e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,42261,-0.0500153245435589,0.00751536219466741,-0.064745434445107,-0.0352852146420107,2.94445678539755e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0414736358984982,0.00623386873964996,-0.0536920186282121,-0.0292552531687843,3.00799968137961e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.0226066999582052,0.00339881440718467,-0.0292683761962872,-0.0159450237201232,3.0380357830273e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0550406091062395,0.0082875833136438,-0.0712842724009813,-0.0387969458114976,3.25508867271027e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.0467582241370028,0.00705062466050521,-0.0605774484715931,-0.0329389998024126,3.44330219921841e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42461,-0.0402572798959263,0.00607196537637844,-0.0521583320336281,-0.0283562277582246,3.48619263787713e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,40532,0.0339677508597551,0.00512372620001023,0.0239252475077351,0.0440102542117752,3.52113422655537e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.0362968342584826,0.00547658532005962,-0.0470309414857994,-0.0255627270311657,3.57006786646247e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAT,Catalase,40361,-0.0374189849819485,0.00564719222066299,-0.048487481734448,-0.0263504882294491,3.60477424597225e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42642,-0.0645174675094262,0.00974205802576128,-0.0836119012399183,-0.0454230337789341,3.66418808947693e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0351288034344682,0.00531490197147079,-0.0455460112985509,-0.0247115955703855,4.0306766743113e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0408377526462005,0.00618238511314042,-0.0529552274679557,-0.0287202778244453,4.11136705307559e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGN,Biglycan,42328,0.0823310273234863,0.0124748530991638,0.0578803152491252,0.106781739397847,4.27636212190601e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.0290694886512114,0.00440748237969284,0.0204308231870135,0.0377081541154094,4.42973803338888e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,40539,-0.0182536899313519,0.00276790441527841,-0.0236787825852976,-0.0128285972774062,4.44841306416017e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.0234092318972044,0.00355041234043186,-0.0303680400844509,-0.016450423709958,4.45868516721727e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0207520050889131,0.00314755011205756,-0.0269212033085459,-0.0145828068692803,4.47098514983571e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0441616251335463,0.00669834972133413,-0.0572903905873612,-0.0310328596797314,4.51058020537052e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,42346,-0.044479874449822,0.00675073418146797,-0.0577113134454992,-0.0312484354541448,4.59990516146153e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0249471201404798,0.00379408911714329,-0.0323835348100807,-0.017510705470879,5.07679894073534e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.0251245819557358,0.00382510002649148,-0.0326217780076591,-0.0176273859038125,5.31893220749407e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,40223,-0.0198456048863651,0.00302199694987738,-0.0257687189081247,-0.0139224908646054,5.36294041150159e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0314310485694903,0.00478835643495958,-0.0408162271820111,-0.0220458699569695,5.46648778175882e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,42370,-0.0769060815519589,0.0117198657120486,-0.0998770183475741,-0.0539351447563437,5.50663700843704e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,40532,-0.061947160394426,0.00943940663082582,-0.0804483973908446,-0.0434459233980074,5.51784831423592e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.0198341870422233,0.0030267448259403,-0.0257666069010663,-0.0139017671833803,5.84636901089922e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0486695101041243,0.00744082303758959,-0.0632535232577999,-0.0340854969504487,6.3427633193378e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.0712822416610422,0.0109137213785111,-0.0926731355629239,-0.0498913477591604,6.79886224810195e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,40539,0.0206303644062831,0.00316096430292799,0.0144348743725442,0.026825854440022,7.0144842455329e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0319263274869992,0.00489471160289218,-0.0415199622286678,-0.0223326927453305,7.15930386984657e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.0379157053784691,0.00581322791413504,-0.0493096320901738,-0.0265217786667644,7.17162813361523e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0495736431506847,0.00760016519923389,-0.0644699669411831,-0.0346773193601863,7.20719450220514e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42600,-0.0204991166338973,0.00314786150826417,-0.0266689251900951,-0.0143293080776995,7.6761040130347e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0789332708371187,0.0121510491964698,-0.1027493272622,-0.0551172144120379,8.59595543789397e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0354938573795768,0.00548147841336339,-0.046237555069769,-0.0247501596893845,9.86595619605017e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.0457931160428107,0.00707362608680084,-0.0596574231729404,-0.0319288089126811,9.89095193860806e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.0191181966461952,0.00295340532811844,-0.0249068710893074,-0.0133295222030831,9.98689916280522e-11
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,40182,-0.046207115292432,0.00714405542003592,-0.0602094639157024,-0.0322047666691616,1.03587568536788e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSG,Basigin,42746,-0.0145598119527938,0.00225358855647349,-0.0189768455234818,-0.0101427783821058,1.07764206854236e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.01786180844302,0.00276532987170435,-0.0232818549915606,-0.0124417618944795,1.08928129834501e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.032165918770725,0.00498006165916699,-0.0419268396226923,-0.0224049979187577,1.09772361217525e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0374067293353198,0.00579297952303455,-0.0487609692004675,-0.0260524894701721,1.11103241434103e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.0459515471991716,0.00714107894613716,-0.0599480619336004,-0.0319550324647427,1.28765493515195e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42594,-0.0620093783710926,0.0096386741213084,-0.0809011796488571,-0.0431175770933282,1.29027287511696e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42587,-0.0543070721241132,0.00844251477310585,-0.0708544010794007,-0.0377597431688258,1.29727671772994e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42771,0.0314882296346237,0.00490534794965635,0.0218737476532973,0.0411027116159502,1.41580284857602e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0454695532037061,0.00708756279939361,-0.0593611762905176,-0.0315779301168946,1.45177972644325e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.0349170010467296,0.00544805448171946,-0.0455951878308997,-0.0242388142625595,1.52376644847625e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0231937098532978,0.00362554246289724,-0.0302997730805764,-0.0160876466260192,1.64560228178376e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.037532294381648,0.00586849902022544,-0.0490345524612898,-0.0260300363020061,1.65379931288706e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,40483,-0.0470591163077779,0.00736050842719449,-0.0614857128250791,-0.0326325197904768,1.68572872692928e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0358896154125342,0.00561857900504172,-0.046902030262416,-0.0248772005626525,1.74100929939349e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,40199,-0.0271084986719493,0.00424518783614428,-0.0354290668307921,-0.0187879305131065,1.77490480507957e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0231086885756189,0.00362158821312959,-0.0302070014733529,-0.0160103756778849,1.81921864814358e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.072463430338005,0.0113576700536743,-0.0947244636432067,-0.0502023970328032,1.82859976111221e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42636,-0.0442304522301912,0.00693463850283248,-0.0578223436957428,-0.0306385607646395,1.8505770891434e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0730182478322113,0.0114711145086066,-0.0955016322690803,-0.0505348633953423,2.01091043186003e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.0456493042722379,0.00717815432020788,-0.0597184867398454,-0.0315801218046305,2.10530612884777e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.0336924700566009,0.00530312508903199,-0.0440865952311036,-0.0232983448820982,2.1746567894982e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.0402649098818935,0.00634730408901415,-0.0527056258963613,-0.0278241938674258,2.31566949592737e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,40482,-0.0502322917275012,0.00792065650451084,-0.0657567784763425,-0.03470780497866,2.35567137631091e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0451425468073595,0.00713088016265743,-0.0591190719261681,-0.0311660216885509,2.53838261601727e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0234828604817302,0.00371289188028504,-0.0307601285670888,-0.0162055923963715,2.63317876149173e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.0608467548575666,0.00963120481761247,-0.079723916300087,-0.0419695934150461,2.73870085961997e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.0636898557832472,0.0100868201642237,-0.0834600233051257,-0.0439196882613688,2.8179622481921e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.0273355779668368,0.00433034557216753,-0.0358230552882852,-0.0188481006453885,2.84994183481286e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.0179477677363827,0.00284415594011387,0.0123732220937595,0.0235223133790059,2.87072425592973e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,40449,-0.0225998888949399,0.00358296344591692,-0.029622497248937,-0.0155772805409427,2.94031572698874e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42636,0.0234381333279196,0.0037204022695119,0.0161461448796762,0.0307301217761629,3.07137682339542e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,42445,-0.0250646890943372,0.00398771465202612,-0.0328806098123084,-0.017248768376366,3.37092710031608e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0274322879303739,0.00436853312241281,-0.035994612850303,-0.0188699630104448,3.52134562846161e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.0249548751618646,0.0039758078410741,-0.0327474585303698,-0.0171622917933594,3.58562106863686e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.025777150405386,0.00411047390771938,-0.033833679264516,-0.0177206215462561,3.69546243993971e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,40532,-0.0527923048405415,0.00841875473586838,-0.0692930641228435,-0.0362915455582395,3.72270093558321e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,40285,-0.0139405701805071,0.00222919537911793,-0.0183097931235782,-0.00957134723743594,4.15767865028806e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0310977087536834,0.00498849220513049,-0.0408751534757392,-0.0213202640316277,4.71234394457032e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0388631648133169,0.00623781664203297,-0.0510892854317015,-0.0266370441949323,4.79623684456841e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.0194078639264688,0.00311718163268733,-0.0255175399265359,-0.0132981879264016,4.92388735089262e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.0173757196157286,0.00279117662748632,0.0119050134258554,0.0228464258056018,4.97915040467762e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.0442461315954898,0.00711106135798853,-0.0581838118571473,-0.0303084513338323,5.04976703444118e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.051963489575478,0.00835742675291305,-0.0683440460111876,-0.0355829331397684,5.22508572906348e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.0135985658480528,0.0021871670947578,0.00931171834232753,0.0178854133537781,5.23627371030799e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,42357,-0.0541004940400826,0.0087160551669927,-0.0711839621673883,-0.0370170259127769,5.56294911528645e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFP,Properdin,40539,-0.0143498080117935,0.0023176290403518,-0.018892360930883,-0.00980725509270397,6.16191279550826e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0533874661185934,0.00863326132303901,-0.0703086583117499,-0.036466273925437,6.43309932796261e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,-0.021923578903858,0.00354738931128297,-0.0288764619539726,-0.0149706958537434,6.58979833442738e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42587,0.0297259106247317,0.00481306643138007,0.0202923004192267,0.0391595208302366,6.76109892193864e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0472715329341439,0.00766776060592178,-0.0623003437217506,-0.0322427221465372,7.294267184503e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42611,-0.0575290391719205,0.00934395685331277,-0.0758431946044135,-0.0392148837394275,7.63378138893887e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0244516444074021,0.00397355742104686,-0.0322398169526539,-0.0166634718621502,7.79538327245775e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0449680326972599,0.007315866497193,0.0306289343627616,0.0593071310317581,8.13770296384981e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.0223053655279604,0.00362980025927084,0.0151909570197895,0.0294197740361312,8.26861115718998e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.0516348867182422,0.00840604577117661,-0.0681107364297484,-0.035159037006736,8.39852877608573e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42587,-0.0290916238361591,0.0047384702612405,-0.0383790255481905,-0.0198042221241278,8.51446426702079e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.0441550902090345,0.00720533513967724,-0.0582775470828019,-0.0300326333352671,9.14057338071401e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0252182225937499,0.00411525402626954,0.0171523247022616,0.0332841204852382,9.1535439193591e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42676,-0.0226836688157758,0.00370394310359434,-0.0299433972988207,-0.0154239403327309,9.36761647079304e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0629717381899484,0.0102834116371697,-0.0831272249988009,-0.0428162513810958,9.46105260301524e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.030720241156239,0.00502182115659308,-0.0405630106231615,-0.0208774716893166,9.83172572454743e-10
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0362900832631525,0.00594008531327603,-0.0479326504771735,-0.0246475160491315,1.03331076577409e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0452802959038129,0.00741299095291277,-0.059809758171522,-0.0307508336361039,1.04046741659814e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42495,-0.0207129085288003,0.00339725591065683,-0.0273715301136877,-0.0140542869439129,1.11101969994916e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.0470404468229426,0.00772103817394141,-0.0621736816438677,-0.0319072120020174,1.1423134129443e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0334440372821966,0.00549633834318314,-0.0442168604348356,-0.0226712141295577,1.19811433204639e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42681,-0.0460141222292886,0.00757355772241264,-0.0608582953652174,-0.0311699490933599,1.26827681177657e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.036010027856929,0.00592908856433396,-0.0476310414430235,-0.0243890142708344,1.2927516995721e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42594,-0.0256596558030974,0.00422706623538746,-0.0339447056244568,-0.017374605981738,1.31100477964546e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.0197083200378244,0.00324910180230638,-0.0260765595703449,-0.0133400805053039,1.35601483450042e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.0441947455053953,0.00728794914830155,-0.0584791258360663,-0.0299103651747243,1.36941404470201e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.0308197072265682,0.00508445008669029,0.0208541850566553,0.0407852293964812,1.38500383869868e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42594,-0.0208197675805885,0.00343845044870814,-0.0275591304600565,-0.0140804047011206,1.44184587003579e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,-0.0328580655686329,0.00543306159574885,-0.0435068662963006,-0.0222092648409651,1.50737950531071e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.0115962626269032,0.00192253734934079,-0.0153644358316112,-0.00782808942219524,1.6724933807813e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.0148962354194636,0.00247233393077563,-0.0197420099237838,-0.0100504609151433,1.74324831873963e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0225694953525184,0.00375269390294791,-0.0299247754022963,-0.0152142153027405,1.86571204561703e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.0233566853765291,0.00389542459201921,-0.0309917175768868,-0.0157216531761715,2.08727091885137e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.0434890770341987,0.00727624047633976,-0.0577505083678247,-0.0292276457005728,2.34370167496724e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.0278502539816225,0.00466047245738277,0.0187157279651523,0.0369847799980927,2.35813765294798e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0667464678852642,0.0111718129018829,-0.0886432211729547,-0.0448497145975737,2.37717061508601e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42611,0.0313044700432835,0.00524093701640313,0.0210322334911334,0.0415767065954336,2.38725097491484e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42611,-0.0407518268267797,0.00682367699536448,-0.0541262337376941,-0.0273774199158654,2.40110304917054e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.0224919598198413,0.00376590852185376,-0.0298731405226746,-0.0151107791170079,2.40656031319886e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.0442560156378669,0.00741182478136336,-0.0587831922093391,-0.0297288390663947,2.41870423429774e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,42475,0.0202631048406049,0.0033949139650482,0.0136090734691104,0.0269171362120994,2.45299884447119e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42500,0.0299195584413238,0.00501681126661187,0.0200866083587645,0.039752508523883,2.52596187164618e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0352655234757995,0.00591802034898272,0.0236662035917934,0.0468648433598056,2.60141849182223e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.0272431503144607,0.00457559303187287,-0.0362113126569316,-0.0182749879719899,2.68177660795662e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.0124790538771457,0.00209871165881594,0.00836557902586644,0.0165925287284249,2.81462079992933e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0198965392559009,0.00334828565266968,0.0133338993766683,0.0264591791351335,2.89316661318102e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,40223,-0.0317053995357586,0.00535884814473224,-0.0422087418994337,-0.0212020571720834,3.38723328644319e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,42346,-0.0354865604626123,0.00600090162759707,-0.0472483276527025,-0.023724793272522,3.43146496231766e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.0385438716832519,0.00652436369316385,-0.0513316245218531,-0.0257561188446508,3.55553903660073e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42681,-0.042431052609896,0.00718449938463163,-0.056512671403774,-0.028349433816018,3.59134452522423e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.0413838515588218,0.00700748118697956,-0.0551185146853018,-0.0276491884323419,3.59826592831931e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,40344,-0.0198767285494402,0.00336706579742487,-0.026476177512393,-0.0132772795864875,3.66727844819615e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,-0.0279567414154828,0.00474743916531063,-0.0372617221794916,-0.0186517606514739,4.00346550216551e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.0142548083495905,0.00242090495645226,-0.0189997820642369,-0.00950983463494407,4.01464017331271e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.0232139362087803,0.00394342328861325,-0.0309430458544622,-0.0154848265630983,4.03472806858547e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0329196605348318,0.00560906206170711,-0.0439134221757778,-0.0219258988938859,4.4874706565413e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0250182013701032,0.00426771744544445,-0.0333829275631743,-0.0166534751770321,4.67429883785686e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,42370,-0.0453767019178316,0.00775718110685434,-0.0605807768872661,-0.0301726269483971,5.04337564837812e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.0244019435398792,0.00417425773750564,0.0162203983743681,0.0325834887053902,5.16025122340401e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0261747518851683,0.00447848465967449,-0.0349525818181303,-0.0173969219522063,5.19623330912531e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.03628379320061,0.00620832228356291,-0.0484521048763933,-0.0241154815248267,5.22464211785834e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42794,-0.052398599993302,0.0089726850706681,-0.0699850627318115,-0.0348121372547925,5.34601892281187e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0368256514527641,0.00631093199623672,-0.0491950781653881,-0.0244562247401402,5.49476528937711e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,40283,-0.0202201191677379,0.0034698855205717,-0.0270210947880585,-0.0134191435474174,5.78937477622318e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.0338428011896243,0.00580909794444116,-0.045228633160729,-0.0224569692185196,5.84040452553575e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.0455569184837406,0.00782234828582061,-0.060888721123949,-0.0302251158435322,5.8818154628891e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.0519925177072484,0.00895153881666126,-0.0695375337879044,-0.0344475016265923,6.48749716521095e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.0286210758419874,0.00492903684377544,-0.0382819880557873,-0.0189601636281876,6.5462550686887e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.0713312287183047,0.0122888440699341,-0.0954173630953756,-0.0472450943412338,6.5991786696257e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0537885029573457,0.00927088796765149,-0.0719594433739426,-0.0356175625407488,6.73363377336131e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.041320128048579,0.007130134630972,-0.0552951919252841,-0.0273450641718739,7.01201453878913e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.0593837592584473,0.0102702254835463,-0.079513401206198,-0.0392541173106966,7.57169807835176e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.0504603820302076,0.00874018053693863,-0.0675911358826074,-0.0333296281778079,7.94517878924362e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0258939930032252,0.00449205774603232,-0.0346984261854485,-0.0170895598210018,8.37456329738194e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,0.0238664644372752,0.00414121608702672,0.0157496809067028,0.0319832479678476,8.4367850326453e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42611,-0.0441450905776251,0.0076677347093311,-0.059173850607914,-0.0291163305473361,8.73652798786056e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,42488,-0.0211831263343216,0.00368055288966179,-0.0283970099980587,-0.0139692426705845,8.83342244994558e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.0550252627214302,0.00958083816115597,-0.0738037055172959,-0.0362468199255645,9.49229706145103e-09
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42611,-0.0229711442999132,0.00400944829750334,-0.0308296629630198,-0.0151126256368067,1.0304027447425e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.0558798610956405,0.00976801964035736,-0.0750251795907409,-0.0367345426005401,1.08793693982736e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,40182,-0.0276695388221907,0.00484018021314043,-0.037156292039946,-0.0181827856044355,1.11485330255089e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0893589346772743,0.0156344386546652,-0.120002434440418,-0.0587154349141305,1.11699490494869e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.0433093251085554,0.00757955786455058,-0.0581652585230745,-0.0284533916940363,1.12773949525353e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42679,-0.0334456346767735,0.00586762523778995,-0.0449461801428418,-0.0219450892107052,1.22295741099346e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.0255838745154331,0.0044899990762885,-0.0343842727049586,-0.0167834763259076,1.23838925635545e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.0413757308510657,0.0072631419979962,-0.0556114891671383,-0.0271399725349932,1.25274157332723e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42594,-0.018470491315201,0.00324457236532024,-0.0248298531512287,-0.0121111294791734,1.27642126795362e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42676,0.0380298408137559,0.00668089900339464,0.0249352787671024,0.0511244028604094,1.27933239838927e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,42357,-0.0459459613747801,0.00807948782190026,-0.0617817575057046,-0.0301101652438555,1.32239485904206e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,42311,-0.0269555710847302,0.00474093378983043,-0.0362478013127979,-0.0176633408566626,1.33048890335862e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0288512013495752,0.00508046397902293,-0.0388089107484601,-0.0188934919506902,1.38950913512126e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0286597510988071,0.00504824483885515,0.018765191214651,0.0385543109829632,1.40388657902714e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.0425307814350557,0.007493864508089,-0.0572187558709101,-0.0278428069992012,1.41186822638754e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.0433822282216944,0.00765684325080213,-0.0583896409932666,-0.0283748154501222,1.49400188419719e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.0266260702247039,0.00471399507877781,-0.0358655005791084,-0.0173866398702994,1.65407030060999e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.0373979397394896,0.00662302734818594,-0.0503790733419341,-0.0244168061370452,1.67542484311024e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.06849984341305,0.0121353955728418,-0.0922852187358199,-0.0447144680902801,1.69662612852439e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.0729463521432275,0.0129260903889056,-0.0982814893054824,-0.0476112149809727,1.708722121408e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.025319812359936,0.00448959620638131,-0.0341194209244434,-0.0165202037954287,1.73834615747364e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.0203190753525304,0.00360908856221677,-0.0273928889344753,-0.0132452617705855,1.83851115176064e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.0229384847587406,0.0040741942516539,-0.0309239054919822,-0.0149530640254989,1.84455801492429e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.0322854945318933,0.00573469409236893,-0.0435254949529364,-0.0210454941108502,1.84679111958152e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,40080,-0.0325317674133859,0.00578898383995953,-0.0438781757397066,-0.0211853590870653,1.96107102970175e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.0226161698692564,0.0040278903731,-0.0305108350005324,-0.0147215047379804,2.01331042915478e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0295548124915693,0.00526739083295978,-0.0398788985241705,-0.0192307264589681,2.05339023769352e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42587,-0.0428779607291912,0.00765405276746846,-0.0578799041534293,-0.027876017304953,2.16074244113963e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42794,-0.0146886433234896,0.00262482239134091,-0.0198332952105178,-0.00954399143646142,2.23524063761967e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0545423400108927,0.00977167930617417,-0.0736948314509941,-0.0353898485707914,2.43810649957052e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,42346,-0.0320838462172466,0.00575128177342541,-0.0433563584931604,-0.0208113339413328,2.47310906889244e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.0340017303079853,0.00609712313340677,0.022051368966508,0.0459520916494626,2.50759490417445e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.0252933948735686,0.00453601195516281,-0.0341839783056877,-0.0164028114414495,2.51598175930897e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.036450665696405,0.00654807796344141,0.0236164328880599,0.0492848985047502,2.65863209746836e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42654,-0.0179214004182701,0.00322573011123266,-0.0242438314362861,-0.0115989694002541,2.81642816629808e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42543,-0.018864436022608,0.0033988244715978,-0.0255261319869397,-0.0122027400582764,2.90645091975362e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,42311,-0.0498196504383434,0.00897683478589523,-0.067414246618698,-0.0322250542579887,2.91541334342664e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42587,0.0169916677330036,0.00306692212987467,0.0109805003584493,0.023002835107558,3.0765109301575e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,42434,-0.0432691686645474,0.00781211906346023,-0.0585809220289294,-0.0279574153001653,3.10492587754863e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.0302073399644088,0.00546239007474162,-0.0409136245109024,-0.0195010554179153,3.26076641748687e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.038074668981532,0.00688719300643025,-0.0515735672741353,-0.0245757706889287,3.30481383499627e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,42292,-0.0509736548273976,0.00922584153412147,-0.0690563042342757,-0.0328910054205195,3.35592329799853e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.0241760779930269,0.00438558538571944,0.0155803306370168,0.0327718253490371,3.61295579190611e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.0232401233965509,0.00421686652587229,-0.0315051817872605,-0.0149750650058412,3.63042994567454e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,40384,-0.0255487455226929,0.00463640559439667,-0.0346361004877104,-0.0164613905576754,3.65813462388083e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.0216644522965007,0.0039320290380221,-0.029371229211024,-0.0139576753819774,3.67392818707494e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,40223,-0.029925075722981,0.00543599502117799,-0.0405796259644899,-0.0192705254814722,3.77460667078123e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,42362,-0.034378505153008,0.00624883162422432,-0.0466262151364877,-0.0221307951695283,3.8341053693603e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.0338777050533652,0.00616495710459278,0.0217943891283633,0.045961020978367,3.97315794228534e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,40460,-0.0525427060076581,0.00956745357625748,-0.0712949150171227,-0.0337904969981934,4.06452010249365e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.027512933447213,0.00501333103566589,-0.0373390622771181,-0.0176868046173078,4.14142364692482e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42721,-0.0168999747364629,0.00308603647340897,-0.0229486062243445,-0.0108513432485813,4.42132705456368e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.0217452280568528,0.0039731735516317,-0.0295326482180509,-0.0139578078956547,4.52058485087579e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42570,-0.0376552062722538,0.00688324191182564,-0.0511463604194321,-0.0241640521250756,4.56673648359807e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.0425238235801343,0.00777595771331904,-0.0577647006982396,-0.027282946462029,4.63350468548972e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42611,0.025336408100165,0.00464338996424036,0.0162353637702539,0.0344374524300761,4.94376112850978e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42666,0.0156989248890772,0.00288354014565311,0.0100471862035971,0.0213506635745573,5.2913548416907e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.0330392343729657,0.00607145372268244,0.0211391850765082,0.0449392836694233,5.36832217639359e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.0436228307416981,0.00801565739390982,-0.0593335192337613,-0.0279121422496348,5.37518484833649e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,42357,-0.0250828338310909,0.00461085816527344,-0.0341201158350269,-0.016045551827155,5.42483800184533e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,-0.0535443121591846,0.00985035104840386,-0.0728510002140562,-0.0342376241043131,5.56966142296371e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.0230439076695475,0.00424133444799791,-0.0313569231876234,-0.0147308921514716,5.65049438564624e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.0343566273544768,0.00632489985694873,-0.0467534310740963,-0.0219598236348573,5.69210827118962e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.0374090267699362,0.0068909715575917,-0.0509153310228159,-0.0239027225170565,5.77728563620667e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,42311,-0.025829150273811,0.00476481800502564,-0.0351681935636612,-0.0164901069839607,6.03808350790238e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0703482459040415,0.0130036210874828,-0.0958353432355077,-0.0448611485725752,6.43924283085765e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.035057042950062,0.00651275303555451,-0.0478220388997488,-0.0222920470003752,7.48324302278642e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0307539101940662,0.00574110720737707,-0.0420064803205253,-0.0195013400676071,8.63822101258499e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0227862588505947,0.00425565652643808,-0.0311273456424133,-0.014445172058776,8.75553681379704e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.0169327529264002,0.00316256238298756,0.0107341306557446,0.0231313751970558,8.76625273952633e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.0161580093956309,0.00301944095513119,-0.022076113667688,-0.0102399051235738,8.87456854285337e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0192241891163676,0.00359985740294236,-0.0262799096261346,-0.0121684686066006,9.43427755015548e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,-0.00749383885772662,0.00140385397367215,-0.010245392646124,-0.0047422850693292,9.58011199125728e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.0337709906625463,0.00632891368574339,-0.0461756614866034,-0.0213663198384893,9.69166547219875e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,40449,-0.0201312676371979,0.00377522625250532,-0.0275307110921084,-0.0127318241822875,9.87632972944573e-08
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0268379785729786,0.00504068345481869,-0.0367177181444233,-0.016958239001534,1.03355395662492e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.031701171548441,0.00596108814747126,-0.0433849043174846,-0.0200174387793973,1.06574918785141e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,40269,0.0116399125863944,0.0021887462329486,0.00734996996981513,0.0159298552029737,1.06913736595509e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0242935701782527,0.00458389364891384,-0.0332780017301239,-0.0153091386263816,1.18186994560173e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42611,-0.0659258177505011,0.0124465920091104,-0.0903211380883576,-0.0415304974126447,1.1977951383063e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.0460442022548156,0.00870701697438907,-0.0631099555246181,-0.028978448985013,1.25843911894831e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.0308749986584133,0.00584072966784798,-0.0423228288073954,-0.0194271685094313,1.27312533338362e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0475123312141307,0.00899570248997724,-0.065143908094486,-0.0298807543337753,1.30453651215687e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42721,-0.0120331661801663,0.00227989656046584,-0.0165017634386794,-0.00756456892165327,1.32660423707076e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42754,-0.0238400590925045,0.00451799061611629,-0.0326953207000925,-0.0149847974849166,1.33560385556317e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.0423911407178562,0.00803897156603806,-0.0581475249872907,-0.0266347564484216,1.36622957864027e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,42346,-0.0361410457171284,0.00686351974558003,-0.0495935444184653,-0.0226885470157916,1.41877788867042e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.0297562107030353,0.00566341208106214,-0.0408564983819171,-0.0186559230241535,1.51020272101355e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.058830398527109,0.0111978221929689,-0.0807781300253281,-0.0368826670288899,1.51379826609532e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,42311,-0.0332929207289409,0.00633705323788462,-0.0457135450751948,-0.020872296382687,1.5141495000229e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42572,-0.0242280359900542,0.00461452644474301,-0.0332725078217505,-0.0151835641583579,1.54106550704918e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,40136,-0.034808952435669,0.00664316471554675,-0.0478295552781406,-0.0217883495931973,1.63727670713545e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.0572790791444012,0.010938863456887,-0.0787192515198996,-0.0358389067689027,1.66780324081425e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.0357040110917455,0.00682273057351449,-0.0490765630158339,-0.0223314591676571,1.69251918265632e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0414120818339677,0.00792454297874639,-0.0569441860723106,-0.0258799775956247,1.76546923662067e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0234688748562447,0.00449239787109139,-0.0322739746835839,-0.0146637750289056,1.77579444300779e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,42357,-0.0308091572775935,0.00591248395917802,-0.0423976258375824,-0.0192206887176045,1.90802534353429e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0358315588540559,0.00687831180667513,0.0223500677129727,0.0493130499951392,1.92310782630306e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0176922426722164,0.00339631546312461,-0.0243490209799407,-0.0110354643644922,1.93010850420815e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0362820940876392,0.00696776974548823,-0.0499389227887961,-0.0226252653864823,1.95155868250752e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,0.0112087304832041,0.00215551206896408,0.0069839268280345,0.0154335341383737,2.02170724524454e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,40223,-0.0631532747194574,0.0121758911924197,-0.0870180214566,-0.0392885279823149,2.1779364413177e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.0233002300922661,0.00449454446705172,-0.0321095372476875,-0.0144909229368447,2.20218916857506e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.0162288974834956,0.00313404556217248,-0.0223716267853537,-0.0100861681816376,2.2788546329716e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,-0.015702824575671,0.00303324508854903,-0.0216479849492271,-0.00975766420211486,2.28812146705424e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,42357,-0.0365895382097652,0.00706846549354255,-0.0504437305771086,-0.0227353458424218,2.29481789583351e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.032908733776969,0.0063670047091389,0.0204294045470568,0.0453880630068813,2.39233005361239e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.00844637951380805,0.00163535512827118,0.00524108346239653,0.0116516755652196,2.44699467390094e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.0418235219942011,0.00809927298295131,-0.0576980970407857,-0.0259489469476165,2.45373460144227e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.0244161103134151,0.00473508123637182,-0.0336968695367038,-0.0151353510901263,2.55292389807002e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.0433601330033513,0.00841222678318559,-0.0598480974983951,-0.0268721685083076,2.58039766426471e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.0232678686273459,0.00451777221556494,-0.0321227021698532,-0.0144130350848386,2.64470212428097e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.0141044365242534,0.00274133079557702,-0.0194774448835844,-0.00873142816492243,2.7109194300418e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,40199,-0.026733424814279,0.00519765080374425,-0.0369208203896177,-0.0165460292389403,2.74499997801915e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.0200793330469173,0.0039054432353136,-0.027734001788132,-0.0124246643057027,2.76571147401306e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0397435383901884,0.00773461975756489,-0.0549033931150156,-0.0245836836653613,2.81083621021314e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,40223,-0.0162379326237884,0.00317000013452347,-0.0224511328874544,-0.0100247323601224,3.06806314636474e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42794,0.0128221074953673,0.00250349269046133,0.00791526182206308,0.0177289531686715,3.06954154744302e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42794,0.0217135096889833,0.00424583214913913,0.0133916786766706,0.030035340701296,3.19566400607283e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.0114559561119245,0.00224244921138219,-0.0158511565662336,-0.00706075565761543,3.29730738739762e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.049094569165142,0.00963913823051049,-0.0679872800969426,-0.0302018582333415,3.56754969477676e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,40527,0.0279590077633116,0.00549878226955968,0.0171813945149746,0.0387366210116486,3.74321197762496e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FST,Follistatin,42654,0.0259239362353558,0.00510557153950148,0.0159170160179329,0.0359308564527787,3.87384884645501e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.0391666091667744,0.00772890256089055,-0.0543152581861198,-0.0240179601474289,4.09447840125887e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,42311,-0.0191137547946116,0.00377262095144765,-0.026508091859449,-0.0117194177297742,4.10836940635471e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0455327015304934,0.00899474447548115,-0.0631624007024365,-0.0279030023585504,4.20064029573374e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.0415769055214112,0.00821477646571128,0.0254759436486171,0.0576778673942053,4.22055540670665e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42754,0.0208188853088359,0.00411639511719531,0.0127507508791331,0.0288870197385387,4.30217396964398e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0371349996138606,0.00734422349886891,-0.0515296776716436,-0.0227403215560775,4.34172688854942e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.0155878851095099,0.00308364016000786,-0.0216318198231253,-0.00954395039589454,4.37249360488429e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0216213844091667,0.00428355454279565,-0.0300171513130462,-0.0132256175052873,4.54525800600551e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.0354127566680856,0.00703843028549095,-0.0492080800276479,-0.0216174333085234,4.94674904383216e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.0124585660502081,0.00247727317850878,-0.0173140214800853,-0.0076031106203309,4.98955867637385e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0577088344230515,0.0114810460932851,-0.0802116847658902,-0.0352059840802127,5.06246141712346e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.0267383512202611,0.00532190419024735,0.0163074190073763,0.0371692834331459,5.13276332499845e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,40451,-0.0429182653994185,0.00854775466698262,-0.0596718645467045,-0.0261646662521326,5.21905681928787e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.0233911649670867,0.00465933341201848,0.0142588714795305,0.0325234584546429,5.22542873477925e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,-0.0207906620170955,0.00414421275328001,-0.0289133190135243,-0.0126680050206667,5.3218836533855e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,40283,0.0484526439868943,0.00966144488512584,0.0295162120120477,0.067389075961741,5.3839655343711e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.0210222563519003,0.00419522293443629,-0.0292448933033954,-0.0127996194004052,5.49899634817054e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0374074408162206,0.00747606665902105,-0.0520605314679019,-0.0227543501645393,5.69917500424721e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.0243317147402971,0.00487506286755889,-0.0338868379607125,-0.0147765915198816,6.08213336978141e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0326621467431202,0.00654663759947487,-0.0454935564380909,-0.0198307370481494,6.15728377976685e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,40116,-0.0208326497767403,0.00417879967092117,-0.0290230971317458,-0.0126422024217348,6.28093792355287e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.0283978924985961,0.00571971661005444,-0.0396085370543028,-0.0171872479428894,6.97706440670118e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.0374317310045781,0.00755270517378389,-0.0522350331451946,-0.0226284288639617,7.28314700268636e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42636,0.0192888934663621,0.00389649730940541,0.0116517587399275,0.0269260281927967,7.49914039419406e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.0117104586115142,0.00236565115888797,-0.0163471348829346,-0.00707378234009382,7.52064967502768e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,-0.0169220876745647,0.00341962873205119,-0.023624559989385,-0.0102196153597444,7.56904689606695e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.0163529960805821,0.00331216669330523,-0.0228448427994604,-0.00986114936170388,8.01861360784692e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.0162472547329421,0.00329233409710081,0.00979427990262449,0.0227002295632597,8.11519584417695e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42677,0.0214077067420949,0.00434462822292777,0.0128922354251565,0.0299231780590333,8.43218284311735e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.050584538740161,0.0103054152887691,-0.0707831527061484,-0.0303859247741736,9.30403345780191e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.0185312336725874,0.00377761112086899,0.0111271158756842,0.0259353514694906,9.42714753834295e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.0357963823847935,0.00729880573268506,-0.0501020416208562,-0.0214907231487308,9.50557575149019e-07
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.0385070953625113,0.00790135930644466,-0.0539937596031428,-0.0230204311218798,1.11189753881821e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.0165125302238165,0.00339022873024254,-0.0231573785350919,-0.00986768191254115,1.12755966600367e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42711,-0.0150448025398811,0.0030946560190614,-0.0211103283372414,-0.00897927674252072,1.17783795127954e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),40324,0.0920141594423491,0.0189533187573488,0.0548656546779455,0.129162664206753,1.22159704753025e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0230450343443051,0.00476220581138522,-0.0323789577346202,-0.0137111109539901,1.3217866892219e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.0296455049677685,0.00613207792643357,-0.0416643777035783,-0.0176266322319587,1.35248467353783e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.0510628704075231,0.0105751351632764,-0.0717901353275449,-0.0303356054875014,1.39358327258609e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.0363545992734546,0.00752983790643019,-0.0511130815700578,-0.0215961169768514,1.39397052222126e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,-0.0421891974933081,0.00874148727909994,-0.059322512560344,-0.0250558824262723,1.40614667091843e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,-0.0165227617283967,0.00342816360166083,-0.023241962387652,-0.00980356106914151,1.4534229353881e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42587,-0.0384818516924031,0.00799106682950136,-0.0541443426782257,-0.0228193607065804,1.48356873450265e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0209848365439769,0.00436318933594006,-0.0295366876424194,-0.0124329854455343,1.53322804477611e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.0141576219746695,0.00294817429234898,-0.0199360435876735,-0.00837920036166549,1.58645614567261e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.023444290322929,0.00488309106252284,-0.0330151488054738,-0.0138734318403842,1.59808526022533e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,42311,-0.0360560539758807,0.00751128572393533,-0.0507781739947939,-0.0213339339569674,1.60215339615492e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.0206905914471682,0.00431099422928403,-0.0291401401365649,-0.0122410427577715,1.61116040735328e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,40235,-0.0208074529936504,0.00433550077718043,-0.0293050345169241,-0.0123098714703768,1.61292386790514e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,40116,-0.0299709721869433,0.00625442028863459,-0.0422296359526671,-0.0177123084212195,1.67329930252422e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,-0.0198281245945346,0.00413890046556377,-0.0279403695070396,-0.0117158796820296,1.68343419931631e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42587,-0.0690685280505483,0.0144366221205518,-0.0973643074068299,-0.0407727486942668,1.73450258937714e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,40293,-0.0122413745431616,0.0025598917180623,-0.0172587623105637,-0.00722398677575949,1.75800550884776e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.0291359585872759,0.00609556014090616,-0.0410832564634519,-0.0171886607110998,1.7728945563858e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42679,-0.0156247543685229,0.00327012227380802,-0.0220341940251866,-0.00921531471185918,1.78883284723703e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.0173149866730101,0.00363104221890163,-0.0244318294220573,-0.0101981439239629,1.87868349913965e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0337137306307906,0.00707406299245308,-0.0475788940959986,-0.0198485671655825,1.9049547305573e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.0349825131037628,0.00734520707067216,0.0205859072452454,0.0493791189622802,1.93469627346445e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,40532,-0.0118635557016674,0.00249365825698329,-0.0167511258853547,-0.00697598551798017,1.98432648619583e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0254921563976822,0.0053751473301689,-0.0360274451648132,-0.0149568676305512,2.13593748881491e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.0267137483670251,0.0056370200709287,-0.0377623077060453,-0.0156651890280048,2.17482088789012e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42652,-0.0188444371753449,0.00397859942550178,-0.0266424920493284,-0.0110463823013614,2.19714938346748e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.0181389942654476,0.00382996987820002,-0.0256457352267196,-0.0106322533041756,2.20187595905278e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0424820076314757,0.00900862757891243,-0.060138917686144,-0.0248250975768073,2.4330741272954e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0466239548953928,0.00992163764606572,-0.0660703646816816,-0.0271775451091039,2.6375253655355e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42689,-0.0234006766684531,0.00497992663798711,-0.0331613328789078,-0.0136400204579983,2.64019694828133e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,-0.0452230006020889,0.00963822913917902,-0.0641139297148798,-0.026332071489298,2.73150484877132e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42495,0.0206168864565144,0.00439690578900536,0.0119989511100639,0.0292348218029649,2.77334598532552e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,-0.0131699417926842,0.00280917696560216,-0.0186759286452645,-0.00766395494010398,2.78357955613672e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.0219242189451311,0.00467993805355845,-0.0310968975301057,-0.0127515403601566,2.83073133867285e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.0107725797386549,0.00230095379647126,0.00626271029757123,0.0152824491797386,2.87754609816661e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.0419724051569676,0.00897996615436558,-0.0595731388195241,-0.024371671494411,2.98242589252368e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42638,-0.0119112120564819,0.00254956565117515,-0.0169083607327851,-0.00691406338017858,3.01378701897669e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,40451,-0.0190478780787968,0.00407735564554701,-0.0270394951440689,-0.0110562610135247,3.02286861794071e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0291685467503829,0.00625853818983217,0.0169018118983119,0.041435281602454,3.18896539283094e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,40482,0.0234415593772412,0.00503006373307761,0.0135826344604091,0.0333004842940733,3.19376396828275e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,42357,-0.0230848376893542,0.00495704700073283,-0.0328006498107906,-0.0133690255679179,3.24029714656977e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.0142422191445288,0.00306182967312764,-0.020243405303859,-0.00824103298519859,3.32672054048295e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.0166104722454574,0.00357787246133072,-0.0236231022696656,-0.00959784222124915,3.48016979650441e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.0474065259913712,0.0102265365236409,-0.0674505375777074,-0.0273625144050349,3.59195873907824e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.0267465802356831,0.00577742824590348,-0.0380703395976539,-0.0154228208737123,3.70061213525966e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.0173826881033155,0.0037576867177959,-0.0247477540701954,-0.0100176221364355,3.76524134835274e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.0177479690251467,0.0038479626110064,-0.0252899757427193,-0.0102059623075742,4.02773429554722e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.0255654629934344,0.00554758951150399,-0.0364387384359822,-0.0146921875508866,4.09608189182301e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.0408975792528444,0.00887785045373997,-0.0582981661421747,-0.023496992363514,4.12870225851133e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.0218050991717514,0.00473310645716784,-0.0310819878278004,-0.0125282105157024,4.13199886786175e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,42261,0.0426943881996467,0.00927035786693219,0.0245244867804596,0.0608642896188338,4.15412776359626e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.0140542062863851,0.00305334847570695,-0.0200387692987707,-0.00806964327399949,4.21227821608028e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42636,0.0130352193498205,0.00283308890996112,0.00748236508629668,0.0185880736133443,4.24183567621673e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.0196165567683834,0.00427353118561122,-0.0279926778921814,-0.0112404356445854,4.47485254163889e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.0218775243517445,0.00476693203888642,-0.0312207111479618,-0.0125343375555271,4.49403297452721e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0181031374852796,0.00394708473544339,-0.0258394235667486,-0.0103668514038105,4.55691453280703e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42794,0.0143598331646071,0.00313486445620371,0.00821549883044786,0.0205041674987664,4.67567057351967e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,0.0143860767348148,0.00314471936713006,0.00822242677523987,0.0205497266943897,4.81195073457766e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.0190171252268222,0.00416474902029497,0.010854217147044,0.0271800333066003,5.01034634862149e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,42346,-0.0378551958938443,0.00829771473135917,-0.0541187167673083,-0.0215916750203803,5.10968764168014e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.0230756435791001,0.00506020214403825,-0.032993639781415,-0.0131576473767851,5.16501765277266e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,0.0175547350367009,0.00385397365274579,0.0100009466773191,0.0251085233960826,5.29406221518751e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.0430647518377966,0.00945581820840784,-0.061598155526276,-0.0245313481493173,5.31165505739976e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.0285620943748199,0.00629009031398219,-0.040890671390225,-0.0162335173594148,5.66387261438845e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.0413816071979544,0.00911467572369225,-0.0592463716163912,-0.0235168427795176,5.67242312830183e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.0245559868060039,0.00540873502302449,-0.0351571074511319,-0.0139548661608759,5.6818394534119e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.0164044052205122,0.00361859553109675,-0.0234968524614619,-0.00931195797956262,5.85634903032059e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.0553881791422567,0.0122205194255753,-0.0793403972163843,-0.0314359610681292,5.88212846114944e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.0591118086065225,0.0130503015506814,-0.0846903996458581,-0.0335332175671869,5.97196556463047e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.0342019202221364,0.00755398525718469,-0.0490077313262184,-0.0193961091180544,6.0162650198646e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0270317845910921,0.00597124776092068,-0.0387354302024966,-0.0153281389796875,6.03547029680178e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.0229555138143012,0.00507217526803733,-0.0328969773396543,-0.013014050288948,6.07920185983047e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.0155235095124556,0.00343697928918604,0.00878703010565093,0.0222599889192602,6.33711530892568e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0283476008851432,0.00629424193995355,-0.0406843150874522,-0.0160108866828343,6.73428913835589e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.0102619405858782,0.00227983585134484,-0.0147304188545141,-0.00579346231724228,6.81447365372248e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.0216479382432854,0.00484372519951226,-0.0311416396343295,-0.0121542368522414,7.91411484415392e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.0176824572385661,0.00395686995024433,-0.025437922341045,-0.00992699213608725,7.94258019543919e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.0199167246486574,0.00447111586910559,-0.0286801117521043,-0.0111533375452104,8.47733374087332e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,-0.0169547274483977,0.00381069381223136,-0.0244236873203711,-0.00948576757642421,8.70108114391651e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.0137666870364242,0.00309595895558942,-0.0198347665893795,-0.00769860748346899,8.80500322796044e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42706,-0.0278445084026936,0.00626593029082273,-0.0401257317727061,-0.015563285032681,8.90891607857413e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,-0.0354280805529155,0.00797427863218209,-0.0510576666719924,-0.0197984944338386,8.96435080029911e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,42134,-0.0279969716848325,0.00630354983486715,-0.0403519293611722,-0.0156420140084929,9.00910335537546e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.0318951379975151,0.00718630650004732,-0.0459802987376078,-0.0178099772574223,9.15272467123944e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0286081660414914,0.00646443368070425,-0.0412784560556717,-0.015937876027311,9.71649442025011e-06
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.0546677616284409,0.0123772784346122,-0.0789272273602808,-0.0304082958966011,1.00965596928897e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.022640656951352,0.00513769596565185,-0.0327105410440296,-0.0125707728586743,1.05755216148041e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.0153362269338728,0.00348221948681109,-0.0221613771280225,-0.00851107673972309,1.0702866738894e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.0285374067526381,0.0064840921492502,-0.0412462273651685,-0.0158285861401077,1.08530543980271e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.0121379008038912,0.00275983196017581,0.00672863016194657,0.0175471714458358,1.10219807347628e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,42311,-0.0235075174608495,0.00535192195759785,-0.0339972844977413,-0.0130177504239577,1.13010715179227e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.0368467595164384,0.00839457205144422,-0.0533001207372691,-0.0203933982956077,1.14572076942162e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0221844618312514,0.00505798513533643,-0.0320981126965108,-0.012270810965992,1.16320447568e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42611,0.0112311519778335,0.00256159890578586,0.00621041812249319,0.0162518858331738,1.17174715116193e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,42334,-0.0267741369681845,0.00611540443849517,-0.038760329667635,-0.0147879442687339,1.20617943850945e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,-0.0234424336407697,0.0053545227053963,-0.0339372981433465,-0.012947569138193,1.20663701262362e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42646,-0.0253756368751487,0.00579885661106038,-0.036741395832827,-0.0140098779174703,1.21803173810861e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,-0.0503394574300499,0.0115359525289523,-0.0729499243867965,-0.0277289904733034,1.29036901039373e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,40516,-0.00666960435502717,0.00153125639376754,-0.00967086688681154,-0.0036683418232428,1.33844987649849e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.0224923609852328,0.00517032261453154,-0.0326261933097146,-0.0123585286607509,1.36987148448518e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42477,-0.0314750761984369,0.0072378423404967,-0.0456612471858105,-0.0172889052110634,1.37978393913426e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42754,-0.0348756113245413,0.00802871437831697,-0.0506118915060425,-0.01913933114304,1.4101811316305e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.0169842564828864,0.00392523951111751,-0.0246777259246767,-0.00929078704109605,1.52503127654981e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,42370,-0.0215122573865559,0.00497621947829901,-0.0312656475640219,-0.0117588672090898,1.5504339851319e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,40511,-0.0433917935932025,0.0100519847153455,-0.0630936836352797,-0.0236899035511253,1.59698125701463e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.016173586094208,0.00374776934192691,-0.0235192140043847,-0.0088279581840312,1.60627136382968e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,-0.0280148184943719,0.00649910285564474,-0.0407530600914356,-0.0152765768973083,1.64242313970844e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.053244789995234,0.0123549963413522,-0.0774605828242844,-0.0290289971661837,1.64735135514568e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.012340749704429,0.00286406535183932,-0.017954317794034,-0.00672718161482392,1.65515671759363e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,-0.0392551016968763,0.00912174265616816,-0.0571337173029659,-0.0213764860907867,1.69568537124593e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,40449,-0.0196525912104181,0.00456676044660564,-0.0286034416857652,-0.0107017407350711,1.69619307817871e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,40116,0.015689646897691,0.00364656335329047,0.00854238272524172,0.0228369110701403,1.70286660572845e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.0170389011501291,0.00396053008187117,-0.0248015401105966,-0.00927626218966163,1.70551872507605e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.0296095657577513,0.00689228391849123,-0.0431184422379941,-0.0161006892775084,1.75125836120288e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,42311,-0.0308679778562093,0.00719201121517458,-0.0449643198379514,-0.0167716358744671,1.78356538403616e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0268202967759118,0.00625319460253014,-0.0390765581968709,-0.0145640353549527,1.80932096327273e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,-0.0210143053036942,0.00490278439847746,-0.03062376272471,-0.0114048478826784,1.83265159866493e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42594,-0.0243416397585445,0.00571760271915143,-0.0355481410880814,-0.0131351384290077,2.08304946801951e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42711,-0.0125648099395657,0.00295661661628317,-0.0183597785074807,-0.00676984137165067,2.15467328015785e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,40516,-0.00981177790168451,0.00230866319040276,-0.0143367577548739,-0.00528679804849511,2.15499756288167e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0269828684909755,0.00635080589076224,-0.0394304480368695,-0.0145352889450815,2.16757019728308e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.0136741535993611,0.00322688659851384,-0.0199988513324482,-0.00734945586627399,2.2779077337037e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.0123321635044741,0.0029125101038053,0.00662364370101573,0.0180406833079325,2.31211563903144e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.0184268600238897,0.00435838331012118,-0.0269692913117272,-0.00988442873605217,2.37468299573199e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,-0.0379839809704967,0.00898568127565465,-0.0555959162707798,-0.0203720456702136,2.38522804125468e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,-0.0166068138972625,0.0039309546309359,-0.0243114849738969,-0.00890214282062818,2.4092103985456e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.0256699240769438,0.00608191005243131,-0.0375904677797092,-0.0137493803741785,2.45145364442263e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,-0.010983865135523,0.00260321994157114,-0.0160861762210024,-0.00588155405004352,2.46633774146334e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,40223,-0.0132824403350921,0.00315016464594034,-0.0194567630411351,-0.00710811762904901,2.5018343857992e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.011816707203628,0.00280352030235542,-0.0173116069962446,-0.00632180741101139,2.51766002313001e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.0126560831973738,0.00300669884234725,-0.0185492129283744,-0.00676295346637318,2.58157815355517e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,0.0309453202145227,0.0073628502143339,0.0165141337944282,0.0453765066346171,2.65546307277483e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.026090701056372,0.00621203972740513,0.0139151031906579,0.0382662989220861,2.68635550992278e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,-0.0274060301948781,0.00653726874986183,-0.0402190769446073,-0.0145929834451489,2.77938319968963e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.034880046787381,0.00832959988116418,-0.0512060625544628,-0.0185540310202992,2.84287698035698e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0245460067889294,0.00586578968239982,-0.0360429545664331,-0.0130490590114258,2.87516196022011e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,-0.0313975010711816,0.00750318193345387,-0.0461037376607512,-0.016691264481612,2.87875306147206e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.0223861388864559,0.00535479879607047,-0.032881544526754,-0.0118907332461577,2.93040225590147e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.0350666054724768,0.00843453347717252,-0.0515982910877349,-0.0185349198572187,3.23745211792144e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,42261,-0.013286886708082,0.00319691463978176,-0.0195528394020543,-0.00702093401410978,3.25704175175725e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.0266542952912387,0.00641577332267851,-0.0392292110036886,-0.0140793795787888,3.2848978703953e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.0243385427367313,0.00586381471545793,-0.0358316195790288,-0.0128454658944337,3.33641448675337e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42587,0.0119906532138627,0.00289186121995213,0.00632260522275654,0.0176587012049689,3.39906334968255e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.0185074010281797,0.00448297627732576,-0.0272940345317382,-0.00972076752462119,3.67588342690525e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,-0.00851233433715431,0.00206344913257389,-0.0125566946369991,-0.00446797403730948,3.7290815991118e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.0166910922914464,0.00404664766849095,-0.0246225217216886,-0.00875966286120412,3.73993948777002e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,40283,-0.0155307611691314,0.00376541540711358,-0.022910975367074,-0.00815054697118877,3.74119912229143e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42563,-0.0155557973888423,0.00378547371779897,-0.0229753258757282,-0.00813626890195629,3.99158646730618e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,40451,0.0492509591181485,0.0120139393866717,0.025703637920272,0.072798280316025,4.16978772293974e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42594,-0.0281878016330361,0.00688172220109516,-0.0416759771471826,-0.0146996261188895,4.2274961206733e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.0301488570709278,0.00736214649557571,-0.0445786642022562,-0.0157190499395994,4.2489627613282e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,-0.0395499659521864,0.00966379683548891,-0.0584910077497446,-0.0206089241546281,4.29074516301767e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,-0.0187143398540751,0.00458216088592911,-0.0276953751904961,-0.00973330451765402,4.44937788980155e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42636,-0.0128004396851234,0.00313728898697672,-0.0189495260995978,-0.00665135327064906,4.52770202544998e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.0178158951285182,0.00436709917075833,-0.0263754095032045,-0.00925638075383189,4.53800045108078e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,40199,-0.0265223826357761,0.00651417238941962,-0.0392901605190386,-0.0137546047525137,4.70404318919559e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,-0.00846489776056452,0.00207998724592622,-0.0125416727625799,-0.00438812275854913,4.73464007838772e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42591,-0.0104741662377532,0.00258584295770359,-0.0155424184348522,-0.00540591404065415,5.13785118458655e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,42381,-0.0193885048375734,0.00479311752746454,-0.0287830151914039,-0.00999399448374288,5.26049723705038e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,-0.0221038525120816,0.00546568280566066,-0.0328165908111765,-0.0113911142129867,5.28693692034357e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.047560491641101,0.0117633563750216,-0.0706166701361434,-0.0245043131460586,5.30993024627148e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,42249,-0.0433285888042546,0.010733693598072,-0.0643666282564757,-0.0222905493520335,5.45201460430021e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,-0.0157874035500133,0.00391484072408992,-0.0234604913692295,-0.00811431573079704,5.54416483512933e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42603,-0.0168833225396615,0.00418859832274309,-0.025092975252238,-0.00867366982708507,5.58990173159079e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.0274487608918076,0.00681262986488828,-0.0408015154269886,-0.0140960063566265,5.63716901480441e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.0211549139472809,0.00528434636091771,-0.0315122328146797,-0.0107975950798822,6.28031100899518e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,-0.0123573474201177,0.00309075604808868,-0.0184152292743715,-0.00629946556586391,6.41816637993485e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0270304704691763,0.00677074949671806,0.0137598014556089,0.0403011394827438,6.57988321340012e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,-0.0180356151867498,0.0045177726384888,-0.0268904495581878,-0.00918078081531173,6.58945327147507e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.0124787618526518,0.00314259641955946,-0.0186382508349884,-0.0063192728703153,7.20740500134675e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,-0.00830334359577639,0.00209129530630824,-0.0124022823961406,-0.00420440479541224,7.21876037408551e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,40223,-0.0288100811038049,0.00728172716501696,-0.0430822663472382,-0.0145378958603717,7.65354205421027e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42531,-0.0186302183301242,0.00473078870092445,-0.0279025641839361,-0.00935787247631227,8.25544474971305e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42618,-0.00997015731670091,0.00253350130003809,-0.0149358198647756,-0.00500449476862626,8.35020854382556e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,40483,-0.0158797639870622,0.00404169571834487,-0.0238014875950181,-0.00795804037910626,8.5813301490654e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.0395959142401363,0.0100970273205463,-0.059386087788407,-0.0198057406918656,8.85063163400293e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',40116,-0.0177224977730761,0.00451955141268195,-0.0265808185419327,-0.00886417700421944,8.86125758179993e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,42353,-0.0361401997787373,0.00922833211724508,-0.0542277307285376,-0.0180526688289369,9.04013855981609e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0235119893305027,0.00600889110399859,-0.0352894158943399,-0.0117345627666654,9.16600555268225e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,40482,0.0145819574524873,0.00372752207826167,0.00727601417909446,0.0218879007258802,9.20826657197667e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.0137873034439746,0.00353222285399903,0.00686414665013653,0.0207104602378127,9.53555013836927e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42594,-0.0157298934985633,0.00403692033448099,-0.0236422573541461,-0.00781752964298059,9.80640877623411e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.0150955868581916,0.00387805180214909,-0.0226965683904038,-0.0074946053259794,9.97679014065044e-05
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.0230085355802419,0.00594046768335902,-0.0346518522396255,-0.0113652189208582,0.000108043906245061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.023461380930321,0.00605855543343038,-0.0353361495798446,-0.0115866122807975,0.000108273179427329
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.024205107503903,0.00625485186057069,-0.0364646171506215,-0.0119455978571844,0.000109436618052883
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.0252141846484675,0.00652242729043333,-0.0379981421377169,-0.0124302271592182,0.000111369578013521
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,40482,-0.0126996481614562,0.00328753511249021,-0.019143216981937,-0.0062560793409754,0.000112643063783666
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,-0.0187899788613757,0.00488296983518062,-0.0283605997383297,-0.0092193579844217,0.000119605650141699
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42594,0.0172722435927101,0.00449032156610906,0.00847121332313632,0.0260732738622838,0.000120347865939963
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,-0.0208347245006576,0.00541782228751395,-0.031453656184185,-0.0102157928171303,0.0001208296208369
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,-0.0210939759049775,0.00548555771107761,-0.0318456690186896,-0.0103422827912654,0.000120929934007331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0216574095983604,0.00563252220453497,-0.032697153119249,-0.0106176660774719,0.000121182725874018
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0130696788396105,0.00340236490623824,-0.0197383140558375,-0.00640104362338358,0.000122932317479729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,40199,-0.0107128873174833,0.00279389317168809,-0.0161889179339919,-0.0052368567009746,0.000126575942333803
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,40269,-0.0233993325833814,0.00610847405057303,-0.0353719417225046,-0.0114267234442583,0.000128518548439862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.0147845176204563,0.00385998583919821,-0.0223500898652848,-0.00721894537562779,0.000128750015048343
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42636,-0.029904415167662,0.0078238866239333,-0.0452392329505713,-0.0145695973847527,0.000132865645377853
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.0163178021420329,0.00427534675538822,-0.0246974817825939,-0.00793812250147202,0.000135961672419553
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.0332245203849109,0.00872390748341179,-0.050323379052398,-0.0161256617174238,0.000140461516585085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42495,-0.0140603508776631,0.00370528550627249,-0.0213227104699572,-0.00679799128536903,0.000148492933522395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,0.00992754205702484,0.00261709400474322,0.00479803780772814,0.0150570463063215,0.000149280121296725
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,40116,-0.0152439411991423,0.00402174138274895,-0.0231265543093303,-0.00736132808895437,0.000151223907269962
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCT,Secretin,40182,-0.019741171813887,0.00520872716574655,-0.0299502770587502,-0.00953206656902377,0.000151441036875733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.0260750038933975,0.00688114168981054,-0.0395620416054261,-0.0125879661813688,0.000151718854264675
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,-0.0360095638356529,0.00951468274275779,-0.0546583420114582,-0.0173607856598476,0.000154751870997861
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LXN,Latexin,42461,0.0265496040341164,0.00702609792230695,0.0127784521063948,0.040320755961838,0.000158330916625811
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,42460,-0.0222376326010825,0.0058953867555193,-0.0337925906419004,-0.0106826745602647,0.000162622196705188
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,-0.0221551576514648,0.00587437581035218,-0.0336689342397551,-0.0106413810631746,0.00016298839668814
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.0192921539792656,0.00511651322004495,0.00926378806797748,0.0293205198905537,0.000163573966286492
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,40451,0.0219017002768986,0.00581510790067235,0.0105040887915808,0.0332993117622164,0.000166498911611011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,-0.0107283011998771,0.00284864875462698,-0.016311652758946,-0.00514494964080825,0.000166656140446145
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0481854939568355,0.0128291060105061,-0.0733305417374274,-0.0230404461762436,0.000173574924490459
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.0247735294404423,0.0066060582172278,-0.0377214035462088,-0.0118256553346758,0.000177627837773472
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42495,-0.0170312941679577,0.00455001685928529,-0.0259493272121568,-0.00811326112375852,0.000182509054963705
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.0284705280284822,0.00761900690164753,-0.0434037815557113,-0.013537274501253,0.000187328312871835
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.00805487523039274,0.00216079643872467,-0.0122900362502931,-0.0038197142104924,0.000194177235788988
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42679,-0.013370807920574,0.00358952759330333,-0.0204062820034485,-0.00633533383769947,0.000196151155239999
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.00839135006784726,0.00225561199669993,-0.0128123495813791,-0.0039703505543154,0.00020004743635897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,-0.00838890299951385,0.00225780135166549,-0.0128141936487782,-0.0039636123502495,0.000203612004899544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,40116,0.0230229931931813,0.00620912582853417,0.0108531065692544,0.0351928798171083,0.000209996211943777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.114313264992504,0.030863940259802,-0.174806587901716,-0.053819942083292,0.000213261564221831
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,-0.00996454420045564,0.00269198503176993,-0.0152408348627247,-0.00468825353818659,0.000215133848975695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.0216773456388854,0.00587109754784296,-0.0331846968326576,-0.0101699944451132,0.000223397327564672
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.0156881092885523,0.00424925711974482,-0.0240166532432522,-0.00735956533385248,0.000223414113023376
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42505,0.0496950979808246,0.0134641069511705,0.0233054483565303,0.0760847476051188,0.000224325926286739
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,42292,-0.0140424160169565,0.00380727006445433,-0.021504665343287,-0.00658016669062604,0.000226656135799294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,40182,-0.0247074373511339,0.00673237404662111,-0.0379028904825113,-0.0115119842197565,0.000243751748415571
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,-0.0160492414274936,0.00437638072699887,-0.0246269476524113,-0.00747153520257577,0.00024631166084222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,0.0107027684013096,0.00291914048322534,0.00498125305418789,0.0164242837484312,0.00024692363910329
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,40483,0.0142487321015707,0.00388671718530826,0.00663076641836651,0.0218666977847749,0.000247497731821534
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,40284,0.0118187502269509,0.00322795842901523,0.00549195170608106,0.0181455487478207,0.000252036389646482
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.0096577904794133,0.00264067807626647,-0.0148335195088956,-0.00448206144993103,0.000256026909684862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,40451,-0.0201707039155706,0.00553409229742571,-0.031017524818525,-0.0093238830126162,0.000268796320282713
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.0107730600602623,0.00295972920657382,-0.016574129305147,-0.0049719908153776,0.00027398021411567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.0103821138093378,0.00285291070378569,0.00479040882991781,0.0159738187887577,0.000274786181358489
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,-0.0273740163808956,0.00754645482805132,-0.0421650678438762,-0.012582964917915,0.000287352593145334
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,40199,-0.0155125793315631,0.00428325365784385,-0.023907756500937,-0.00711740216218913,0.00029401092082736
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.0126549649267943,0.00349519076948487,-0.0195055388349847,-0.00580439101860399,0.00029514764414216
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.0332432315541363,0.00918402564165817,-0.0512439218117863,-0.0152425412964863,0.000296281554240143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.0108321967196539,0.00299491388231447,-0.0167022279289902,-0.00496216551031752,0.000299494374115416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42711,-0.0241274903622138,0.00667561860064955,-0.0372117028194869,-0.0110432779049407,0.000302288684172949
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIM,Vimentin,42357,-0.0434608561118699,0.0120746373204654,-0.0671271452599821,-0.0197945669637578,0.000320184185498437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,40116,-0.0237886889352339,0.00661179773884729,-0.0367478125033746,-0.0108295653670932,0.000322195997801142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.0151510358309586,0.00421577166083936,-0.0234139482862038,-0.00688812337571349,0.000327206748892888
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42611,-0.0199642228168157,0.00556415673365145,-0.0308699700147725,-0.00905847561885885,0.000334404259880996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42563,-0.0241581014956176,0.00674510345227759,-0.0373785042620817,-0.0109376987291536,0.0003427398837144
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,40449,-0.0226704398716625,0.0063361079618197,-0.0350892114768291,-0.0102516682664959,0.00034772052867798
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.0164199145814513,0.00459194691396608,-0.0254201305328248,-0.0074196986300778,0.000350632546421212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,0.00998838187353544,0.00279573226505914,0.00450874663401952,0.0154680171130514,0.000354507380143013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.0205142448112826,0.00574231937012727,-0.031769190776732,-0.00925929884583311,0.000355147598677837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,40527,-0.0163891862433079,0.00459090484009288,-0.0253873597298899,-0.00739101275672583,0.000358560760037321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.0373915260703512,0.0104806005524572,-0.0579335031531674,-0.016849548987535,0.00036168581551453
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.0201282374561821,0.00564911957716578,-0.031200511827427,-0.00905596308493714,0.000367832886294018
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.0179249416070505,0.00504103677251824,0.00804450953291471,0.0278053736811862,0.000378123013312862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42676,-0.0286273050836206,0.00805549199268939,-0.0444160693892918,-0.0128385407779494,0.000381060306724914
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.0242645979253774,0.00682837812505911,-0.0376482190504932,-0.0108809768002615,0.000381718107267778
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42587,-0.0104882973674433,0.00295449734619206,-0.0162791121659798,-0.00469748256890691,0.000386635155300078
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42770,-0.0219596830926073,0.00619174066588576,-0.0340954947977434,-0.00982387138747118,0.00039153812610741
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0153470052823265,0.0043328580019108,-0.0238394069660716,-0.00685460359858131,0.000398454568856077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,40532,0.00928126654587307,0.00262275216166925,0.00414067230900133,0.0144218607827448,0.000403633963517468
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,40451,-0.0258377934568725,0.00730355699728425,-0.0401527651715496,-0.0115228217421954,0.00040525356881871
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.0142910058149078,0.0040412820441495,-0.0222119186214408,-0.0063700930083748,0.000407510990935171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.02736533273596,0.00776002209553855,-0.0425749760432156,-0.0121556894287044,0.000422575031888836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,40384,-0.0115765260465694,0.00328494844785212,-0.0180150250043596,-0.00513802708877928,0.000426601206836565
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0181653129093165,0.00515812046444205,-0.0282752290196229,-0.00805539679901009,0.000430534242384236
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42636,-0.0148336136067463,0.00422664562917332,-0.023117839039926,-0.00654938817356663,0.000450338589514845
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPL,Periplakin,40199,-0.0121849464336237,0.00347401017257885,-0.0189940063718782,-0.00537588649536914,0.000454213448671063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.0177540519747053,0.00507015153342768,0.00781655496918708,0.0276915489802236,0.000463838115969161
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42734,-0.0125477046197726,0.00358337987084009,-0.0195711291666192,-0.00552428007292604,0.000463894208964573
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,-0.039458955871322,0.0112731977600467,-0.0615544234810135,-0.0173634882616306,0.00046634010116983
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.0121593666984241,0.00347404227156736,-0.0189684895506961,-0.00535024384615206,0.000466989011851894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,-0.00902767943834112,0.00258053444786289,-0.0140855269561524,-0.00396983192052986,0.00046993600187447
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,40479,-0.00940805396710334,0.00269533380818392,-0.0146909082311438,-0.00412519970306285,0.000483965034087274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,42154,-0.0135140204915759,0.0038769479079711,-0.0211128383911993,-0.00591520259195257,0.000492407239061373
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.0164468744066814,0.00472792953563106,0.00718013251684449,0.0257136162965183,0.00050582163984379
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.0108960877900713,0.00314601425881259,-0.0170622757373439,-0.00472989984279859,0.000534949749717432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,-0.0155677186805311,0.00449676862855737,-0.0243813851925036,-0.00675405216855869,0.000537923153171466
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,-0.0362504701516691,0.0104785850718745,-0.0567884968925432,-0.015712443410795,0.000542913533713521
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42721,0.0217511843423138,0.00629474856217134,0.00941347716045794,0.0340888915241696,0.000551062231545862
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.0164478067559244,0.00476512214688613,-0.0257874461638212,-0.00710816734802755,0.000559097733728415
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.0164983041209624,0.00479306915912625,-0.0258927196728499,-0.00710388856907497,0.000579278941661463
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,-0.0225523251318676,0.00657302578007424,-0.0354354556608131,-0.00966919460292205,0.000603413352292163
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.0139607956727438,0.00407295798864822,0.00597779801499331,0.0219437933304943,0.000611008501049739
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,42347,-0.0153729740327716,0.00448707532934578,-0.0241676416782893,-0.00657830638725385,0.00061428479710904
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,40539,-0.0181788605901807,0.00531059076808982,-0.0285876184956368,-0.00777010268472464,0.00062122413499439
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,-0.0100960660651312,0.00295251742065716,-0.0158830002096192,-0.00430913192064311,0.000629267242864837
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.0104269891626408,0.00305217472264459,-0.0164092516190242,-0.0044447267062574,0.000636782773874284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,42237,0.0249643107871655,0.00731166131293172,0.0106334546138193,0.0392951669605117,0.000641373420978495
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42721,-0.0105937400628799,0.00310471282373405,-0.0166789771973986,-0.00450850292836112,0.000646417683157133
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0171513169395536,0.00503517934469353,-0.0270202684551529,-0.00728236542395431,0.000660420244620072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42594,-0.01791598874253,0.0052661064477493,-0.0282375573801187,-0.00759442010494139,0.000670578103185502
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.0178475319202168,0.00525676149866374,-0.0281507844575977,-0.00754427938283588,0.000687924648829947
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,40449,-0.0109471124667604,0.00322984732407403,-0.0172776132219455,-0.00461661171157527,0.000702966677094773
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,-0.0242465928469336,0.00716404808558627,-0.0382881270946827,-0.0102050585991845,0.000715556134067284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,-0.00766854735550527,0.00226916975222162,-0.0121161200698596,-0.00322097464115089,0.000728402083568966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0251372142352725,0.00744418386582762,-0.0397278146122947,-0.0105466138582504,0.000735525842580153
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.033198618594773,0.00985054142308201,-0.0525056797840137,-0.0138915574055322,0.000753622929553611
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,40136,-0.0155810789044297,0.00462733404869249,-0.024650653639867,-0.00651150416899245,0.000762020432656911
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.0214010165282582,0.00639999266620376,-0.0339450021540175,-0.00885703090249879,0.000828845647491101
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42594,-0.0219414718387451,0.00656282906551105,-0.0348046168071467,-0.00907832687034341,0.000830167397702579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,40116,-0.0189270576518608,0.00566453538990465,-0.0300295470160739,-0.00782456828764767,0.000836590561527647
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.0165401860715719,0.00495131448378734,-0.0262447624597951,-0.00683560968334872,0.000838793565723245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.0148688805041983,0.0044561238054908,-0.0236028831629602,-0.00613487784543629,0.000850058955198091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,-0.0228242269617029,0.00684088338654004,-0.0362323583993214,-0.00941609552408441,0.000850854034037755
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,40483,-0.0337379675576977,0.0101264539357112,-0.0535858172716917,-0.0138901178437037,0.000866048127804287
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.010822575881741,0.00326760479904327,0.00441807047561615,0.0172270812878658,0.000928952132454451
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.0190253865528198,0.00574761794925575,-0.0302907177333611,-0.00776005537227855,0.000935424201166668
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.00878680910572626,0.00265920820842937,0.0035747610172047,0.0139988571942478,0.000954644679433022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,-0.0230575154306638,0.00698124000902658,-0.0367407458483559,-0.0093742850129717,0.000960383141068519
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,-0.0308802934243818,0.00935917795186124,-0.0492242822100298,-0.0125363046387337,0.000971215356420532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.0111437927220418,0.00337869545799521,-0.0177660358197124,-0.00452154962437121,0.000975415135671881
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0223330948357973,0.00679817206092503,-0.0356575120752104,-0.00900867759638425,0.00102181654858697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,42346,-0.0254798723486661,0.00776241751713973,-0.04069421068226,-0.0102655340150723,0.00103171706892812
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42656,-0.0108219868572287,0.00329767462992728,-0.0172854291318862,-0.00435854458257128,0.00103445079761174
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.0114197177385396,0.00348065981006294,-0.0182418109662629,-0.0045976245108162,0.00103796675480165
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.0189772833543741,0.00578982050936335,-0.0303253315527263,-0.00762923515602192,0.00104928248959475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,40199,0.0105017211101878,0.00320760625591914,0.00421481284858632,0.0167886293717893,0.00106361846548229
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42578,-0.0373294298331316,0.0114191271850564,-0.0597109191158421,-0.0149479405504211,0.00108190556062403
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42679,0.0126354599736992,0.00386657029757807,0.0050569821904462,0.0202139377569522,0.00108630133093853
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42636,-0.0227503974078479,0.00696287485968401,-0.0363976321328286,-0.00910316268286724,0.00108817978426302
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,-0.0201457591676938,0.0061718148279978,-0.0322425162305695,-0.0080490021048181,0.00110117946734087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.0134572997306822,0.00412560991939356,0.00537110428867083,0.0215434951726936,0.00110998021014472
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.00798594016419185,0.00244932055619735,-0.0127866084543387,-0.00318527187404504,0.00111504869304938
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.0176839396038251,0.00544151475456649,-0.0283493085227754,-0.00701857068487477,0.00115760107499009
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,42483,-0.034652085191432,0.0106659425065246,-0.0555573325042202,-0.0137468378786438,0.0011615899307725
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42794,-0.0179155192653047,0.00551710180031964,-0.0287290387939312,-0.00710199973667823,0.00116800138972319
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,42311,0.0251709947477112,0.00776012756423215,0.00996114472181624,0.0403808447736063,0.00118311584988438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.0175889786908699,0.00542412827835915,-0.0282202701164538,-0.00695768726528594,0.00118744028841637
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0202204690968258,0.00624112045535091,0.00798787300433802,0.0324530651893136,0.00119872469515313
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42636,-0.028549774968914,0.00881659517395638,-0.0458303015098685,-0.0112692484279595,0.00120584248901105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,40482,-0.0229824729422865,0.00710752122103316,-0.0369132145355115,-0.00905173134906152,0.00122616549076413
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.0182420341275398,0.00564892105997181,-0.0293139194050846,-0.00717014884999509,0.00124401157366055
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.0163552262021376,0.00510366904184086,-0.0263584175241457,-0.00635203488012952,0.00135565316833254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,40116,0.0106293129310984,0.00331940899472718,0.00412327130143312,0.0171353545607637,0.0013678724410472
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,-0.0305533572614921,0.00954744820882023,-0.0492663557507798,-0.0118403587722045,0.00137731540915746
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0292995123553891,0.00916120246498142,-0.0472554691867527,-0.0113435555240255,0.00138676603531285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.0133312833136776,0.00417068712258132,-0.021505830073937,-0.00515673655341817,0.00139534908168989
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.0111528400554903,0.00349178228941529,-0.0179967333427443,-0.00430894676823637,0.00140634435412656
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,-0.0144265833442166,0.00452166607296655,-0.023289048847231,-0.00556411784120214,0.00142393933495304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.0105413430583612,0.00330633918889554,-0.0170217678685965,-0.00406091824812593,0.00143551299495854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,-0.0116101513197322,0.00364684651050926,-0.0187579704803304,-0.00446233215913408,0.0014578227915321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42562,-0.0118475581595646,0.00372569082915813,-0.0191499121847146,-0.00454520413441468,0.00147630087340704
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.0150148229565969,0.00473343855527087,-0.0242923625249278,-0.00573728338826602,0.00151695416009071
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,0.0103581341549401,0.00327454023628423,0.00394003529182299,0.0167762330180572,0.00156452220932125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,42370,-0.0161765479677273,0.00511475053348698,-0.0262014590133618,-0.00615163692209283,0.00156654745733293
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,-0.00845616530848218,0.00267360114737933,-0.0136964235573457,-0.00321590705961869,0.00156663338267856
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42587,0.025379415453427,0.00802737618145349,0.00964575813777815,0.0411130727690758,0.00157250542095159
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,40539,0.00755443369367463,0.0023995243944223,0.00285136588060692,0.0122575015067423,0.00164646113686341
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.010350270877546,0.00330122732979309,0.00387986531115159,0.0168206764439405,0.00172142872570793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.00915996431562014,0.00292223648357999,0.00343238080780336,0.0148875478234369,0.00172471492617966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.0282277664307121,0.00901003478330865,-0.045887434605997,-0.0105680982554271,0.00173523436834477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.0126216313400426,0.00403541007019104,-0.020531035077617,-0.00471222760246813,0.00176628351409199
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,0.0143041764789849,0.00457637199312605,0.00533448737245781,0.0232738655855119,0.00177872504387658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.0187853004040126,0.00602944798415707,-0.0306030184529605,-0.00696758235506479,0.00183970237013821
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.0187331881371779,0.00602551728916299,-0.0305432020239374,-0.00692317425041845,0.00188205273390921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0171831535378601,0.0055278154765959,-0.0280176718719881,-0.00634863520373211,0.00188515408807745
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.0140950445943529,0.00454738838010022,-0.0230079258193493,-0.00518216336935645,0.00194197061442957
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0157337953447425,0.00508137984601245,-0.0256932998429269,-0.00577429084655814,0.00196391923853235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0772648182997909,0.0249687535608376,-0.126203575279033,-0.0283260613205492,0.00197653311220703
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0161173024652453,0.0052165983352142,-0.0263418352022652,-0.00589276972822552,0.00200901882947071
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,0.00843254579323933,0.00273106494456227,0.00307965850189728,0.0137854330845814,0.0020225450097824
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,39042,-0.0354722620847208,0.0114934739300242,-0.0579994709875682,-0.0129450531818733,0.0020322953760268
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.0204207947048221,0.00661777858035269,0.00744994868733085,0.0333916407223134,0.00203545804887975
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,40080,0.0152825580472942,0.00495936720022548,0.00556219833485223,0.0250029177597361,0.00206437228419092
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42664,-0.0137429138404157,0.00446105577340331,-0.0224865831562862,-0.00499924452454522,0.00206971413116899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42771,-0.00987543270678777,0.00320656297372609,-0.0161602961352909,-0.00359056927828464,0.00207583779475895
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,40482,-0.00828517222313509,0.00269075674472186,-0.0135590554427899,-0.00301128900348025,0.00208109058347253
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42587,-0.013350706963555,0.0043535742938266,-0.0218837125794551,-0.00481770134765483,0.0021693392834422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.0166662558825026,0.00543940951619526,-0.0273274985342453,-0.00600501323075984,0.00218928036419672
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.0126182194930535,0.00413161620849625,0.00452025172440086,0.0207161872617062,0.00226302448004413
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00937949566607112,0.00307378093510286,-0.0154041062988727,-0.00335488503326952,0.00228266250128112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,-0.0338389438525127,0.011091022384498,-0.0555773477261288,-0.0121005399788966,0.00228620678983699
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.0158871705806883,0.00521498589459055,-0.0261085429340858,-0.00566579822729083,0.00232100513903793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.020556791768272,0.00675085807554981,-0.0337884735963496,-0.00732510994019433,0.00233179956562193
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,-0.00765435522143218,0.00251682363921662,-0.0125873295542968,-0.0027213808885676,0.00236032519203395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.0312593825184301,0.0102821882152303,-0.0514124714202815,-0.0111062936165787,0.0023691688730296
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42587,0.00482414085379774,0.00158791499262553,0.0017118274682517,0.00793645423934379,0.00238585186932194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42674,-0.0192731716976707,0.00635080337750126,-0.0317207463175732,-0.00682559707776823,0.00241185060883633
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,42370,-0.026782972078531,0.00883023616703766,-0.0440902349659248,-0.00947570919113715,0.0024252803833249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,-0.00709701022083581,0.00234677923469055,-0.0116966975208293,-0.00249732292084233,0.0024989354338982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42689,0.00947497368046477,0.00314172827634326,0.00331718625883198,0.0156327611020976,0.00256738924508819
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,42292,-0.0190686912378553,0.00632544491886523,-0.0314665632788311,-0.00667081919687945,0.00257810340688627
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0120053079614773,0.0039862702321103,0.00419221830654111,0.0198183976164135,0.00260313335135796
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,0.0360855545876764,0.0119859742592583,0.0125930450395303,0.0595780641358226,0.00261174492015589
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.00982129964918938,0.00326784293388341,-0.0162262717996009,-0.00341632749877789,0.00265682140958669
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,40136,0.0131859128262587,0.00439642706415824,0.00456891578050858,0.0218029098720089,0.00271268360925642
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.0135507145898106,0.00451904507872479,-0.0224080429441112,-0.00469338623551001,0.0027184006824779
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,40116,0.0125267111717719,0.00419157338055199,0.00431122734589004,0.0207421949976539,0.00280931567669331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.00909070206174234,0.00304561113599427,-0.0150600998882911,-0.00312130423519357,0.00284333293268722
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.0149346439401947,0.00500466773654248,0.00512549517657141,0.0247437927038179,0.00285003083292423
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,40483,-0.00952396925435533,0.00319310723893746,-0.0157824594426727,-0.00326547906603792,0.00286361138599164
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.00745801089477692,0.00250451755007272,-0.0123668652929195,-0.00254915649663439,0.00290822678584404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42721,-0.0067070215447525,0.00225271496001063,-0.0111223428663733,-0.00229170022313167,0.00291308822318695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,40449,-0.0205650178068305,0.00691240503151622,-0.0341133316686023,-0.00701670394505869,0.00293525838608955
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,40182,-0.0148599101484865,0.00499857236956534,-0.0246571119928346,-0.00506270830413843,0.0029570702075646
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.00848048874852754,0.00286108324254484,0.00287276559313966,0.0140882119039154,0.00304112478969717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42638,-0.0104579309613751,0.00352821926330036,-0.0173732407174438,-0.00354262120530641,0.00304119834955416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.0171269783764966,0.00578317081073065,-0.0284619931655287,-0.00579196358746454,0.00306779034453336
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,-0.0241131266525664,0.00818027254240779,-0.0401464608356857,-0.00807979246944714,0.00320797304711629
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,-0.0090252114164594,0.00306406204675402,-0.0150307730280973,-0.00301964980482152,0.00322977323723971
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.0108956657183029,0.00370000050832075,-0.0181476667146116,-0.00364366472199423,0.00323866674158042
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,40182,-0.0095999065183136,0.00326442598980323,-0.0159981814583279,-0.00320163157829926,0.00328086478858069
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,40136,0.0281369959198578,0.00959635188051732,0.00932814623404385,0.0469458456056717,0.00337428589823794
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.0177552736825247,0.00606590191858395,-0.0296444414429492,-0.00586610592210015,0.00342888168245209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.0063478143082344,0.00216958239406666,0.00209543281586375,0.0106001958006051,0.00344253602527129
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.0160181876619507,0.00547563893242514,-0.026750439969504,-0.00528593535439744,0.00344750448268992
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.00987200518138711,0.00337618752477641,-0.0164893327299489,-0.00325467763282535,0.003462373778235
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,-0.0170900725000722,0.00585423442448016,-0.0285643719720533,-0.00561577302809109,0.00351551093071319
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,40539,-0.00631419028246587,0.00216531916948551,-0.0105582158546575,-0.00207016471027427,0.00355181941258155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,-0.0182741564357984,0.00629733103487895,-0.0306169252641611,-0.00593138760743566,0.00371639011466386
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.00822589699121693,0.00284572600605985,-0.0138035199630942,-0.00264827401933963,0.00385219189849629
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,42311,-0.0117049209965931,0.00405094623801301,-0.0196447756230986,-0.00376506637008759,0.00386574542325899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,-0.00994212362608635,0.00344297880274838,-0.0166903620794732,-0.00319388517269953,0.00388746593694426
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.00987810346607317,0.00342261568833932,0.0031697767169281,0.0165864302152182,0.00390751230187592
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,40223,0.0161803344653555,0.00564700758606369,0.00511219959667064,0.0272484693340403,0.0041741025464792
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.0238937070448135,0.00836821178423439,-0.0402954021419129,-0.00749201194771406,0.00430773893659255
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,-0.0202142766936528,0.00710675174214104,-0.0341435101082493,-0.00628504327905638,0.00445653805962445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,40116,0.0109214950096918,0.00384950466024064,0.00337646587562012,0.0184665241437634,0.00456067595925488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,40182,-0.0224322268561739,0.00791825092384203,-0.0379519986669043,-0.00691245504544348,0.00462005962848642
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.0191997995980911,0.00678733707873141,-0.0325029802724046,-0.00589661892377752,0.00467967779508045
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,40267,0.00889228852827643,0.00315662052621306,0.00270531229689884,0.015079264759654,0.00485560993277966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.0110077622875094,0.00391833305025659,0.00332782950900648,0.0186876950660123,0.0049724365678032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.0139721195300132,0.00498066549035085,0.00421001516892556,0.0237342238911009,0.00503633656284033
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42608,0.0171118226694342,0.0061089219449153,0.00513833565740025,0.0290853096814682,0.00509985045994206
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.0175318031286729,0.00626073952516215,0.00526075365935512,0.0298028525979907,0.00511312242784186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00848598032709894,0.00303257395983935,0.00254213536581381,0.0144298252883841,0.00514659628166269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0287787978320617,0.0103036529738514,-0.0489739576608105,-0.00858363800331298,0.00523015948944332
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.0113769964923647,0.00407700410236948,-0.0193679245330089,-0.00338606845172048,0.00527133278719624
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.0130271864392881,0.00466934531207511,-0.0221791032509554,-0.00387526962762093,0.00528094194102312
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42636,-0.0117366578940455,0.00422006486041358,-0.0200079850204561,-0.00346533076763489,0.00542411463486149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.0139936214453738,0.00503196828412267,-0.0238562792822542,-0.00413096360849333,0.00542785274286054
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,40527,-0.0283426050261615,0.010199815200774,-0.0483342428196785,-0.00835096723264455,0.00546605076935447
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42721,-0.00938113172407135,0.00337775126208141,-0.0160015241977509,-0.00276073925039178,0.00548828625054815
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.0116597454652216,0.00420409515518407,-0.0198997719693824,-0.00341971896106085,0.00555608116473221
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.0101560464192847,0.00368675745026136,-0.017382091021797,-0.00293000181677245,0.00588201257770185
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,40199,-0.0142579219096189,0.00518726361533782,-0.0244249585956811,-0.00409088522355681,0.00599405677016972
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42594,-0.0102146575194883,0.003722171397511,-0.0175101134586099,-0.00291920158036678,0.00607256517177753
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0163399988544207,0.00596331150608041,-0.0280280894063383,-0.00465190830250314,0.00615195307960364
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.00800244487830949,0.002922020592995,-0.0137296052405797,-0.0022752845160393,0.00617718652605975
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.0206894388867581,0.00755809637241331,-0.0355033077766882,-0.00587556999682802,0.00620262694401651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.023123926021957,0.0084720966470282,-0.0397292354501323,-0.00651861659378178,0.00635440857729445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,-0.00896459469842858,0.0032919317870405,-0.015416781001028,-0.0025124083958292,0.00647356609010857
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0241626289741953,0.00887505149764126,-0.0415577299095721,-0.00676752803881838,0.00648860101358527
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,0.0122532303327046,0.00452123395763472,0.00339161177574056,0.0211148488896687,0.00673558463566406
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.0182064493600402,0.00672495768949659,0.00502553228862689,0.0313873664314535,0.0067939119246278
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42488,-0.0145362570154354,0.00537178370512339,-0.0250649530774773,-0.00400756095339361,0.00681778843394802
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.0144149479130152,0.00534642356817923,-0.0248939381066465,-0.00393595771938388,0.00702455221479576
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.0097645480598635,0.00362203717364272,-0.0168637409202032,-0.00266535519952376,0.00702918122073401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0118599113646741,0.00440147788284514,0.00323301471429759,0.0204868080150505,0.0070575442311141
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,40539,-0.00726104385832205,0.00269630124220759,-0.0125457942930489,-0.00197629342359518,0.00709238341231709
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,0.0164313541819342,0.00610383587874265,0.00446783585959858,0.0283948725042698,0.00711185608998871
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42679,0.00785609133101664,0.00291893496953861,0.00213497879072096,0.0135772038713123,0.00712354881791363
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.00994775062284298,0.00370728384177629,-0.0172140269527245,-0.00268147429296145,0.00729882649251428
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,42311,0.00928673813467359,0.00347334949255014,0.00247897312927532,0.0160945031400719,0.00751096261006506
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.0233221236579954,0.00872758366865355,-0.0404281876485564,-0.00621605966743447,0.00754605099241203
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0329201251784017,0.0123394906612053,-0.0571055268743641,-0.00873472348243933,0.00764260742560564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,0.00903173614540231,0.00339245128581581,0.00238253162520332,0.0156809406656013,0.00777212611009176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.00642316999790278,0.00241944412478736,-0.011165280482486,-0.00168105951331956,0.00794455278325152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,40116,0.0139518953011589,0.00526320649536995,0.00363601057023381,0.024267780032084,0.00804087224845995
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00781058933240514,0.00295191531014567,0.00202483532451962,0.0135963433402907,0.00815592262388388
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.00937979076762065,0.00355520159108706,0.00241159564909002,0.0163479858861513,0.0083433702060954
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42626,0.018178526630604,0.00689125261497371,0.00467167150525548,0.0316853817559524,0.00835140568511634
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,0.0131416908638458,0.0049816858904298,0.00337758651860338,0.0229057952090882,0.00835146344493578
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,42311,-0.017887752895314,0.00678140036333259,-0.0311792976074459,-0.00459620818318211,0.00835524160882737
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42794,-0.00538253171102338,0.00204258148055026,-0.00938599141290189,-0.00137907200914487,0.00841926735939526
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.00885879928370837,0.0033896876021118,-0.0155025869838475,-0.00221501158356924,0.00897505439058634
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,40116,0.0154750266626446,0.00595311441891244,0.00380692240157621,0.027143130923713,0.00934895789283617
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,-0.00920207661540827,0.00354086437567416,-0.0161421707917296,-0.00226198243908691,0.00936467955838228
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42584,-0.0192374372095482,0.00740375288240651,-0.0337487928590649,-0.0047260815600314,0.00937794174452908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42721,0.0120127980021014,0.00463325131552564,0.00293162542367113,0.0210939705805317,0.00953182581068345
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.0165435297398642,0.00641042117935534,-0.0291079552514007,-0.00397910422832775,0.00986994138188536
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.0110095269493611,0.00426815290566519,-0.0193751066444649,-0.00264394725425732,0.0099080537468711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,0.0118662873959837,0.00460076845116938,0.00284878123169174,0.0208837935602757,0.00991589187294062
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00759951857304209,0.0029482578639438,-0.0133781039863719,-0.00182093315971225,0.00996060286274925
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42794,0.00465507387631511,0.00180753288953403,0.0011123094128284,0.00819783833980181,0.0100236282957217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0174320686169235,0.00679790675657424,-0.030755965859809,-0.00410817137403799,0.0103482690960306
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,40483,-0.0139307886812323,0.00545530598982355,-0.0246231884212864,-0.00323838894117809,0.0106739204303974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,40116,0.010854841850656,0.00425219648364778,0.0025205367427064,0.0191891469586057,0.0107007557525097
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.0157458758809005,0.00617124495171231,-0.0278415159862567,-0.0036502357755444,0.0107371648769043
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42495,-0.0148428449955787,0.00583270890298313,-0.0262749544454256,-0.00341073554573178,0.0109464823477316
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.00858955723553182,0.00338812979276148,-0.0152302916293443,-0.00194882284171933,0.0112523990781772
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0105837247041427,0.00417538900181045,-0.0187674871476912,-0.00239996226059421,0.0112653887819019
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.00745006345110306,0.00294186110059275,0.00168401569394126,0.0132161112082648,0.0113386782307954
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGN,Cingulin,40182,-0.0108923992585197,0.00430199101330429,-0.0193243016445961,-0.00246049687244331,0.0113570322390021
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.0116312012861867,0.00459986454643905,-0.0206469357972073,-0.00261546677516621,0.0114659254881687
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42559,-0.0189472915431469,0.00752566746380529,-0.0336975997722052,-0.0041969833140885,0.0118243437670908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.00904508208132645,0.00359502756255395,-0.0160913361039322,-0.00199882805872071,0.0118814266530395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,40136,0.0126031262938716,0.0050227173693419,0.00275860024996151,0.0224476523377818,0.0121139825259105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42553,-0.0155427580305721,0.00620101330440318,-0.0276967441072023,-0.00338877195394183,0.0122055452887583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00633093780516505,0.00253996103346305,-0.0113092614307526,-0.00135261417957748,0.0126981285528952
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.0106247854481323,0.0042655207509637,-0.0189852061200211,-0.00226436477624343,0.0127582125577245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.00688775061553713,0.00276609272062439,0.00146620888311332,0.0123092923479609,0.0127838843814865
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.00878236692749491,0.00352931830876658,-0.0156998308126774,-0.00186490304231241,0.0128461218068762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.0101781425177066,0.00409154379706983,-0.0181975683599635,-0.00215871667544977,0.0128754708136135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.00815513817897132,0.00328147400950893,-0.0145868272376088,-0.00172344912033381,0.0129599896294824
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.0385902208930152,0.0155452005265088,-0.0690588139249724,-0.00812162786105797,0.0130605619903161
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,40283,-0.0115324421107048,0.00467601719496435,-0.020697435812835,-0.0023674484085747,0.0136668637582762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,40182,-0.0135894705662944,0.00552383459353391,-0.0244161863696209,-0.00276275476296797,0.0139031124564376
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,-0.00748621532736608,0.00305139198731891,-0.0134669436225111,-0.00150548703222101,0.0141671310671348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,0.00684682270236989,0.0027912622992127,0.001375948595913,0.0123176968088268,0.0141843496031084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,-0.0155080560649027,0.00632839644672406,-0.0279117131004819,-0.00310439902932356,0.0142763615308445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.0212393052553984,0.00869194811487525,-0.0382755235605539,-0.00420308695024293,0.0145587110145054
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.012305693836481,0.00503846523531552,-0.0221810856976995,-0.00243030197526262,0.0146051144344823
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42611,0.0051219338570806,0.00210094388568399,0.00100408384113998,0.00923978387302121,0.0147849192743461
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,-0.0152562656312996,0.00626227482853595,-0.0275303242952301,-0.00298220696736915,0.0148547762829355
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,40199,-0.0112573052289735,0.00465502167393635,-0.0203811477098887,-0.00213346274805827,0.0156087305781599
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,-0.0119635660761697,0.00496178182280421,-0.021688658448866,-0.0022384737034735,0.015916225908139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,40199,-0.00659700661192588,0.00274016636059129,-0.0119677326786848,-0.00122628054516695,0.016077614032315
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.0112360230405455,0.0046674699223113,-0.0203842640882757,-0.00208778199281537,0.0160869532884474
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,-0.0122134326696567,0.0050769103929792,-0.022164177039896,-0.00226268829941752,0.0161559926830958
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.00458009392056902,0.00190699821263691,0.000842377423800677,0.00831781041733736,0.0163337810601607
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,0.0157009405821683,0.00655198640982631,0.00285904721890873,0.0285428339454279,0.0165722677012828
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0200370387928959,0.00837657714815164,-0.0364551300032731,-0.00361894758251871,0.01676934613922
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,0.00202926417725841,0.000852030243365611,0.000359284900261809,0.003699243454255,0.0172505243146896
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42782,0.0112615044170166,0.00474239306861881,0.00196641400252371,0.0205565948315095,0.0175795947130941
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,-0.0144803287997638,0.00610409349110819,-0.0264443520423359,-0.00251630555719176,0.0176980572819921
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42721,-0.017905515891939,0.00758270367623914,-0.0327676150973677,-0.00304341668651025,0.0182219923639362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,-0.0189644650095666,0.00803876387873551,-0.0347204422118882,-0.00320848780724502,0.0183325206219956
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.0132991326416482,0.00566588028663451,-0.0244042580034518,-0.00219400727984458,0.018930679631219
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,40116,-0.0175369569542112,0.00747237036397619,-0.0321828028676045,-0.00289111104081788,0.0189477524398253
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.00955419990109376,0.00407537674678332,-0.0175419383247891,-0.00156646147739846,0.0190763819679603
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.00693290235120649,0.00295764992845832,0.00113590849142819,0.0127298962109848,0.0190896180066282
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.041848784120506,0.0178715944961421,0.00682045890806752,0.0768771093329446,0.0192141425407863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.0090752086290061,0.00388179039211409,0.00146689946046248,0.0166835177975497,0.0194106739614674
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.0150448886728035,0.00643889342321873,0.00242465756329484,0.0276651197823123,0.0194798008135462
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,0.00995642935156354,0.00427018733647585,0.00158686217207088,0.0183259965310562,0.0197357490812658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.00871592708821244,0.00374282237417357,0.00137999523483224,0.0160518589415926,0.0198894192895227
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,40283,-0.00981161066735567,0.00422147140118923,-0.0180856946136866,-0.00153752672102478,0.0201319019038493
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,-0.00659920087517066,0.00284965325114167,-0.0121845212474083,-0.00101388050293299,0.0205875737880184
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,42322,-0.0206200952939764,0.00893210308222567,-0.0381270173351387,-0.0031131732528141,0.02098471599884
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42587,-0.0456886270312905,0.0199643083851489,-0.0848186714661822,-0.00655858259639874,0.0221230248189165
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.01557872025946,0.0068190573939456,-0.0289440727515933,-0.00221336776732659,0.0223562924664048
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,42293,-0.0134894827128139,0.00590596270057633,-0.0250651696059435,-0.00191379581968433,0.0223848320609804
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42611,0.0156373717147323,0.0068499860863535,0.00221139898547941,0.0290633444439851,0.0224557999455906
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,40199,-0.00846583545385379,0.00371303093856529,-0.0157433760934418,-0.00118829481426583,0.0226247357743927
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,40527,0.023283087137635,0.0102345242396598,0.00322341962790177,0.0433427546473682,0.0229271949307256
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00650473108815115,0.00286353958904461,0.000892193493623717,0.0121172686826786,0.0231281701440733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.0132869963302123,0.00585725874739793,0.00180676918531238,0.0247672234751123,0.0233169575400014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.012025798626797,0.00530229440409526,0.00163330159477025,0.0224182956588237,0.0233457771462112
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,42370,-0.0080859071613671,0.00357950518809037,-0.0151017373300242,-0.00107007699270997,0.0239030493643551
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,40136,0.00827430898357405,0.00367579215102124,0.00106975636757241,0.0154788615995757,0.024403564127863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00716971834203299,0.00319597171711486,0.000905613776487869,0.0134338229075781,0.0248901210295466
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,-0.00783356972548441,0.00349265513935288,-0.0146791737986161,-0.000987965652352763,0.0249246083097636
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,40199,-0.00724127590307297,0.0032321076974251,-0.0135762069900262,-0.000906344816119765,0.0250835985979659
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,-0.0110523263035576,0.00494017601249435,-0.0207350712880466,-0.00136958131906872,0.0252877796998714
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.0115312620678968,0.00515783913649023,-0.0216406267754177,-0.00142189736037596,0.0253924108929264
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,42332,-0.0117423094157538,0.00526845627176867,-0.0220684837084204,-0.00141613512308724,0.0258443912882056
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.0213938756970949,0.00964086252456068,-0.0402899662452338,-0.00249778514895595,0.0265015379576002
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,-0.00862930915814595,0.00389844363695686,-0.0162702586865814,-0.0009883596297105,0.0268813268504803
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.0107947402526578,0.00488763254631299,-0.0203745000434313,-0.00121498046188435,0.0272236247365586
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.0107591613116331,0.00487429180236008,-0.0203127732442588,-0.00120554937900731,0.0273112435378608
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,40527,0.00751113677296103,0.00340355463646891,0.000840169685481961,0.0141821038604401,0.0273444683811526
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,0.0040128090012514,0.00181944300285199,0.000446700715661504,0.0075789172868413,0.0274348319415648
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.00849365205448731,0.00385232726346735,0.000943090618091304,0.0160442134908833,0.0274878063567651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,-0.0071389293468539,0.00324217528305983,-0.0134935929016512,-0.000784265792056643,0.0276934013993019
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.0140630597765035,0.00638880267133002,0.0015410065406967,0.0265851130123104,0.0277389197287591
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.0193360121171528,0.00879389263304594,-0.0365720416779228,-0.00209998255638276,0.0279094732841486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,-0.00850955388182499,0.00387981258374305,-0.0161139865459614,-0.000905121217688622,0.0283075022848313
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.0141422676935784,0.00648479553211736,-0.0268524669365284,-0.00143206845062833,0.02921674001365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.0144897724503121,0.00666382316166146,-0.0275508658471686,-0.00142867905345569,0.0296968430793075
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,-0.00610561068163588,0.00281382091723093,-0.0116206996794085,-0.000590521683863263,0.0300377949415839
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.00928977886019447,0.00428675557119517,0.000887737940651941,0.017691819779737,0.0302496465066664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,42311,0.0119840411649011,0.00553551351051444,0.00113443468429276,0.0228336476455094,0.0304104405161679
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.0124732848926793,0.0057647743841202,-0.0237722426855549,-0.00117432709980374,0.0305048087970186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00775720995739784,0.00359396747510669,0.000713033706188724,0.014801386208607,0.0309143918519891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,0.0148007483079593,0.00685953305267296,0.00135606352472033,0.0282454330911983,0.0309728502561911
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLU,Clusterin,40539,0.0070663378182582,0.00328796990113716,0.000621916812029371,0.013510758824487,0.0316436651809841
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.0240686605805894,0.0112135177123325,-0.0460471552967612,-0.00209016586441766,0.0318631490214818
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,-0.0104830292490534,0.0049235189140435,-0.0201331263205786,-0.000832932177528105,0.0332581691823064
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,-0.0101449384163954,0.00479177087493413,-0.0195368093312663,-0.000753067501524464,0.0342646426108347
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,-0.00956848872173928,0.00452169640948208,-0.0184310136843242,-0.000705963759154399,0.034356308617043
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0155942163117872,0.00737982294460249,-0.0300586692832081,-0.00112976334036636,0.03461546828648
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,40199,-0.0105205867682285,0.00499052721841549,-0.0203020201163228,-0.000739153420134135,0.0350439123294624
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.0167214932251889,0.00793719336685986,-0.0322783922242342,-0.00116459422614353,0.0351639296423752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42711,0.00697766704176131,0.00332796172686289,0.000454862057110051,0.0135004720264126,0.0360405489789409
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.0092060025295313,0.00440394796777212,0.000574264512697945,0.0178377405463647,0.0366052317452269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42611,0.0072685956988508,0.00349824413220744,0.000412037199724223,0.0141251541979774,0.0377482276496275
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.00718489091772521,0.00346914298096562,-0.0139844111604178,-0.000385370675032598,0.0383699014363387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.0130285844531768,0.00630058355901786,-0.0253777282288518,-0.000679440677501779,0.0386787752005813
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.00945527205231317,0.00457454105028773,-0.0184213725108771,-0.000489171593749213,0.0387595590880708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.00961424637903628,0.00465756252870645,-0.0187430689353009,-0.000485423822771633,0.0390199861145836
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,42017,-0.00601045136184941,0.00292568619190843,-0.0117447962979899,-0.000276106425708886,0.0399598056992904
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,-0.00599030735573921,0.00291755405220345,-0.011708713298058,-0.000271901413420442,0.040076573023874
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.0111608264062594,0.00544044407830669,-0.0218240967997405,-0.00049755601277824,0.0402463078170636
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.00620067547426734,0.00302263481889009,-0.0121250397192919,-0.000276311229242768,0.0402505200890895
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,40182,-0.0130166071548594,0.00635703180663484,-0.0254763894958637,-0.000556824813855097,0.0406237232731491
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,40482,-0.0133733916434189,0.00653236042796883,-0.0261768180822378,-0.000569965204599966,0.0406563926747463
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.00726211158276163,0.00355436309973197,0.000295559907286976,0.0142286632582363,0.0410567370106116
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,40154,-0.014661590739329,0.00718427715575855,-0.0287427739646158,-0.000580407514042289,0.0412957559588306
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,-0.0111541672948402,0.00547049472338605,-0.0218763369526768,-0.000431997637003512,0.0414762995859249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00598865151680377,0.00294352922337118,-0.0117579687946113,-0.000219334238996259,0.0419237196851682
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.0157706816745632,0.00776795920628817,-0.030995881718888,-0.000545481630238352,0.0423573184351459
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.00671815228803193,0.00331275912595068,-0.0132111601748953,-0.000225144401168588,0.0425874234252717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.010009901455619,0.004942844327558,-0.0196978763376327,-0.000321926573605363,0.0428781276750354
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,40182,0.00832189696312272,0.00410945400309794,0.000267367117050754,0.0163764268091947,0.042885183511561
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,40136,0.0200473272945879,0.00991824481886303,0.00060756744961632,0.0394870871395594,0.0432774103116097
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.00799367877672021,0.00395616044402621,0.000239604306428842,0.0157477532470116,0.0433490401080399
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00790499354830462,0.00392255246551732,-0.0155931963807186,-0.000216790715890674,0.0438965041078946
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00823998293545509,0.00409072285677233,0.000222166136181326,0.0162577997347288,0.0440014906176463
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0126597320569299,0.00630025010409419,0.000311241852905327,0.0250082222609545,0.0445145956090106
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42636,0.00805434124663879,0.00402512268381035,0.000165100786370513,0.0159435817069071,0.0454105648720651
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,40182,-0.0142508340687535,0.00713458343847478,-0.028234617608164,-0.000267050529342892,0.0458030581776974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.00530842925679578,0.00266605514668208,8.29611692988964e-05,0.0105338973442927,0.0464919057916692
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.0104167575704733,0.00523933089144405,0.000147669023242982,0.0206858461177037,0.0468158014852756
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.010938535914217,0.00550426183890495,0.000150182709963297,0.0217268891184707,0.0469158626452589
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.00612265423957738,0.00308520424310454,-0.0121696545560623,-7.56539230924776e-05,0.0472218409779049
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.0118462471353994,0.00598061459534872,-0.0235682517422829,-0.000124242528515936,0.0476412266975185
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00843958400370722,0.00426176325238861,8.65280290255413e-05,0.0167926399783889,0.0476936948374473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,0.00591660924463303,0.00298787432336669,6.03755708343144e-05,0.0117728429184317,0.0477008950498186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,40283,0.0112118498936186,0.00569845349526563,4.28810428979402e-05,0.0223808187443392,0.0491475984376059
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,42262,-0.00944188901528893,0.00481858318270989,-0.0188863120534003,2.53402282245074e-06,0.0500785151393117
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.0174141183448785,0.00890918125515591,-0.0348761136049841,4.78769152270839e-05,0.0506484292332395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.0122288362274952,0.00625685215019519,-3.459398688733e-05,0.0244922664418778,0.0506710168028445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.00813881692866303,0.0041689930797643,-0.016310043365001,3.2409507674986e-05,0.0509367328512825
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.0110076640980685,0.0056422585542712,-0.0220664908644401,5.11626683030158e-05,0.0510902148849154
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.0056684463244379,0.00290610070160805,-0.0113644036995897,2.75110507138802e-05,0.0511332944116855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,40199,0.011460523261063,0.00588451975705819,-7.31354627710196e-05,0.0229941819848971,0.0514916465150473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00622562221499751,0.00320222033117264,-5.07296341008545e-05,0.0125019740640959,0.0518976800943191
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,40539,-0.00424443157761571,0.00218637847151423,-0.0085297333817836,4.08702265521834e-05,0.052245795020727
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,40080,-0.0148173854247883,0.00763848463580715,-0.0297888153109703,0.000154044461393754,0.0524257710052483
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,0.00736105594053549,0.00380527388747941,-9.72808789241495e-05,0.0148193927599951,0.0530852761792632
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.0104441691705003,0.00539955872672896,-0.000138965933888506,0.021027304274889,0.0531019263269162
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERVV_1,,40116,0.00878713463888839,0.00455841044665742,-0.000147349836560144,0.0177216191143369,0.0539214415173088
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,-0.00555996841708606,0.00289040731198881,-0.0112251667485841,0.000105229914411996,0.0544271109581044
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,0.00564301215029386,0.00293993045957901,-0.000119251550481009,0.0114052758510687,0.0549549924443935
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,40182,-0.00462960836762036,0.00241891615137098,-0.00937068402430748,0.000111467289066756,0.0556565206189212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,40483,0.0155276216094117,0.00814848401475458,-0.000443407059507234,0.0314986502783307,0.0567295634296152
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C5,Complement C5,40539,-0.0029887888061616,0.00156887093584903,-0.0060637758404257,8.61982281024918e-05,0.056797901044849
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.00535167029969088,0.00281092456211638,-0.010861082441439,0.000157741842057219,0.0569518204005457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42638,0.0067574932240194,0.00355743849102277,-0.00021508621838523,0.013730072666424,0.0575150220677838
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,42370,-0.00763621998524316,0.00403005515853698,-0.0155351280959756,0.000262688125489316,0.0581384246970594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.0104156307890442,0.00549990342674393,-0.000364179927373875,0.0211954415054623,0.0582792604912788
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.0079620390296385,0.0042053593239257,-0.0162045433045329,0.000280465245255872,0.0583433740374609
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,42332,-0.0146839091773771,0.00775803528616508,-0.0298896583382607,0.000521839983506437,0.0584150061503131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,40080,-0.0121224478854592,0.00640590977630418,-0.0246780310470154,0.000433135276096959,0.05846620431454
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42594,-0.0108159723049194,0.00573299368026125,-0.0220526399182314,0.000420695308392682,0.059233248808185
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.00634373848675541,0.00337114557104271,-0.0129511838059991,0.0002637068324883,0.0598878673887439
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,0.00663025371200943,0.00352689776269569,-0.000282465902874133,0.013542973326893,0.0601419038798883
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.0100813861849155,0.00536727625408645,-0.000438475273093908,0.020601247642925,0.0603659589311913
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,-0.00550202882004405,0.00294725035327267,-0.0112786395124585,0.000274581872370378,0.061951207151745
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,40250,-0.0165867016755949,0.0089090258033128,-0.034048392250088,0.00087498889889823,0.0626597404866061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.0111190289951785,0.0059768395222652,-0.0228336344588183,0.000595576468461262,0.0628574132214695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.0149485908416844,0.00804420009821157,-0.030715223034179,0.000818041350810324,0.0631521981201223
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00867950966188102,0.004673025201994,-0.000479619734027211,0.0178386390577893,0.0632853829808332
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.0126162121752877,0.00680173193455672,-0.0259476067670189,0.000715182416443479,0.063643714957222
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42794,-0.00600638435722105,0.00324793278833077,-0.0123723326223494,0.000359563907907252,0.064436978630288
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,40451,-0.00689672704888997,0.00373602366847201,-0.0142193334390951,0.000425879341315171,0.0649173802665914
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.0061043547910452,0.00330817875406032,-0.000379675566913019,0.0125883851490034,0.0650309107982286
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.0123479053079131,0.00672415451131035,-0.0255272481500813,0.000831437534255238,0.0663327757711969
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00433856038778458,0.00236540241241077,-0.000297628340540521,0.00897474911610968,0.066649956018183
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00886558592189022,0.00483570455076545,-0.0183435668413905,0.000612394997610056,0.0667710718890124
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00574801705072504,0.00315436804506096,-0.000434544317594442,0.0119305784190445,0.0684457916916058
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.00550477187763063,0.00302371952019804,-0.000421718381957534,0.0114312621372188,0.068705237483892
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,0.00747715089040058,0.00411696173030002,-0.000592094100987465,0.0155463958817886,0.0693689382374685
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,42346,-0.00737360958578716,0.00406210675336609,-0.0153353388223847,0.000588119650810382,0.0695131693944038
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,-0.00699472561075526,0.00385506287453094,-0.0145506488448359,0.000561197623325375,0.0696349256704946
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00615201630580334,0.00339215617373426,-0.000496609794715801,0.0128006424063225,0.0697666780839543
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,-0.00775712341317345,0.0042800914435872,-0.0161461026426044,0.000631855816257458,0.0699513297401588
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42587,-0.00623760466787512,0.00344341108627493,-0.012986690396974,0.000511481061223745,0.0700919218556155
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42636,-0.00493102674099807,0.00272544437278185,-0.0102728977116505,0.000410844229654352,0.0704335620044149
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.0111790336105888,0.00618334990874449,-0.023298399431728,0.000940332210550437,0.0706457435894135
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PALLD,Palladin,40199,0.00728568855037091,0.00406967827267292,-0.000690880864068013,0.0152622579648098,0.0734433022449392
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,40199,-0.00558029777266196,0.00312979984318027,-0.0117147054652953,0.000554109919971377,0.0746208982437424
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,40060,-0.00823656583202728,0.00462419979801146,-0.0172999974361298,0.000826865772075186,0.0749097876997283
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0127308177430002,0.00715727073411701,-0.00129743289586914,0.0267590683818696,0.0753076611771273
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,42209,0.0127362520917374,0.00718369515676345,-0.001343790415519,0.0268162945989937,0.0762622273034084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,40136,0.0101030202301346,0.00571120090697437,-0.00109093354753521,0.0212969740078043,0.0769244790380251
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,40482,-0.00892410846328865,0.00505320516813795,-0.018828390592839,0.000980173666261743,0.0774179571835465
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0267542846888528,0.0151830515879259,-0.00300449642348209,0.0565130658011876,0.078076793010401
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42711,0.0042608038372436,0.00243171996540955,-0.000505367294959118,0.00902697496944632,0.0797660475985937
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,42370,0.00894088400034749,0.00511327776411296,-0.00108114041731391,0.0189629084180089,0.0803900193395919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,40449,-0.0204044220111131,0.0117042867935688,-0.0433448241265079,0.00253598010428162,0.0813034770606032
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.0132239907077054,0.00758946749270425,-0.0280993469934057,0.00165136557799495,0.0814643526327898
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.011377351313659,0.00653100787596219,-0.0241781267505449,0.0014234241232269,0.081526764975173
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.00785371602996766,0.00452371613458405,-0.00101276759381709,0.0167201996537524,0.0825707410424136
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00493902099134276,0.00284515116681872,-0.000637475295621941,0.0105155172783075,0.082602068635855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,0.0134779289595041,0.00778067794340007,-0.00177219980956003,0.0287280577285683,0.0832607320518473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,40182,-0.00986390439872641,0.00569654139209561,-0.0210291255272338,0.00130131672978099,0.083379963596114
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.0140964365003923,0.00819970481283681,-0.00197498493276783,0.0301678579335525,0.0856172551835547
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,40199,-0.00584798699490736,0.00341463239830165,-0.0125406664955786,0.000844692505763864,0.0868096023647552
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,40302,-0.00793969576021964,0.00464661513258409,-0.0170470614200845,0.00116766989964518,0.087533493418249
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.00940653312135893,0.00551172873433202,-0.0202095214406497,0.00139645519793183,0.0879127766643925
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.0105314286451844,0.00618901995926746,-0.00159905047497979,0.0226619077653487,0.0888529586471727
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.0116603325444461,0.00686309436055637,-0.0251119974911366,0.00179133240224434,0.0893445689948833
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,-0.00965841287558797,0.00569102900692536,-0.0208128297291617,0.00149600397798574,0.0897005114813322
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.0116638662662599,0.00687891517317807,-0.0251465400056889,0.00181880747316913,0.0899899254547061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.015479746265387,0.00914598111548931,-0.00244637672097202,0.0334058692517461,0.0905703312283833
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00649227590428159,0.00384149155620466,-0.0140215993544427,0.00103704754587955,0.091048858601068
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,-0.0099564214488708,0.00589573264560787,-0.0215120574342622,0.00159921453652063,0.0912957990442558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.00946009188196598,0.00560227067419122,-0.0204405424033808,0.00152035863944882,0.09132110009763
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F2,Prothrombin,40539,-0.00259736915124175,0.00154897880892804,-0.00563336761674071,0.000438629314257208,0.0936039090622109
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,-0.0177663781116122,0.0106094919890884,-0.0385609824102254,0.00302822618700099,0.0940456514243107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,42370,-0.0105546488153071,0.00631136391490953,-0.0229249220885298,0.00181562445791556,0.0944840838805463
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,-0.00446525882413925,0.00267630932653676,-0.00971082510415129,0.000780307455872791,0.0952564296287683
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,40182,-0.00619155551319802,0.00371143728283954,-0.0134659725875635,0.00108286156116748,0.0952972605265074
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,40136,0.00912802185587434,0.0054767349600057,-0.00160637866573683,0.0198624223774855,0.0956045932944854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,-0.00683923488081204,0.00411612328277332,-0.0149068365150478,0.00122836675342367,0.0966224699351847
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.015692863789744,0.00945760278662756,-0.00284403767204606,0.034229765251534,0.0970867567253395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,-0.00691566314985959,0.00420779109101004,-0.0151629336882393,0.00133160738852008,0.100295409376309
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,40182,-0.00693742895905317,0.00423583682977479,-0.0152396691454118,0.00136481122730541,0.101493267058995
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.00386419123960301,0.00236216470061772,-0.00849403405281373,0.000765651573607718,0.101895609728625
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42721,0.00782565084847349,0.00478855811882948,-0.0015599230644323,0.0172112247613793,0.102231840800157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTTG1,Securin,40302,-0.00698552312482508,0.00427602699256746,-0.0153665360302573,0.00139548978060715,0.102361113977432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0040016596909676,0.00246835086939781,-0.000836308013052104,0.00883962739498731,0.105000920861826
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00579707448201618,0.00358303276527782,-0.00122566973792835,0.0128198187019607,0.105702497144984
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.00902169743196766,0.0056037346108649,-0.0200050172692629,0.00196162240532755,0.107438178889323
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,-0.0141111616246244,0.00877669691312632,-0.031313487574352,0.00309116432510313,0.107903347546063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.0123448554137095,0.00769632802387441,-0.0274296583405034,0.00273994751308432,0.108739631783697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.0116941729578576,0.00729162973839157,-0.00259742132938992,0.025985767245105,0.10879089372027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.00810292370249742,0.00505574725098855,-0.00180634090944013,0.018012188314435,0.109026430986377
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,40116,0.00575817684294594,0.00360284580582121,-0.00130340093646363,0.0128197546223555,0.110020689978332
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.00833419912826376,0.00521766036795884,-0.00189241519293557,0.0185608134494631,0.110226489194268
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,0.00481564843627932,0.00302333542237399,-0.00111008899157371,0.0107413858641323,0.111223231939132
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,-0.00664543758262531,0.00418908681445279,-0.0148560477389528,0.00156517257370216,0.112683709000202
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,42370,0.0103042442001158,0.00651668738499331,-0.00246846307447111,0.0230769514747027,0.11385427997042
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,40182,0.00977478725271982,0.0061905475548178,-0.00235868595472306,0.0219082604601627,0.114368078053451
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,0.00387316081651703,0.00246120723794923,-0.000950805369863462,0.00869712700289753,0.115589359880591
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.0120026548754969,0.0076661665112026,-0.00302303148646017,0.027028341237454,0.117455789931025
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,40182,-0.0140930314488293,0.00900995465942283,-0.031752542581298,0.00356647968363943,0.117808254607934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00351514106418214,0.00224984894439434,-0.00089456286683077,0.00792484499519505,0.118219862748194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,0.0087694423319836,0.00563203542533377,-0.0022693471016706,0.0198082317656378,0.119484150164504
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,42357,-0.00630556928730437,0.00405485033778769,-0.0142530759493683,0.00164193737475951,0.119953841152176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,42370,-0.00479743142109659,0.00308668892807777,-0.010847341720129,0.00125247887793584,0.120153049409365
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,-0.00494427660972712,0.00318615436983224,-0.0111891391745983,0.00130058595514408,0.120733801482463
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.00824888082289656,0.00531708136477143,-0.00217259865205544,0.0186703602978486,0.120836595182826
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.00950351674388215,0.0061317053790293,-0.0215216592867796,0.00251462579901527,0.121189631077671
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,40199,-0.00279460825252557,0.00181268436640162,-0.00634746961067274,0.000758253105621614,0.123176234417271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,0.00495027961537482,0.00321346979383386,-0.00134812118053955,0.0112486804112892,0.123472939860613
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,40182,0.011229507036071,0.00729594849581915,-0.00307055201573457,0.0255295660878765,0.123798218448777
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,0.00782970019881137,0.00509776035524414,-0.00216191009746715,0.0178213104950899,0.124584112290891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,0.00898576369152295,0.0058611525810528,-0.00250209536734054,0.0204736227503864,0.125274080665967
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.00683736393977514,0.00445984330174294,-0.0155786568111913,0.00190392893164102,0.125280525201556
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,0.00576306301742627,0.00376609841465529,-0.0016184898752981,0.0131446159101506,0.125983477773973
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00850513149839593,0.00557578534701704,-0.00242340778175746,0.0194336707785493,0.127195979330687
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,40283,-0.00554405037573721,0.00364079912930225,-0.0126800166691696,0.00159191591769521,0.127848162853087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.00939960350431332,0.00617364286608751,-0.0214999435218448,0.0027007365132182,0.127903473350987
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.00751599414486856,0.00493810563546799,-0.0171946811903858,0.0021626929006487,0.128022629231715
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.0137789002718703,0.00906482763092381,-0.031545962428481,0.00398816188474035,0.128529659999586
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,-0.0139641855625208,0.00918757769627009,-0.0319718378472102,0.00404346672216853,0.128559975841909
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.00709534543566944,0.00467541550204395,-0.0162591598196756,0.00206846894833669,0.129142772240023
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.00859963030765384,0.00566831780950571,-0.019709533214285,0.00251027259897736,0.129259859340375
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,0.0135691163405018,0.00896506578989564,-0.00400241260769369,0.0311406452886972,0.130163198894686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,40136,0.0121779623550097,0.00804852456314733,-0.00359714578875907,0.0279530704987785,0.130291350546009
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42538,-0.0091970804728262,0.00609167125823578,-0.0211367561389683,0.00274259519331593,0.131123371042179
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,-0.00763638849272465,0.00506324733432268,-0.0175603532679971,0.0022875762825478,0.131527404529348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.00823935855092271,0.00546365713462057,-0.018948126534779,0.0024694094329336,0.131575303292021
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42588,-0.0122609327066592,0.00817075715509189,-0.0282756167306393,0.0037537513173209,0.133485963461942
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,-0.0134337078659581,0.00897334859212559,-0.0310214711065243,0.00415405537460803,0.134399310104611
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.0122872022254306,0.00822944077357524,-0.00384250169077687,0.0284169061416381,0.135445315212189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.0053611778938961,0.00359236431158213,-0.00167985615680488,0.0124022119445971,0.135628003100944
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.00512297663555734,0.00343591702950105,-0.0118573740133794,0.00161142074226471,0.135983573538271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00763675398010516,0.00514374992270068,-0.0177185038285985,0.00244499586838817,0.137660835114986
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,0.0123500976597525,0.00837564634897126,-0.00406616918423117,0.0287663645037362,0.14036928251362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,-0.00520176691422801,0.00352852180379212,-0.0121176696496606,0.00171413582120454,0.140449489867013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00642329226983391,0.00438159294469022,-0.00216462990175892,0.0150112144414267,0.142684669335783
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,0.00933801970883115,0.00637595672134119,-0.00315885546499758,0.0218348948826599,0.143067653322113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.00744921432333079,0.00509508986199677,-0.0174355904528445,0.00253716180618288,0.143758599744589
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,40009,-0.00598303665497218,0.00409244973922642,-0.014004238143856,0.00203816483391161,0.143778626307011
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.0154920751085707,0.0106084594283522,-0.036284655588141,0.00530050537099964,0.144222158734707
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,40080,0.00801096725349392,0.00548807197225638,-0.00274565381212859,0.0187675883191164,0.144399964928475
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,0.0102083421260302,0.00703138607476287,-0.00357317458050507,0.0239898588325654,0.146578819941374
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,0.00657601608906724,0.00454400075186758,-0.00233022538459322,0.0154822575627277,0.147873208033168
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,40449,-0.0401344302948805,0.0277664411837923,-0.0945566550151135,0.0142877944253524,0.148365153523414
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.0083535778218546,0.00580326926869009,-0.0197279855884872,0.00302082994477798,0.150048801391848
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39926,0.0104331080327203,0.00729938813439348,-0.00387369271069091,0.0247399087761315,0.152943489155321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42543,0.00743929834913515,0.00521073948057561,-0.00277375103279305,0.0176523477310634,0.153405730602766
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,40483,0.00387898915934245,0.00272223704928309,-0.00145659545725242,0.00921457377593731,0.154205939318082
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,-0.00988942060575771,0.0069434528256465,-0.0234985881440248,0.00371974693250942,0.154389494259938
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42652,0.00676450974645578,0.00475784652694151,-0.00256086944634959,0.0160898889392611,0.155119482717855
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.00714431053025882,0.00503268507779867,-0.00271975222222658,0.0170083732827442,0.155757816302481
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00466867540763884,0.00329907710017013,-0.00179751570869461,0.0111348665239723,0.157049381600844
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,40080,0.00503248760954789,0.00358519940201248,-0.00199450321839657,0.0120594784374924,0.160441446403569
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,40080,0.0138487498844979,0.00990469265931387,-0.00556444772775724,0.0332619474967531,0.162081240379922
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.00649812166390219,0.00464783790170528,-0.0156078839512445,0.00261164062344015,0.162111909609727
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,40136,-0.0070141164769565,0.00503078249851737,-0.0168744501740505,0.00284621722013754,0.163273554277318
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.0041554626875981,0.00299064091696744,-0.0100171188848543,0.00170619350965808,0.1647122105277
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,0.00543469588737592,0.00391336140575627,-0.00223549246790638,0.0131048842426582,0.164930610846276
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.0103894492170184,0.00748652868995572,-0.00428414701529485,0.0250630454493316,0.165240720645252
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,40136,0.0074010446077478,0.00534271473502298,-0.00307067627289725,0.0178727654883928,0.166001470314041
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,40136,-0.0159564100488721,0.0115337546411382,-0.038562569145503,0.00664974904775882,0.166554163878678
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,40302,0.00507838193317036,0.00367603234855708,-0.00212664147000152,0.0122834053363422,0.167157807710981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,-0.00717580966253739,0.00519468976388053,-0.0173574015997432,0.00300578227466845,0.167192237202762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,40080,0.011435510942644,0.00828642986348968,-0.00480589158979575,0.0276769134750838,0.167606152093194
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,40136,0.0135509512436282,0.00985193922235114,-0.00575884963218006,0.0328607521194364,0.169016943542274
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.00735699622575642,0.00535219788494857,-0.00313331162874279,0.0178473040802556,0.169290490290523
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42495,-0.0128225338474316,0.0093527798703786,-0.0311539823933736,0.00550891469851048,0.17040233230859
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,-0.00547994205399482,0.00399892255563644,-0.0133178302630422,0.0023579461550526,0.170604315926911
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.00870522169646527,0.00637040846469372,-0.021191222287265,0.00378077889433441,0.171807117054733
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.00487968365698101,0.00357109152092597,-0.0118790230379959,0.0021196557240339,0.171829004251178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.00639539380532419,0.00468622692459119,-0.0155803985775229,0.00278961096687454,0.17236876939607
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.0203933075011139,0.0149769010549025,-0.0497480335687228,0.00896141856649503,0.17333633204434
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00697978664329206,0.00513816143452104,-0.00309100976836919,0.0170505830549533,0.174353480404051
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,-0.00264786776805232,0.0019535571267236,-0.00647683973643058,0.00118110420032595,0.175314452997711
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,42276,-0.00685381863607473,0.00505904859544304,-0.0167695538831431,0.00306191661099363,0.175516046204323
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,-0.0062857317836746,0.00464188153261007,-0.0153838195875903,0.00281235602024114,0.175721445648292
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00639197927785219,0.00472651717240933,-0.0156559529357745,0.0028719943800701,0.176286476611445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42569,0.00400818071440168,0.00297224614227593,-0.00181742172445914,0.00983378315326251,0.17750890562957
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.00767113231772301,0.00569282002074414,-0.0188290595583815,0.00348679492293551,0.177843495255653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.0121742651148513,0.00904764704916412,-0.0299076533312129,0.0055591231015104,0.17846844823321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00850637961044719,0.00632921805084169,-0.0209116469900969,0.00389888776920252,0.178980822724355
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,-0.0161586749772542,0.0120289831241666,-0.0397354819006208,0.0074181319461124,0.179198037667684
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,-0.006188360814879,0.00463261559845205,-0.015268287387845,0.00289156575808703,0.181633690745968
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,40302,0.00531520104130697,0.00398305004028539,-0.0024915770376524,0.0131219791202663,0.182082138829506
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,40527,-0.0066601709469998,0.00499733886436641,-0.016454955121158,0.00313461322715836,0.182642782183478
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,40451,-0.00605343754656484,0.00454276367716433,-0.0149572543538069,0.00285037926067725,0.182708098948291
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,40527,-0.0128993803924218,0.00968990138741696,-0.031891587111759,0.0060928263269155,0.183143754173981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00680915374662075,0.00512381467712717,-0.01685183051379,0.00323352302054851,0.183896009928505
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42673,-0.00522069113595627,0.00393774978101927,-0.012938680706754,0.0024972984348415,0.184926529525059
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,40199,0.00624487270986074,0.00471270994688864,-0.00299203878604099,0.0154817842057625,0.185161221572685
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.00545545424974381,0.00412108675263453,-0.00262187578541987,0.0135327842849075,0.185595801759137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,40116,0.00833010423678845,0.00630915357711538,-0.0040358367743577,0.0206960452479346,0.186755731604349
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,-0.0065078082465535,0.00494156926459173,-0.0161932840051533,0.00317766751204629,0.187882380884455
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.00638344363879277,0.00485835201376571,-0.00313892630818803,0.0159058135857736,0.188902832869379
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00389546933300638,0.00296688263536911,-0.00971055929832984,0.00191962063231707,0.189215727876474
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.0121280672297527,0.00925444736635891,-0.0302667840678161,0.00601064960831081,0.19004993046488
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42710,0.00603523501967803,0.00462872167499167,-0.00303705946330563,0.0151075295026617,0.192301317980172
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,40182,0.00812174429598544,0.00624288834493015,-0.00411431686007765,0.0203578054520485,0.193299631308941
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42587,-0.00261700679483776,0.00201307600238882,-0.00656263575951984,0.00132862216984432,0.193621980869232
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,40136,0.00674390735253656,0.00519966917022715,-0.00344744422110865,0.0169352589261818,0.194662740240973
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_DRA,,42549,-0.00496885788333698,0.00383281881048949,-0.0124811827518964,0.00254346698522242,0.194860869274899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,40080,0.015989658925765,0.0123470130145398,-0.00821048658273301,0.0401898044342631,0.195339952541839
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,42370,-0.0063144699762408,0.00490172934917744,-0.0159218595006286,0.00329291954814697,0.197694555376125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,40302,0.00474923046731734,0.00369936778702033,-0.00250153039524251,0.0119999913298772,0.199240415089418
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,42370,-0.00778131376031455,0.00606273344570243,-0.0196642713138913,0.00410164379326221,0.199351348374523
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00350933230667535,0.00273536229412572,-0.00185197778981107,0.00887064240316176,0.199537003357392
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.0161829778149462,0.0126159056341497,-0.0409101528578795,0.00854419722798716,0.199608934889827
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00477501907266639,0.00372867577101864,-0.00253318543853015,0.0120832235838629,0.200349119327362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,-0.00703084402851816,0.00550790421450046,-0.0178263362889391,0.00376464823190274,0.201801090097816
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,-0.0111759056517503,0.00877740060959472,-0.0283796108465559,0.00602779954305538,0.202953032523234
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,40116,0.00647086256756499,0.00512977512747238,-0.00358349668228089,0.0165252218174109,0.207180180900916
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00669538564840654,0.00531896609066827,-0.00372978788930327,0.0171205591861164,0.208138076378724
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00697082057460109,0.00554479736583204,-0.0178386234116319,0.00389698226242972,0.208714637001172
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,0.00377608890124548,0.00300763518320387,-0.0021188760578341,0.00967105386032507,0.209318778733715
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,40199,-0.00726308928306524,0.0057883343300755,-0.0186082245700132,0.00408204600388275,0.209585085047337
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00328374798616938,0.00263493680681503,-0.00844822412752683,0.00188072815518807,0.212704239018439
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.00570827605418378,0.0045837371157918,-0.0146924008011357,0.00327584869276814,0.213031781682077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,42370,-0.00544098977991356,0.00437786374377596,-0.0140216027177144,0.00313962315788731,0.213948443814886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,0.00578354419991898,0.00468670070103903,-0.00340238917411753,0.0149694775739555,0.217216300453707
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,42346,-0.0040855446235275,0.00331187417331471,-0.0105768180032243,0.00240572875616934,0.217372164623632
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,42370,0.0178517541895972,0.0144973175169855,-0.0105629881436945,0.0462664965228888,0.218201530445856
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,-0.00462631313098256,0.00378781358762766,-0.0120504277627328,0.00279780150076764,0.221968295283688
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42689,-0.00390941227103267,0.00320375280413673,-0.0101887677671407,0.00236994322507533,0.22238754736875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00472719610371089,0.00387442297483446,-0.00286667292696466,0.0123210651343864,0.222451917900555
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,0.00449559576087165,0.0037032015660464,-0.00276267930857929,0.0117538708303226,0.22477895840247
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.00368455916358715,0.00303763306786389,-0.00963831997660038,0.00226920164942608,0.225167152244003
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.00853359611492668,0.00704690081782061,-0.0223455217178551,0.00527832948800172,0.225932369178064
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.00986554615623715,0.00817823488690183,-0.0258948865345647,0.00616379422209044,0.227721254251448
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,-0.00565377415744235,0.00469289111437702,-0.0148518407416213,0.0035442924267366,0.228320387569088
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,0.00366481179659493,0.00304193664971899,-0.00229738403685429,0.00962700763004415,0.228320872693695
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,40511,0.00378768487609315,0.0031481461311156,-0.00238268154089342,0.00995805129307971,0.228944325745437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42654,-0.0137127260491087,0.0113994347634105,-0.0360556181853932,0.00863016608717579,0.22902443310064
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,40302,0.00743052984323066,0.00618024923245956,-0.00468275865239008,0.0195438183388514,0.229271931043361
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.0120932008021594,0.0100864017061345,-0.031862548146183,0.0076761465418642,0.230568405022227
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.00431152365121462,0.00360812058320368,-0.0113834399942938,0.0027603926918646,0.232127495551143
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.00640690669024968,0.00536908641837931,-0.00411650268977378,0.0169303160702731,0.232779534637912
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.00272575414765485,0.0022886615122002,-0.00721153071156725,0.00176002241625754,0.233681668762031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.00323387028151066,0.00271917850833768,-0.00856346015785251,0.00209571959483119,0.234349802026457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,42370,-0.00638774334100751,0.00539171317755047,-0.0169555011690064,0.0041800144869914,0.236144193086895
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,40449,-0.013975721966253,0.0118528662532496,-0.0372073398226223,0.0092558958901163,0.238383035765741
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00271819467455993,0.00231608546696741,-0.0018213328406962,0.00725772218981605,0.240569758132311
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,42247,0.00814848313837911,0.00694858075641248,-0.00547073514418935,0.0217677014209476,0.240944316240734
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,-0.010286937235974,0.00877536325756404,-0.0274866492207995,0.00691277474885155,0.241121306592477
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.00446252002960805,0.0038218997207324,-0.0119534434822436,0.00302840342302746,0.242985498102201
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,0.00331706378912218,0.00284521725183976,-0.00225956202448375,0.00889368960272812,0.243704381760323
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,40116,-0.00483844745699447,0.00415907725209444,-0.0129902388710996,0.00331334395711064,0.244714410725321
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,0.00363762273732509,0.00313555900894289,-0.00250807292020297,0.00978331839485315,0.246020864649453
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.00942150656619458,0.00812229187303603,-0.0253411986373452,0.00649818550495603,0.246091890819708
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.00980157718700542,0.00846951979348474,-0.00679868160822468,0.0264018359822355,0.247184249699302
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,40302,-0.00854473888668436,0.00739563103805704,-0.0230401757212762,0.00595069794790743,0.247961100438658
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.00361537749748552,0.00313337404995403,-0.00975679063539542,0.00252603564042438,0.248591350602259
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,-0.00590542427990781,0.00512757714597899,-0.0159554754860266,0.00414462692621102,0.249470088482586
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00534517022619533,0.00465593224795107,-0.00378045697978877,0.0144707974321794,0.250979100232247
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00309198007879361,0.00270196978962909,-0.0022038807088794,0.00838784086646662,0.2525065155628
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,0.00821712665675145,0.00721387785276749,-0.00592207393467282,0.0223563272481757,0.254698167286756
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,40527,0.00303513775246496,0.0026649876875169,-0.00218823811506816,0.00825851361999808,0.254771556322425
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.00560365936842917,0.00492833897694929,-0.0152632037632498,0.00405588502639143,0.255551340679178
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,40199,0.0124596105683504,0.0109694746161721,-0.00904055967934695,0.0339597808160477,0.256046645320463
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.00876126780317876,0.00773123092620419,-0.00639194481218146,0.023914480418539,0.257141866749285
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.0039257703883078,0.00346846902725581,-0.00287242890511358,0.0107239696817292,0.25772009501042
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,40482,-0.00538694051436148,0.00475990654061981,-0.0147163573339763,0.00394247630525335,0.257770991643505
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00393211236635959,0.00347693547944357,-0.0028826811733498,0.010746905906069,0.258116396859294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0106750401352829,0.00945673407333311,-0.0292102389190158,0.00786015864844997,0.258993832641814
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,0.00359464829494112,0.00319302893083566,-0.00266368840949679,0.00985298499937902,0.260282949401791
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,40116,-0.0077972272188623,0.00693216821386716,-0.0213842769180419,0.00578982248031734,0.260703134022594
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.0120734236778503,0.0107422043016828,-0.0331281441091487,0.00898129675344801,0.261069725359555
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00540329871674514,0.00481210657023583,-0.00402843016091708,0.0148350275944074,0.261523545286319
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.00468535644427154,0.00419043456449424,-0.0128986081906803,0.00352789530213717,0.263545477048289
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.0119500309824321,0.0106891285517452,-0.0329007229438527,0.00900066097898861,0.26360777740724
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,-0.00800148577636798,0.00721150548988868,-0.0221360365365498,0.00613306498381384,0.26721957875348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,0.00618415172428363,0.00558706397097494,-0.00476649365882725,0.0171347971073945,0.268374283330699
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.00493601282311555,0.00447225625821692,-0.00382960944298962,0.0137016350892207,0.26974905760849
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,40116,0.00848707192685575,0.00769139564057225,-0.00658806352866587,0.0235622073823774,0.269856025218762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00809904549917032,0.00736079052299191,-0.00632810392589382,0.0225261949242345,0.271227187950078
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,0.00364088097604519,0.00331622470721618,-0.00285891945009851,0.0101406814021889,0.272268537758303
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.0055237189726193,0.00503733457347505,-0.00434945679139179,0.0153968947366304,0.272859748808919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VIT,Vitrin,40511,0.00439189789029826,0.00401763081822972,-0.00348265851343199,0.0122664542940285,0.274348508666352
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,42357,-0.00554508665173629,0.00507632099275531,-0.0154946757975367,0.00440450249406411,0.274702103296091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,-0.00381460166550937,0.00349512546903991,-0.0106650475848276,0.00303584425380886,0.275118019767678
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.00348187951001962,0.0032009140804274,-0.00279191208761808,0.00975567110765731,0.276717814502565
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,0.00651495547464724,0.00599016346274835,-0.00522576491233951,0.018255675861634,0.276787333883793
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.0052308074241956,0.00481541933062212,-0.00420741446382374,0.0146690293122149,0.277386850398473
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,0.00652583311667387,0.00601492295004145,-0.00526341586540738,0.0183150820987551,0.277971941088325
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,0.00761860884647455,0.00706095865330668,-0.00622087011400655,0.0214580878069556,0.280622006316389
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,-0.00372833085868801,0.00347040051036637,-0.0105303158590061,0.00307365414163007,0.28270087449182
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.00405507349471979,0.00378002838978062,-0.0114639291386898,0.00335378214925022,0.283401155636699
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,40080,0.00458170652290097,0.00427923957103536,-0.00380560303632833,0.0129690160821303,0.284335993557828
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,40182,0.00544397121102545,0.00512248074721649,-0.00459609105351886,0.0154840334755698,0.28791384309882
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,40182,-0.00670398308633649,0.006335782286811,-0.0191221163684861,0.00571415019581307,0.290026506558387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,0.00217929960732549,0.00206195991886182,-0.00186214183364368,0.00622074104829467,0.29057659650648
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,42346,-0.015258100857878,0.0145330890337809,-0.0437429553640886,0.0132267536483326,0.293789372546156
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.00375008175002203,0.00357509609611827,-0.0107572700984138,0.00325710659836977,0.294225558611996
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.00768677623029864,0.00733460440824321,-0.0220626008704553,0.00668904840985805,0.294654794362728
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.00397302560632637,0.00380859948526628,-0.0114378805974483,0.00349182938479553,0.296887624211844
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42794,-0.00777877732567121,0.00746932273574791,-0.0224186498877371,0.00686109523639469,0.297694503769208
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42495,0.00366497212336745,0.00352143039867203,-0.00323703145802973,0.0105669757047646,0.298004782073408
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.00687625775882097,0.00663009693733248,-0.0198712477559926,0.00611873223835068,0.299698952430618
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,0.00300196258221719,0.00290474615593548,-0.00269133988341635,0.00869526504785073,0.301406960553552
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-0.00831604212259161,0.00804823126877697,-0.0240905754093945,0.00745849116421124,0.301493926782894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,-0.00273849243632601,0.0026532959452581,-0.00793895248903189,0.00246196761637987,0.302039145854637
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,0.00457161593760089,0.00443733156409484,-0.00412555392802499,0.0132687858032268,0.302909726192414
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,40302,0.00437206734188048,0.00427663564318853,-0.00401013851876903,0.01275427320253,0.306654257220186
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,-0.00435225296334308,0.00431461740555105,-0.0128089030782231,0.00410439715153697,0.313125991943016
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.00745114061664798,0.00738992448231815,-0.0219353926019915,0.00703311136869559,0.313340234421138
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,0.00511943393713815,0.00508056166878245,-0.00483846693367545,0.0150773348079517,0.31364427468077
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,-0.00923378043307652,0.00920456055989657,-0.0272747191304738,0.00880715826432074,0.315798972037613
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.0155282031665961,0.0155029428631618,-0.014857564845201,0.0459139711783933,0.316544155534161
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00306909478901488,0.00306437895982189,-0.00907527755026579,0.00293708797223603,0.316587717855832
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,-0.00415685224878686,0.00416127852498257,-0.0123129581577527,0.00399925366017897,0.317847671690213
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NENF,Neudesin,40451,-0.0114284684730759,0.0114889412317092,-0.033946793287226,0.0110898563410742,0.319885848872599
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,40182,-0.00287588317633232,0.00289140943338833,-0.00854304566577344,0.0027912793131088,0.319938050481632
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00723938300892766,0.00730291134978437,-0.021553089254505,0.00707432323664971,0.321560606291226
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.00219992166708054,0.00223000999202471,-0.0021708979172879,0.00657074125144897,0.323901857160518
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.00372307243425927,0.00378738403518797,-0.00370020027470914,0.0111463451432277,0.325619606530976
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42636,-0.00480227805310004,0.00489343676594946,-0.014393414114361,0.0047888580081609,0.326427371169022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.00528519396777691,0.00539110205348086,-0.00528136605704557,0.0158517539925994,0.32693317099372
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00344556106503982,0.00351582577589008,-0.0103365795857844,0.00344545745570473,0.327100552251331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00414493999158062,0.00424668935430854,-0.00417857114286411,0.0124684511260253,0.329066066685346
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,40223,0.00746501080393273,0.00765398041273764,-0.00753679080503305,0.0224668124128985,0.329427438105476
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00608975961524508,0.00624532666577995,-0.00615108064968362,0.0183305998801738,0.329533216855275
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,40116,-0.0113972639620777,0.0116895751204373,-0.0343088311981348,0.0115143032739794,0.329584899165432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,-0.00533353838996753,0.00548794378939923,-0.01608990821719,0.00542283143725496,0.331139066167934
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42618,0.00370674847524856,0.00382094427694624,-0.00378230230756607,0.0111957992580632,0.33200754911193
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,40482,-0.00367147804162623,0.00379698358740946,-0.0111135658729488,0.00377060978969631,0.333591751808166
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,0.00673863245334965,0.00697755874226621,-0.00693738268149213,0.0204146475881914,0.334183145956537
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.00391729560383213,0.0040591258410932,-0.00403859104471054,0.0118731822523748,0.334536667754055
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,42370,-0.00321324945728841,0.00333658305250933,-0.0097529522402067,0.00332645332562989,0.335547151749305
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,42311,-0.00384397682335588,0.00399394805625715,-0.0116721150136199,0.00398416136690813,0.335841158916268
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,0.00395102856132996,0.00413021756807243,-0.00414419787209201,0.0120462549947519,0.338782523690978
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,-0.00753364314945089,0.00787615194854437,-0.0229709009685978,0.00790361466969607,0.338833512978037
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,40383,-0.00299978207504163,0.00313798686439258,-0.00915023632925108,0.00315067217916782,0.33911436041078
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,0.00707328530869209,0.00744625783331633,-0.00752138004460791,0.0216679506619921,0.342178158692402
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42638,-0.00292125368478782,0.00307791187587154,-0.00895396096149603,0.00311145359192039,0.342585571661559
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,40302,0.00277848644590075,0.0029341149091091,-0.00297237877595309,0.0085293516677546,0.34368028359125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,40036,-0.00345720347864096,0.00365425756227636,-0.0106195483007026,0.0037051413434207,0.344131172798331
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,-0.00404654867933951,0.00429238593724106,-0.012459625116332,0.00436652775765297,0.345837357061744
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,40302,0.00343658738071371,0.00367471652354758,-0.00376585700543953,0.010639031766867,0.349706621511122
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,-0.0062341886544291,0.00669040997936093,-0.0193473922139765,0.00687901490511833,0.351455565569755
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,42370,0.00302292963509716,0.00324509098266579,-0.00333744869092778,0.0093833079611221,0.351591756687974
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,40532,0.0056552755993651,0.00607201857582378,-0.0062458808092495,0.0175564320079797,0.35168376679993
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.00729233097934241,0.00783333530923963,-0.0226456681854521,0.00806100622676726,0.351907398280993
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00618892355029645,0.00666721174070608,-0.00687881146148746,0.0192566585620804,0.353291825909398
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,0.00406339058459262,0.00438618975685843,-0.0045335413388499,0.0126603225080351,0.354255601477723
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,42346,0.00754691737003126,0.00818712068744437,-0.00849983917735971,0.0235936739174222,0.356647935058449
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,40223,0.0017495021827269,0.00189913130181835,-0.00197279516883707,0.00547179953429086,0.356960003493029
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.00520952009946866,0.005706534063595,-0.0163943268641149,0.00597528666517753,0.361313901709914
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,0.00258500955223444,0.00283793672870762,-0.0029773464360325,0.00814736554050139,0.362376652677147
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.00573384935764529,0.00631339192883698,-0.00664039882287518,0.0181080975381658,0.363790322971018
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,-0.00361124932691847,0.00397997266983791,-0.0114119957598008,0.00418949710596383,0.36423861834558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00596623962490459,0.00659899707578524,-0.0189002738934437,0.00696779464363447,0.3659554459328
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00313181892174658,0.00349041801576509,-0.00997303823264616,0.003709400389153,0.369598986271049
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,40434,-0.00553617608081839,0.00623080291972577,-0.0177485498034809,0.00667619764184412,0.374281576941176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00481286473664288,0.00542934801103517,-0.00582865736498606,0.0154543868382718,0.375392699471896
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,0.00291637585506019,0.0033104347116325,-0.00357207617973952,0.0094048278898599,0.37835623880396
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.00509041270820872,0.00580149225321586,-0.00628051210809437,0.0164613375245118,0.380267987251059
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.00560137488291373,0.00640533674225141,-0.0181558348977265,0.00695308513189904,0.381872753415776
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,40080,0.00599547961350785,0.00693852941682193,-0.00760403804346314,0.0195949972704788,0.387560203473481
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,40223,-0.00770560615852239,0.00894567684538849,-0.0252391327754838,0.00982792045843904,0.389048804129328
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,42357,0.00472453672829346,0.00550027295024764,-0.00605599825419192,0.0155050717107788,0.390375992050022
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,-0.00269691363704451,0.00314052508755972,-0.00885234280866155,0.00345851553457254,0.390499348958804
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,-0.0100514468755724,0.0117081413032988,-0.0329994038300381,0.0128965100788933,0.390634878986311
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00443069050299358,0.0051938795809968,-0.0146106944817473,0.00574931347576015,0.393644880928811
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.0076847109578788,0.00906427675396126,-0.0254506933956429,0.0100812714798853,0.396566577761107
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,0.00445252172178861,0.00527973177533875,-0.00589575255787534,0.0148007960014526,0.399065917530729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00392239311733641,0.00466214059364223,-0.0130601886808752,0.00521540244620237,0.400182150504209
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,-0.00561575029392268,0.00670102780706752,-0.018749764795775,0.00751826420792967,0.40202468329969
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,40136,0.00573266517152678,0.00685983461494035,-0.00771261067375631,0.0191779410168099,0.403350032193416
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.00676952711594611,0.00810815811603349,-0.0226615170233717,0.00912246279147952,0.403787368349046
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,0.00425802097581563,0.0051170705492572,-0.00577143730072848,0.0142874792523597,0.405359000558902
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,40136,-0.0053506487156804,0.00647131204600146,-0.0180344203258433,0.00733312289448247,0.408353750356023
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.00528904511607149,0.00639855871448475,-0.0178302201964616,0.00725212996431861,0.408482077682495
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,40198,0.00600536223492255,0.00727699024909553,-0.00825753865330469,0.0202682631231498,0.409245531134433
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,42459,0.00573284898696424,0.00694835408579051,-0.00788592502118517,0.0193516229951136,0.409349098861216
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,40451,-0.00293800207529257,0.00356154154769493,-0.00991862350877464,0.0040426193581895,0.409432063896513
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,-0.00612887950134888,0.00752556318023748,-0.0208789833346143,0.00862122433191658,0.415428388587577
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00321649972953135,0.0039583419984561,-0.0109748500465053,0.00454185058744261,0.416472239152502
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,42311,-0.00379603097011709,0.00467827044954286,-0.0129654410512211,0.00537337911098691,0.417140619768434
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,-0.00515410016515342,0.0063655584119436,-0.0176305946525629,0.00732239432225604,0.418135606275362
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,40080,0.00268391597865113,0.00331890126061256,-0.00382113049214949,0.00918896244945175,0.418719177314433
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,-0.00208341828860751,0.00258381960752191,-0.00714770471935044,0.00298086814213543,0.420065490531051
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,42357,-0.00276638935508696,0.00346077921724188,-0.00954951662088105,0.00401673791070713,0.424099323618269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41779,0.00415769766395628,0.00520812590949133,-0.00605022911864672,0.0143656244465593,0.424705828296196
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,-0.00380315257845458,0.00476962113595437,-0.0131516100049251,0.00554530484801598,0.42525028907493
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,-0.00588611992698836,0.00741475658971266,-0.0204190428428252,0.00864680298884846,0.427306519251239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,42370,0.00390697415480963,0.00493810147524224,-0.00577170473666515,0.0135856530462844,0.428847645384533
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.00294394017008739,0.0037352341692005,-0.0102649991417204,0.00437711880154559,0.430623751908176
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,40539,0.00596259579414553,0.00757625481925929,-0.00888686365160268,0.0208120552398937,0.431291873608084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00240471525980427,0.00306091580758095,-0.00359467972305439,0.00840411024266294,0.432107328678789
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.00533668209132719,0.00679716699202993,-0.00798576521305147,0.0186591293957058,0.432389539230368
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,0.0051094813422133,0.00651290876430523,-0.00765581983582495,0.0178747825202516,0.432751482413244
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,40482,0.0130852880668045,0.0166925619634311,-0.0196321333815205,0.0458027095151295,0.433115633617486
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,-0.00341376167319408,0.0043559408836278,-0.0119514058051046,0.00512388245871642,0.433231757606963
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42721,0.00517290037997353,0.00660759023499348,-0.0077779764806137,0.0181237772405608,0.43371572008532
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,40511,-0.00218530487207089,0.00279822606310336,-0.00766982795575348,0.00329921821161171,0.434841884490737
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,-0.00324300928714972,0.00416205729822808,-0.0114006415916768,0.00491462301737731,0.435887549084436
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,-0.00455802439304371,0.00589412855695077,-0.0161105163646672,0.0069944675785798,0.43934923968994
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,-0.00314791099043417,0.00408030671046709,-0.0111453121429497,0.00484949016208132,0.440430860495245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00608713710575429,0.00790384644093706,-0.00940440191848235,0.0215786761299909,0.441228313772284
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.0043034346568342,0.00560168270103135,-0.00667586343718724,0.0152827327508556,0.44236141119254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,40302,0.00450316037873107,0.00587239125636956,-0.00700672648375327,0.0160130472412154,0.443195391405457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42590,-0.00577270159809048,0.00757662529240321,-0.0206228871712008,0.0090774839750198,0.446127526926692
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.00393084605223253,0.0051757381898207,-0.00621360079981604,0.0140752929042811,0.447584590031074
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,40302,-0.00652695484358017,0.00867164497416155,-0.0235233789929368,0.0104694693057765,0.451659490949422
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,40182,-0.00708735004475488,0.00949766313729558,-0.0257027697938542,0.0115280697043444,0.455550247326721
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,-0.00181837082533963,0.00244010980916492,-0.00660098605130288,0.00296424440062362,0.456163653102489
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,42370,0.00220141589756028,0.00297943047658439,-0.00363826783654512,0.00804109963166568,0.459998266144445
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.00419882304532038,0.00568761512050878,-0.00694890259087682,0.0153465486815176,0.460384452838374
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,0.00364877685235496,0.00497691459716245,-0.00610597575808343,0.0134035294627934,0.463485664173111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,0.00371873781791081,0.00508619197580231,-0.00625019845466171,0.0136876740904833,0.464704571873908
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.00477255606647666,0.00653872130564516,-0.00804333769258786,0.0175884498255412,0.465472106897897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42594,-0.00705633783414761,0.00966850325469741,-0.0260066042133545,0.0118939285450593,0.465508499348953
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,40182,0.00369485585823486,0.00506638755648824,-0.0062352637524821,0.0136249754689518,0.465841030393676
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,-0.00166117195712606,0.00228053864988137,-0.00613102771089354,0.00280868379664142,0.466374007207682
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,0.00190954044523158,0.00263560181600261,-0.00325623911413354,0.00707532000459671,0.468763470579804
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,0.00349892751288182,0.00483608645872035,-0.00597980194621006,0.0129776569719737,0.469383088583028
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,-0.00435839709621053,0.00605784164969398,-0.0162317667296107,0.00751497253718966,0.471868085544539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,40451,0.00285784648187077,0.00399118082657195,-0.00496486793821025,0.0106805609019518,0.473981292350988
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,42357,-0.00459158345553434,0.00643238013677663,-0.0171990485236165,0.00801588161254785,0.475349044920558
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00431088641972209,0.00613639645515992,-0.00771645063239135,0.0163382234718355,0.482375523686297
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,42370,-0.00549855389828017,0.00786005397074366,-0.0209042596809378,0.00990715188437741,0.484216503079899
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,-0.00197669682943989,0.00283657971558435,-0.00753639307198522,0.00358299941310544,0.485905228577346
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.0196599024652656,0.0282720760549447,-0.0750731715329572,0.0357533666024259,0.486830374316266
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,-0.00553062686336028,0.00795760330114718,-0.0211275293336088,0.0100662756068882,0.487062653119297
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42699,-0.0111154604722737,0.0160457190836071,-0.0425650698761435,0.0203341489315962,0.488486637090964
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,-0.00349764637069221,0.00508071032508092,-0.0134558386078508,0.00646054586646639,0.491204965271157
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,40199,0.00210306474678102,0.00306012743583376,-0.00389478502745314,0.00810091452101518,0.491941296102755
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,40269,-0.00267424777410255,0.00389629049235941,-0.010310977139127,0.0049624815909219,0.492502135898787
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESPL1,Separin,40080,0.00412192325595325,0.00601216385962389,-0.00766191790890957,0.0159057644208161,0.492981689614631
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.00193704089316373,0.00285016295716139,-0.00752336028920006,0.0036492785028726,0.496753748764336
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,40482,-0.00271797164717835,0.00400836389196963,-0.0105743648754388,0.00513842158108214,0.49773799226332
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,-0.00357993427402846,0.00529115284054428,-0.0139505938414952,0.00679072529343832,0.498678874669105
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,0.00594693655359006,0.00884017225647379,-0.0113798010690986,0.0232736741762787,0.501141456931278
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,42357,0.00744475806050823,0.0110857256444914,-0.0142832642026948,0.0291727803237113,0.501874018653317
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,0.00699460650645447,0.0104409869736587,-0.0134697279619166,0.0274589409748255,0.502924141981031
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.00427657790149398,0.00640279663433704,-0.00827290350180663,0.0168260593047946,0.504196582596395
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,-0.00443222534126831,0.0066519805178479,-0.0174701071562502,0.00860565647371356,0.505231989880671
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,0.00146646041089483,0.00221562525522168,-0.00287616508933965,0.00580908591112932,0.50806461858807
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.00562416479019681,0.00851253488157498,-0.0223087331580838,0.0110604035776902,0.508823254334
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.00271709146152571,0.00411821238969413,-0.0107887877453262,0.00535460482227478,0.509412470696696
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.00493282646352798,0.0074770832495436,-0.0195879096326334,0.00972225670557746,0.509443083167998
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00537357245702218,0.0081451973274097,-0.0105910143047008,0.0213381592187452,0.509445612167808
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,0.00364626085982876,0.00555100400486995,-0.00723370698971634,0.0145262287093739,0.511281285299069
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00278765490946016,0.00427790784755479,-0.00559704447174723,0.0111723542906675,0.514644593319387
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,40482,-0.00150334801212687,0.00231896773653632,-0.00604852477573805,0.00304182875148431,0.516814932306589
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,0.00594583199220656,0.00917535587311733,-0.0120378655191034,0.0239295295035165,0.516984417655404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00318084380641441,0.00494294261801649,-0.0128690113377267,0.00650732372489792,0.51990509531404
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.001750154667802,0.00271992712089644,-0.00358090248915501,0.00708121182475902,0.519938977336125
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,-0.00439694369282261,0.00683833456438142,-0.0178000794390102,0.00900619205336496,0.520245343451019
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,-0.00475148891077794,0.00741300550669675,-0.0192809797039036,0.00977800188234769,0.521555252222689
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42636,0.0052765289817132,0.0082434792746495,-0.0108806903965998,0.0214337483600262,0.522128127695894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.00266492788100664,0.00416919763405148,-0.00550669948173427,0.0108365552437475,0.522709639363017
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,0.00206471392440246,0.0032374118830364,-0.00428061336634887,0.0084100412151538,0.523636566305879
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,0.0042662316395395,0.00670590620488956,-0.00887734452204403,0.017409807801123,0.524663526993265
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,42201,0.00177783028538807,0.00283675010282492,-0.00378219991614877,0.0073378604869249,0.530857890336296
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,40136,-0.00298734221196915,0.00478291420171827,-0.012361854047337,0.00638716962339865,0.532255701297348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,40080,-0.00245932821423038,0.00397345261147141,-0.0102472953327143,0.00532863890425359,0.535968927945814
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,-0.00261769250542072,0.00423053612594506,-0.010909543312273,0.0056741583014316,0.53608623500279
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.00551142315053763,0.00894773871185547,-0.0230489910257743,0.0120261447246991,0.537935649297931
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00231965138888967,0.00378801521291779,-0.00510485842842919,0.00974416120620853,0.540308361898487
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,0.00217858314482099,0.00356243757542079,-0.00480379450300375,0.00916096079264574,0.540850742528902
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,-0.00185420121176201,0.00304171511784157,-0.00781596284273148,0.00410756041920747,0.542143540396466
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00234013596157879,0.00384901455661477,-0.00520393256938617,0.00988420449254374,0.543211220866629
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.00289757945624473,0.00481239644352861,-0.0123298764855608,0.00653471757307135,0.547113036132986
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,40199,-0.00460160475703056,0.00766500106631988,-0.0196250068470175,0.0104217973329564,0.548292200254212
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,0.00255810777497471,0.0042613884670264,-0.00579421362039704,0.0109104291703464,0.548319355621647
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00172862572843375,0.00288055404055717,-0.0039172601910583,0.00737451164792579,0.548448454697939
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,-0.00267889030554781,0.00447043743624023,-0.0114409476805787,0.00608316706948305,0.549021422279468
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.00173574251946075,0.00289878208861061,-0.00394587037421604,0.00741735541313753,0.549329424037668
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00219151994452763,0.00366066899217636,-0.0093664311691933,0.00498339128013804,0.549405593174897
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,40302,-0.00336736765674777,0.00568050130278279,-0.014501150210202,0.00776641489670651,0.553331024379213
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TTN,Titin,40116,0.00405512275950649,0.0068563524447851,-0.00938332803227231,0.0174935735512853,0.554237723044924
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,40532,0.00137605201128525,0.00233169456635933,-0.00319406933877903,0.00594617336134954,0.555101143110229
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.0069314184972526,0.0118508071566282,-0.0301590005242439,0.0162961635297387,0.558631703995607
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,40302,0.00329709135682076,0.0056824448853996,-0.00784050061856246,0.014434683332204,0.561775286201941
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EPGN,Epigen,40451,-0.00275474139955439,0.00475066117788671,-0.0120660373082123,0.00655655450910357,0.562017370718875
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,40116,-0.00511738706267045,0.00885247982708134,-0.0224682475237499,0.012233473398409,0.563226181584489
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,40116,-0.00260071753822786,0.00453796243865619,-0.011495123917994,0.00629368884153826,0.566587105088366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,40451,-0.00463110128780739,0.00809485528856448,-0.0204970176533938,0.011234815077779,0.567262759608768
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,0.00294885439731853,0.00520953904911758,-0.00726184213895192,0.013159550933589,0.571372027107085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,-0.0043319507336848,0.00768769202844625,-0.0193998271094395,0.0107359256420699,0.573111583958271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.0029753590225839,0.00528387314193479,-0.00738103233560829,0.0133317503807761,0.573377092752771
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,40199,0.00274826666243704,0.00489008217513118,-0.00683629440082007,0.0123328277256941,0.574121824936389
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,-0.0022045568039707,0.00393445899113486,-0.00991609642659502,0.00550698281865361,0.575272178209381
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00644577144438602,0.0115157364388138,-0.0161250719756891,0.0290166148644611,0.575671049529737
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00238124863574864,0.0042628181204883,-0.00597387488040844,0.0107363721519057,0.576438120829887
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.00492593700161638,0.00884802385965258,-0.0222680637665354,0.0124161897633027,0.577725013892579
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,40199,0.00334048536942772,0.00601216808478608,-0.00844336407675299,0.0151243348156084,0.578481434646514
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.00382453256788983,0.00689794387941715,-0.00969543743576779,0.0173445025715474,0.579285520713348
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,0.00311856460194174,0.00564675257613385,-0.0079490704472806,0.0141861996511641,0.580770711901997
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,-0.00727744506005233,0.0132071767561718,-0.0331635115021491,0.0186086213820444,0.581627947691237
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,40286,-0.0057315728090157,0.0104091587121221,-0.026133523884775,0.0146703782667436,0.58189989399805
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,0.00396960315609258,0.00726628017954669,-0.0102723059958189,0.0182115123080041,0.584867651527981
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.00518666600784073,0.00949602250130238,-0.0134255380947119,0.0237988701103934,0.584944052160923
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,0.00313095006444241,0.00573787822420589,-0.00811529125500114,0.014377191383886,0.585308467405084
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00329786177656344,0.00605240747687597,-0.00856485687811345,0.0151605804312403,0.585844260894849
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,-0.00201042314252014,0.0036977192446627,-0.00925795286205903,0.00523710657701874,0.586661956217487
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,42346,0.00303138380446045,0.00561781773556709,-0.00797953895725105,0.0140423065661719,0.589480903136142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.00540873003554877,0.0100628834917028,-0.0143145216081887,0.0251319816792862,0.590938064393757
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,-0.00206948426647699,0.00385354529532463,-0.00962243304531326,0.00548346451235928,0.591254775096669
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,0.00198130248995036,0.00370434636248235,-0.00527921638051504,0.00924182136041577,0.592756489389965
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,-0.00515599797302698,0.00965736919518829,-0.024084441595596,0.0137724456495421,0.593426741751057
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,40539,-0.00107971028167901,0.00202499090093737,-0.00504869244751626,0.00288927188415824,0.593910667509357
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,42311,-0.00317447031435597,0.00606789186746983,-0.0150675383745968,0.0087185977458849,0.60087266851307
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,-0.00308308622743414,0.00590921944090751,-0.0146651563316129,0.00849898387674458,0.601858952769886
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,-0.00322390724883061,0.00618451591672683,-0.0153455584456152,0.00889774394795397,0.602177481131175
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,40080,-0.00336085674219409,0.00645873706324404,-0.0160199813861524,0.00929826790176423,0.602824525994798
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,40116,0.00244067985057096,0.00473721968816797,-0.00684427073823826,0.0117256304393802,0.60641421699667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,40080,0.00221775173921299,0.00431201072415392,-0.00623378928012869,0.0106692927585547,0.607038983568432
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,-0.00302294150164393,0.00589215037550902,-0.0145715562376416,0.00852567323435374,0.607927919380655
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,-0.00340620928969135,0.00664469767279467,-0.0164298167283689,0.00961739814898621,0.608226893177526
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,40483,0.00226335820175587,0.00441690631495903,-0.00639377817556382,0.0109204945790756,0.608359665428835
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,42357,0.00381130258344219,0.00745788402506192,-0.0108061501056792,0.0184287552725636,0.60932922205126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.00214392621105383,0.0042094522714863,-0.010394452663167,0.00610660024105933,0.61054183990817
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,42346,-0.00555622614976129,0.011001688450171,-0.0271195355120965,0.0160070832125739,0.613543454707758
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00123626727533022,0.00247747706552906,-0.00609212232376717,0.00361958777310673,0.617787339651504
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,0.00163621087689071,0.00329693345531649,-0.0048257786955296,0.00809820044931103,0.619705024651264
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,0.00268054151513694,0.00544018134894508,-0.00798221392879541,0.0133432969590693,0.622213204141151
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,0.00151209232163249,0.00308810937329602,-0.00454060205002772,0.00756478669329269,0.624391447825496
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,-0.00333762290652223,0.00696541931891937,-0.0169898447716042,0.0103145989585597,0.631825383161528
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00130299072356505,0.00272378537817311,-0.00664161006478436,0.00403562861765425,0.632392615714616
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,0.00207840714353141,0.00435440332230221,-0.00645622336818092,0.0106130376552437,0.633149742702894
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,40116,-0.0023358645299531,0.00494453402520558,-0.012027151219356,0.00735542215944984,0.636641122779678
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.00174828376761841,0.00370314701546592,-0.00900645191793162,0.0055098843826948,0.636859156748704
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,40451,-0.00130080628840445,0.00275737455208416,-0.0067052604104894,0.00410364783368051,0.637110544192521
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,0.00389484146303404,0.00833715724367216,-0.0124459867345634,0.0202356696606315,0.640388230814557
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,40136,0.0018143301828808,0.00388960165711806,-0.00580928906507059,0.00943794943083219,0.640898025529467
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42721,-0.00120198760468244,0.00258619232466565,-0.00627092456102711,0.00386694935166222,0.642102824116686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,40302,0.00297266768166765,0.00643263438749135,-0.00963529571781539,0.0155806310811507,0.64400223706518
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,0.00208836520541243,0.0045340960108155,-0.00679846297578595,0.0109751933866108,0.645100866500481
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,-0.0058675368179874,0.0127807970894555,-0.0309178991133201,0.0191828254773454,0.64617708620748
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42495,0.000562168956164694,0.00124627185410286,-0.0018805238778769,0.00300486179020629,0.651938870399544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,40483,0.00486779537281003,0.0107926372136397,-0.0162857735659237,0.0260213643115438,0.651977110469517
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00230220640174146,0.00511254717673201,-0.00771838606465328,0.0123227988681362,0.652499285423403
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,40116,0.00243719059553415,0.00544413855340566,-0.00823332096914094,0.0131077021602092,0.654398518916024
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,-0.00182253253743363,0.00407464336073595,-0.00980883352447609,0.00616376844960884,0.654677188496729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,0.00193749954789249,0.00434228307037682,-0.00657337527004608,0.0104483743658311,0.655464607036083
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42654,-0.00149090098284763,0.00336505673532766,-0.00808641218408984,0.00510461021839458,0.657733982409197
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.00189488966938926,0.00427987707967627,-0.00649366940677623,0.0102834487455547,0.657959666736302
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,40483,-0.00103762533312944,0.0023581008488005,-0.00565950299677843,0.00358425233051955,0.659926808233189
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,-0.00342651098285625,0.00783375481830692,-0.0187806704267378,0.0119276484610253,0.661827323315637
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.00128962067230269,0.00296953172573153,-0.00710990285473649,0.0045306615101311,0.664090599223389
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,40527,-0.00406913945516676,0.00942213873037918,-0.02253653136671,0.0143982524563764,0.665844084771291
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BSND,Barttin,40080,-0.00148941472179164,0.00356837207056323,-0.00848342398009556,0.00550459453651229,0.676398959897649
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00272858984708824,0.00661688492548795,-0.0156976843010446,0.0102405046068681,0.680077866610357
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.00366383253073981,0.0089105290025842,-0.0138008043143252,0.0211284693758048,0.680947151872072
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,0.00208039232055054,0.00507981491763651,-0.00787604491801702,0.0120368295591181,0.682150739340979
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,0.00155659395917923,0.00380854821731733,-0.00590816054676273,0.00902134846512119,0.682759800418224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.00154801043625879,0.00379741567404812,-0.00589492428487554,0.00899094515739311,0.683538258390424
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42711,0.00125195459700325,0.0030750797367054,-0.00477520168693933,0.00727911088094582,0.683919582135543
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,40527,0.00183816674745474,0.00451783614740586,-0.00701679210146074,0.0106931255963702,0.68411200735759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.00598112377470947,0.0148045792176546,-0.0349980990413126,0.0230358514918936,0.686216678087063
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00205753951875376,0.005125731807233,-0.0121039738609304,0.00798889482342292,0.688121854454282
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,0.00145185090393728,0.00362651952235651,-0.00565612735988148,0.00855982916775604,0.688911893498764
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00238090531648745,0.00595381536432684,-0.0140503834305681,0.00928857279759316,0.689241126468505
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,-0.00528085672876703,0.0132388760508737,-0.0312290537884794,0.0206673403309454,0.689980477739902
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,-0.00231054932045492,0.00580813878110972,-0.01369450133143,0.00907340269052014,0.690776059998056
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,40136,0.00256296745462499,0.00652067482092778,-0.0102175551943935,0.0153434901036434,0.694288372849639
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,0.0017486830707316,0.00445763415274408,-0.00698827986864679,0.01048564601011,0.694852001310254
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,-0.00155288772450981,0.00397011846264456,-0.00933431991129315,0.00622854446227353,0.69569844054566
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,40136,-0.00232196932325919,0.00596009436556159,-0.0140037542797599,0.00935981563324153,0.696850288323437
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,40302,-0.000949527310245698,0.00244483347385625,-0.00574140091900395,0.00384234629851255,0.697741412422061
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,40116,0.00155604140298282,0.00401371285292664,-0.0063108357887534,0.00942291859471904,0.698259453302982
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00170697729833372,0.00443413232606593,-0.00698392206075551,0.0103978766574229,0.700272198601309
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,0.00172453275012145,0.00452017565714716,-0.00713501153788698,0.0105840770381299,0.702825607533779
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.00167412590243223,0.00438826935218627,-0.00692688202785286,0.0102751338327173,0.702839454330564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,-0.00317970772164083,0.00834196294957476,-0.0195299551028074,0.0131705396595257,0.703084246674239
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,0.00283543478339856,0.00744294024107986,-0.011752728089118,0.0174235976559151,0.703243090383087
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARTN,Artemin,42370,-0.00176753235424833,0.00464955544025128,-0.0108806610171408,0.00734559630864418,0.703839584527231
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,0.00102952481925341,0.00273276436431153,-0.00432669333479718,0.00638574297330401,0.706378752955539
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00141117901566314,0.00375727743072936,-0.00595308474856641,0.00877544277989269,0.707231110905877
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,42346,0.00650922856180045,0.0173662521243461,-0.0275286256019179,0.0405470827255188,0.707799956815515
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,40337,0.00133275327150121,0.0035751673003495,-0.00567457463718382,0.00834008118018623,0.709318778817567
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,42370,0.00180682135285719,0.00485914035822272,-0.00771709374925934,0.0113307364549737,0.710018173676392
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,-0.00239943656131066,0.00646245707141248,-0.0150658524212791,0.0102669792986578,0.710429785447739
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,-0.00294965657303317,0.00803655963024671,-0.0187013134483167,0.0128020003022504,0.713603951722483
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,-0.0011984783276197,0.00329336597648188,-0.00765347564152419,0.00525651898628478,0.715933317857447
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,0.00183409791770405,0.00504407408246652,-0.00805228728393033,0.0117204831193384,0.716153017821878
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.00159734325715972,0.00446568324971937,-0.0103500824266097,0.00715539591229025,0.720579980805139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00223220944515448,0.00626422841155787,-0.0145100971318079,0.0100456782414989,0.72159113157142
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,-0.00163160962998153,0.0045829146838271,-0.0106141224102827,0.0073509031503196,0.721832203921583
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.0013917124159933,0.00394223987181065,-0.00633507773275557,0.00911850256474217,0.72407580283735
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,40302,0.00635246990168286,0.0180344857427496,-0.0289951221541065,0.0417000619574722,0.724664853547098
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.000941844034965074,0.00267487673397988,-0.00618460243356564,0.0043009143636355,0.724764406334126
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,0.00296926661027933,0.00843954661077423,-0.0135722447468382,0.0195107779673968,0.724974272789593
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,42346,0.00305166006691678,0.00876864002258283,-0.0141348743773456,0.0202381945111791,0.727830907420085
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,0.0010395797628423,0.0030125544351179,-0.00486502692998878,0.00694418645567338,0.730037819061639
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,42357,0.000988276788803914,0.00287816333881741,-0.00465292335527822,0.00662947693288604,0.731325127785431
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42636,0.00420552258334067,0.0122707104070469,-0.0198450698144713,0.0282561149811526,0.73180805380048
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,40482,-0.001287833858971,0.00379388503193829,-0.00872384852157005,0.00614818080362805,0.734277154959464
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,0.00258397287292558,0.00761242732403469,-0.0123363846821824,0.0175043304280336,0.734283761124148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,-0.0018018134461524,0.00538326437408077,-0.0123530116193507,0.00874938472704592,0.737852964593846
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,40065,0.00142593903905719,0.00430743875250147,-0.0070166409158457,0.00986851899396008,0.740619860507081
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,-0.00123464360026067,0.00373814148724917,-0.00856140091526905,0.00609211371474771,0.741192659185187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,0.000977583969147977,0.00302102402817663,-0.00494362312607822,0.00689879106437417,0.746250860932554
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00193714386938386,0.00598662606893188,-0.00979664322572262,0.0136709309644903,0.746263313944748
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,40199,-0.00197425110311023,0.00617267656300186,-0.0140726971665939,0.0101241949603734,0.749097877244156
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,40080,-0.00248391291703065,0.00780706630661374,-0.0177857628779936,0.0128179370439323,0.750368053322304
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00184748720497654,0.00580695565725421,-0.00953414588324171,0.0132291202931948,0.750376703973564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42595,0.00435785062918663,0.0137107577068256,-0.0225152344761916,0.0312309357345649,0.750609964848975
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.00290596377542737,0.00915188055123342,-0.0208436496558449,0.0150317221049901,0.750850227316604
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.00180414336244989,0.00574010140670964,-0.009446455394701,0.0130547421196008,0.753295121166723
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,0.0013448947872499,0.00429068624137661,-0.00706485024584825,0.00975463982034806,0.753948427681822
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,-0.000720168015733835,0.00229869860700031,-0.00522561728545445,0.00378528125398678,0.754063399306722
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,40509,-0.00116591460882078,0.0037762554993208,-0.00856737538748954,0.00623554616984799,0.757518251933645
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,-0.00084192895283138,0.00276799071291719,-0.00626719075014907,0.0045833328444863,0.761007171718294
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,42370,0.00292728778203997,0.00974140216269037,-0.0161658604568332,0.0220204360209131,0.763800816794702
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,42370,0.00157020025102966,0.00525639113566719,-0.00873232637487805,0.0118727268769374,0.765156796474013
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,-0.00180248566234939,0.00606655651224275,-0.0136929364263452,0.0100879651016464,0.766381744847752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,-0.00166875720729646,0.00580781241565894,-0.013052069541988,0.00971455512739507,0.773865254350965
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,40182,0.00125130118217016,0.00436832703037901,-0.00731061979737269,0.00981322216171302,0.774539952943729
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,42357,-0.00420078225667935,0.0147549852643733,-0.033120553374851,0.0247189888614923,0.775876498658891
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.000885904763450083,0.00313299712623499,-0.00525476960397049,0.00702657913087066,0.777361457198427
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00126873896854717,0.00458256011968185,-0.0102505568031236,0.00771307886602927,0.781890853402034
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00223416496272926,0.0082047150236666,-0.0138470764836573,0.0183154064091158,0.785394499047139
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,40136,-0.00206817945160297,0.00762263396176059,-0.0170085420166537,0.0128721831134478,0.786149397488361
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.000918152921548619,0.00340263855752479,-0.00575101865119997,0.00758732449429721,0.787291852838667
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42711,-0.00209363793791735,0.00777608384450791,-0.0173347622731529,0.0131474863973182,0.787748603272922
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,-0.00307941373785447,0.011457610259529,-0.0255363298465313,0.0193775023708224,0.788114813664303
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,-0.000908290632919187,0.00338074947076863,-0.00753455959562571,0.00571797832978734,0.788191342837248
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00184394488370221,0.00699859734542138,-0.0155611956807281,0.0118733059133237,0.79219053914765
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,40479,0.00129565238445476,0.00497771985635932,-0.0084606785340095,0.011051983302919,0.794644573749443
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,40199,-0.00264490279928547,0.0102149128062678,-0.0226661318995703,0.0173763263009994,0.795697460183271
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,40182,-0.00173135490163504,0.00676469359932099,-0.0149901543563042,0.0115274445530341,0.79800204728231
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0011593125037365,0.00460452289072676,-0.00786555236208795,0.0101841773695609,0.801218203830449
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,-0.00147100604258797,0.00600150536260984,-0.0132339565533033,0.0102919444681273,0.806378043447869
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,0.00120839190286414,0.00498535672495196,-0.0085629072780417,0.01097969108377,0.808483902643752
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,40421,-0.00178605267594839,0.00750532492019644,-0.0164964895195334,0.0129243841676366,0.811907619556716
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00155064092601603,0.0066190953220167,-0.0114227859051367,0.0145240677571688,0.814781484737493
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.000918456812700043,0.00394274164361403,-0.00680931680878346,0.00864623043418355,0.815805392711474
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00138114682839238,0.00600033774979758,-0.0131418088179956,0.0103795151612109,0.817957640767804
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,40080,-0.000741670921468181,0.00326633170996885,-0.00714368107300712,0.00566033923007076,0.820377150701911
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,40199,0.00131831867770392,0.00584390558890652,-0.0101357362765529,0.0127723736319607,0.821525570911171
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,0.00212620935344809,0.00951635204617751,-0.0165258406570598,0.020778259363956,0.823207415275196
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,40080,-0.00155242998791916,0.00696776563941875,-0.0152092506411799,0.0121043906653416,0.823694029615907
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,0.00165862764762235,0.00747919041897219,-0.0130005855735631,0.0163178408688078,0.824500454253717
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,0.00129368463607099,0.0058423225972301,-0.0101572676545,0.012744636926642,0.824759199134937
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42651,-0.000806261201747053,0.00365273718432376,-0.00796562608302161,0.00635310367952751,0.825307613451426
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,40199,0.000968203779903173,0.00441163597334856,-0.00767860272786,0.00961501028766635,0.826291189202465
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,0.00106034842926882,0.00494783067036451,-0.00863739968464563,0.0107580965431833,0.830311888020544
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,42292,0.000780568120578342,0.00364990665793119,-0.00637324892896679,0.00793438517012347,0.830659758731457
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,-0.00185264580303014,0.00867320361100601,-0.0188521248806019,0.0151468332745416,0.830858474370919
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,0.00165536036721345,0.00781848650354934,-0.0136688731797433,0.0169795939141702,0.832326272412522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,-0.00115402156929243,0.00547566936018095,-0.0118863335152471,0.00957829037666223,0.833082831850685
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,-0.00155418203418953,0.0074424502873639,-0.0161413845974228,0.0130330205290437,0.834587429514853
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,0.00134080878700537,0.00642386810747283,-0.0112499727036414,0.0139315902776521,0.834668375761928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,40199,-0.000716956190116282,0.0035084102895013,-0.00759344035753884,0.00615952797730628,0.838080984205761
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.000967699794073225,0.00476023861294565,-0.0102977674754467,0.00836236788730024,0.838912916449113
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.000832987374415635,0.00412093191562113,-0.00724403918020178,0.00891001392903304,0.839814314908438
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.00204411110091215,0.0101917430993009,-0.0179317053737175,0.0220199275755418,0.841042137315878
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,-0.000827887983872024,0.00417352075120837,-0.00900798865624042,0.00735221268849637,0.842761742001553
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00119410528138499,0.00602783567839447,-0.0106204526482682,0.0130086632110382,0.842971687630628
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,-0.00178989733062566,0.00919150179962153,-0.0198052408578839,0.0162254461966325,0.845604864706762
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,-0.00101205852937306,0.00522024921365649,-0.0112437469881398,0.00921962992939366,0.846279951175923
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,42346,0.00175802259647585,0.00915748446917944,-0.0161906469631159,0.0197066921560676,0.847763510445392
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,-0.000756801660340747,0.0039493018887616,-0.00849743336231348,0.00698383004163199,0.848036210723014
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.000568209240531896,0.00297968134810195,-0.00640838468281171,0.00527196620174792,0.848768258169943
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,40080,-0.000920675657720984,0.00482817306729763,-0.0103838948696243,0.00854254355418238,0.848773435705131
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00138735547878896,0.00748767025688411,-0.0132884782247039,0.0160631891822818,0.853008661038928
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00030714022389021,0.00165807246240927,-0.00294268180243196,0.00355696225021238,0.853044088134554
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42594,0.001181177910572,0.00640552375872266,-0.0113736486565244,0.0137360044776684,0.853702542356556
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,42370,0.000949002966964134,0.00535446697249354,-0.0095457522991232,0.0114437582330515,0.859325940416743
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00176088279491809,0.00999246745679858,-0.0213461190102433,0.0178243534204071,0.860123575762027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,40116,-0.00084603456449146,0.00481982484638276,-0.0102928912634017,0.00860082213441874,0.860664708388467
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,-0.0011270962829646,0.00653728870760467,-0.0139401821498697,0.0116859895839405,0.86311813508706
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,0.000637626403535554,0.00387419897933346,-0.00695580359595803,0.00823105640302913,0.869275339917951
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,40199,0.000550529292347908,0.00335164821620837,-0.0060187012114205,0.00711975979611632,0.869532408460381
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,40080,0.000723220630989169,0.00441918663609536,-0.00793838517575774,0.00938482643773608,0.870006024595137
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,0.000989599737689162,0.00611237694740731,-0.0109906590792292,0.0129698585546075,0.871386830732644
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.000804030116252731,0.00497073196148565,-0.00893860452825914,0.0105466647607646,0.871503467508187
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,-0.00086700816586228,0.00542963497160412,-0.0115090927102064,0.00977507637848179,0.873135020367552
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.00158687428873336,0.0101276921795897,-0.0182634023832625,0.0214371509607292,0.875494144473146
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,40080,-0.000733154099536407,0.00468837714844542,-0.00992237331048943,0.00845606511141661,0.875738807899562
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42654,-0.00133665368856363,0.0086071508142296,-0.0182066692844536,0.0155333619073264,0.876590517747635
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,0.000606987642370267,0.00394209231434015,-0.00711951329373644,0.00833348857847697,0.877631496697684
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.000535674641882032,0.00354561993464456,-0.00748508971378537,0.0064137404300213,0.879914869247182
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,40116,-0.000526728549322697,0.00352172511036637,-0.00742930976564077,0.00637585266699538,0.881110196719804
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,40482,0.00073721039822097,0.00500163798311235,-0.00906600004867924,0.0105404208451212,0.882823836158772
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,0.00094631307325609,0.00654388118991379,-0.0118796940589749,0.0137723202054871,0.885021173386224
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,40182,0.000518928009608531,0.00361003110317284,-0.00655673295261024,0.0075945889718273,0.885703576941522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,0.000495871304252236,0.00349498938914255,-0.00635430789846716,0.00734605050697163,0.887176893905593
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NEB,Nebulin,40116,-0.000568188503665269,0.00401157733587819,-0.00843088008198653,0.00729450307465599,0.887369209377686
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,-0.000704089613688639,0.00502783724144612,-0.010558650606923,0.00915047137954575,0.888631900040966
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,40199,0.000597742333190959,0.00433133297106089,-0.00789167029008839,0.00908715495647031,0.890239588081463
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.000782632206954725,0.00572516794162626,-0.0120039613725422,0.0104386969586327,0.891270188565653
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,-0.00246244182045407,0.0190532293668251,-0.0398067713794312,0.0348818877385231,0.897169587323854
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,40429,-0.000713342830536687,0.00557202875933351,-0.0116345191988304,0.010207833537757,0.89813377394634
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,40199,0.00038866176933003,0.0030386925427818,-0.0055671756145223,0.00634449915318236,0.898227064207723
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,C7,Complement component C7,40251,0.000431517901001428,0.00343522185206037,-0.0063015169290369,0.00716455273103976,0.900038394554588
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,-0.000535973554080344,0.00427476011541613,-0.00891450338029596,0.00784255627213527,0.900224188475002
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.000476906569699701,0.00386810584513944,-0.00710458088677361,0.00805839402617301,0.901878109104091
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.000823959807088238,0.00687040136377298,-0.0126420268659068,0.0142899464800833,0.904541624846324
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,42311,0.00058165010075043,0.00494252810739839,-0.00910570498975042,0.0102690051912513,0.906320869038498
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.000658583862379291,0.00562920952784451,-0.0116918345369545,0.010374666812196,0.906866938045115
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,-0.000605332341069776,0.00525803369589218,-0.0109110783850185,0.0097004137028789,0.90834797429975
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,DCN,Decorin,42357,0.000282838011234584,0.00250683626477095,-0.00463056106771647,0.00519623709018564,0.910169686921926
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42594,0.000670537008123248,0.00617252052022951,-0.0114276032115266,0.0127686772277731,0.913495522109955
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,-0.000461449535451392,0.00434255984065593,-0.00897286682313701,0.00804996775223423,0.915375990402706
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,40461,0.000259217110536036,0.00249811496729258,-0.00463708822535743,0.0051555224464295,0.917357622273977
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.000553384977142212,0.00540914922569986,-0.0111553174595139,0.0100485475052295,0.918516165108027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,42370,0.000346233597902444,0.00340498257729999,-0.00632753225360553,0.00701999944941042,0.91900873514269
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,40199,-0.000278145971296042,0.00277671788057022,-0.00572051301721368,0.0051642210746216,0.920210575202679
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-0.000379026911826972,0.00384642279464434,-0.00791801558932989,0.00715996176567594,0.921505204564167
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000301006644361544,0.0030946371552464,-0.0057644821799214,0.00636649546864448,0.922515694490516
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.000746636400551526,0.00799939192271265,-0.0149321717679653,0.0164254445690683,0.925637782029533
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.000540530521313664,0.00587394272467178,-0.010972397219043,0.0120534582616704,0.926682439109037
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.000629833345308981,0.00730605354748307,-0.0136900316077578,0.0149496982983758,0.931303093167103
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,0.000742237020225205,0.00878681787600785,-0.0164799260167502,0.0179644000572006,0.932682986191245
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,-0.000308015848630832,0.00368567706633715,-0.00753194289865164,0.00691591120138998,0.933399016756347
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,-0.000375805789887207,0.00475094200832702,-0.00968765212620817,0.00893604054643375,0.936953239261863
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,40116,0.000419326426446119,0.0053909587074133,-0.0101469526400839,0.0109856054929762,0.938001875177359
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,0.000398855648973051,0.00513375859521228,-0.00966331119764301,0.0104610224955891,0.938073673334581
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42629,-0.00140483202173998,0.0193018524334124,-0.0392364627912282,0.0364267987477483,0.941980488767148
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.000249604618816189,0.00358909169654462,-0.00678501510641126,0.00728422434404364,0.9445568141026
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,0.000249142544541242,0.00408288913839661,-0.00775332016671611,0.00825160525579859,0.951343299654499
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,0.000666767409494327,0.0110946564967535,-0.0210787593241425,0.0224122941431312,0.952078590664415
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.000348975620657619,0.00610498283599256,-0.012314741979203,0.0116167907378878,0.954416668707241
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,40199,-0.000322534365704921,0.00577623854452999,-0.0116439619129837,0.0109988931815739,0.955471771665366
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,-0.000151229765972039,0.00305774947630868,-0.00614441873953705,0.00584195920759297,0.960555188045324
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,-0.000377977083234437,0.00774792095536549,-0.0155639021557508,0.0148079479892819,0.961092065619019
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.000184115142093157,0.00396563244239568,-0.00795675472918868,0.00758852444500237,0.962970216477459
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.000302695578051512,0.0065703395095227,-0.012575169860613,0.013180561016716,0.9632552808379
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,-0.000227084363043149,0.0051139345375962,-0.0102503960567317,0.0097962273306454,0.964582366233342
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,42311,0.000237240303023018,0.0055461170124072,-0.0106331490412951,0.0111076296473411,0.965880804032233
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,-0.000138934782515395,0.00337454725465008,-0.00675304740162955,0.00647517783659876,0.967159892808298
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.000335597765682026,0.00841250932647427,-0.0168241160455716,0.0161529205142075,0.968179382759522
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,40080,-0.000163465911312663,0.00444957851072383,-0.00888463979233138,0.00855770796970605,0.97069506762111
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.000282727232815105,0.00777427077475926,-0.0155202979513432,0.014954843485713,0.970990356751504
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.000178130989550811,0.00539233396590583,-0.0107471055627262,0.0103908435836246,0.973647983811074
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,-0.000116834574797289,0.00375908348380923,-0.00748463820306338,0.0072509690534688,0.975205809647913
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,-9.36353047429199e-05,0.00301595229214725,-0.00600490179735153,0.00581763118786569,0.975232772161217
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,42370,0.000130139225569432,0.00455572917870295,-0.00879908996468835,0.00905936841582721,0.977211115172566
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,40080,0.000138699398305365,0.00499701688544867,-0.00965545369717403,0.00993285249378476,0.977856917365759
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,40199,0.00010389709942787,0.0039097768467798,-0.00755926552026054,0.00776705971911628,0.97880026009856
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,-5.44870828570916e-05,0.00267845886556722,-0.00530426645936884,0.00519529229365466,0.983770296176027
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.000100768410997142,0.00501743439536698,-0.00973340300392214,0.00993493982591642,0.983977007450664
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-6.91500577948486e-05,0.00361541571307456,-0.00715536485542099,0.0070170647398313,0.984740583986806
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,40302,-7.01098754120552e-05,0.00428812242813308,-0.00847482983455289,0.00833461008372878,0.98695563459564
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,-0.00028853671513129,0.0182749276238986,-0.0361073948579726,0.03553032142771,0.987403270966016
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,-6.14481500753111e-05,0.00438179797990672,-0.00864977219069249,0.00852687589054187,0.988811479993697
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,40136,-6.38169052335094e-05,0.00526054525288652,-0.0103744856008911,0.0102468517904241,0.990321134289574
NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,HLA_A,,40482,-2.7300486072461e-05,0.00346268912957396,-0.00681417118003743,0.00675957020789251,0.993709534001345
